var title_f32_41_33424="AML FAB M3 Faggot cell";
var content_f32_41_33424=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F73965&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F73965&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute promyelocytic leukemia (M3)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 416px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bone marrow aspirate from a patient with the hypergranular promyelocytic variant of AML (FAB classification M3). (Wright-Giemsa stain). The cell in the top center and far left are \"faggot\" cells, with numerous intertwining Auer rods (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Brunning, RD, McKenna, RW. Tumors of the bone marrow. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 9, 1994, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33424=[""].join("\n");
var outline_f32_41_33424=null;
var title_f32_41_33425="SIS endometrial polyp2";
var content_f32_41_33425=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F71802&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F71802&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sonohysterogram of an endometrial polyp",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 387px; height: 265px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEJAYMDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDidM+Lmiy6Xqj69Z65Lq892v2dotQkKQWW5C1urM2cfKeoOcjpiux1L40fDbUPOiv/AA34gu4JVCOtxeMwkVTuAKmQggHnHrXy2evFGaDL2SPYNN+L8Wh61qzaXpM82kyuV0+2n1GeL7FDkny1CNjBJzirtn8aNN+2+bd+Drfy/s/2d3i1G58wxjlEyX+4GwcdOuK8RzRmgfs0es6v8WrDWL/7Xq/gfRb+fZtMl1c3Ern/AIEzk49veqv/AAsrQAMJ8NvDKj03z/8AxVeYE5ooHyR7Hp5+JWiDp8OfC3Tv55/9nqex+Jnh0XA+2fDjw2YADxD5obdg7eS+MZxn2rymjvQHJE9OHxN0vbz8PPCOf+uc3P8A5Epp+Jul4x/wrnwb/wB+Jv8A45XmdFA+Rdj0v/hZ+n5yPh14L/8AAWb/AOOVYsvilo6XGbz4ceD3g2MNsVtIrbsfKclyMZxkY59q8rpfxosDgux6anxUtQAf+FeeB93r9hl/+OUf8LUtg3yfD7wKPUnT5D/7UrzKlUFiAoJJ4AHegXJHsenr8WIuMeAPAvXp/Zz/APxyur+Hni678Va8tlYfDPwdfgoQRDY+SI2IwrO7MQFB6jqRwK5f4e/C2XVZLe98SNLa6c6llhiI8+TBxzn7o9zz7V7f4bsbPw/LJZ2NrFbaQ5WSCNDyZF+7vb+JvXNNROWpUgtIohubKbSLa4t9Q8L+Bpr4ZUNDpW2NXA4XBbJyeM15JrnxJvdJvnt7jwT4GU9Vzo/b8W7V9JeJLJfE2npfRRRrO5BubdOSNnQg9c145498GjxBcM2xftrgtjGPM7Bgeit6joaprsZQqJP3tjz4/Fy6LceD/BGP+wMv/wAVW74G+Kdrf+LdKtfEnh7wZZaPLNsuZ49HRTGmD0POOcdq821vwfqulSlZYHZcZ4GCB7isCWNo2KupVh2IwajY7EoSWh6lqHxbuYr24Sz8O+DZLdZGETnRI+UycH8sVD/wuHU85/4RzwcP+4LHXmQUtgAck9O5ra0PwzqGq3KxRwugOD90kn6DrQNqEVqei6B8T9a1XUI4I9A8JAABmI0SMnHt7nOK9h1HUjBbafG2keHbfULeBZLxX0aMxyyseIj3QAdx3rmvBXg218HW8FxMkMurAB4YmG4Rv/fl9xnham1ufEE1tGRLOxBmfdl5XY55qrW3OOdS790891z4k+KNIuGW80Hw1bq7EoW0WEqRngBsc8Vkt8Y9fI/5Bvhn/wAEsH/xNeo39hbzaelhdWv2uMjfKs68An/D1FeQ+Ivh/NbQC40uUSvI+BZkZdV9Q3ek0a06sXpIt/8AC4vEIJxY+Gxnv/Y0H/xNT2nxo8QRXUMk+n+HZoVYM0R0iBQ47rkLkZ9RXmM0bwytHKjJIh2srDBB9CKZSOnkjY9NPxm8TFnKw6CAxyB/Y9v8vt92mj4zeKh0GiD6aRb/APxFeaUUB7OPY9KX40eLhnEmkAHsNJtv/iKkg+Nvi6K5jkdtHlRWBaJtKtwrj0OEB/I15jRQHs49j0r/AIXT4zyxF5p65PAGl2/H0+SgfGrxqF2rqFmoxjjTrf8A+IrzWjtQHs49j0lvjX44JyNUtweOFsIAP/QKms/jh43t7qOWTUbadVIJiksodrexwoOPxrzCigPZw7HozfGjx2c41sLk5wLWHA/8dpG+NHj1jzrzf+A0X/xNedUlAeyh2PRx8afH2P8AkYZR9IIv/iaavxl8eqrKPEc6qQRxDH/8TXndHegXsodj1X9ogmfxJ4dvpcNc3vh+yubiXaAZZGQ7mOO5xXlVfRGs6Pp2vfEfwBa6wnm2p8IQT+WWwHaO3ldQfUblHHfpWpf+DPCdx4Hs5ItDt4NU1Kze8LBGWKKcQb2iMpb9yFIyFIJJOO9CM/a8itY+Y6U17b8PvB3h5LaSPVoBd6vbQ28twoQzhPPlChBEGG5kXBJ4wWPpz1/h/wAG+H7PxCLXUdNspLeW+1PSrorb9raFpFlRSSFb5hwP7opjdfsj5ipK7/4w6RbaNqnh63tbSK236FZySeWABK5TmQ46lsZJrgaRrF8yuFFJRQUen+DfF+l6X4bs7O78FaLqk0e/dd3M0iySZdiMgccA4+gorjdNeQWUYVgBz29zRXPKVS+lSS/7fkvwuarbb8jDoNKRgkelJXQZCUtJS0AGOM0lFLQAlKKSigBaSiigBaKSrIt9tss8hGxjhQDyaBN2EsrSW8mEcIGe5PAX3Jr0DRtDs9JkgmTN3ckBxKVxsI5yo/xrH8OWQnRZoQf3XGV6sM9xWxYz3MTuLqMYGAPm7elM5ak3LQ77QPFL2DGWWBZnkPBkBAPqPf611cPiawv9ONm8hZDIHVVHzKc8Z/HvXm8MCTBHgJEak4jJxtz1Iz0qR4nhmzGJjgmRnC8hs9M07s53FHuOlPrtpqEc9g0cs8Sh3UkASJt6AetdFHcaf4w3bW/svWYm5RsAS9jwevfivDfDnjTVNGvRudJoguPLlJO08dGHSu3ufH9rqVpD9t0lI50GPPD4cA8bmI7elVcmzWht+IfDL2qi31KziukZi0atHuRQOvv+RrnJvh14cvQ0lxaOA64RY5cEE98HPH610Xhzxdphhit59ZndIuVSVNwX1Gc5NdidY0m9ngb7ZpFysY2u7MqOMjO3rinoL0PF28EeHovs8cGmSMycxNJcHhhk8gAdRXRWL6XYxSfY7WRPlO5EOwJ6ZY8k/wBK6i70jR9SkaJtTitbrdmN3lBB44A2nApll4H0iFXa+1qKQRPh13g7G7Ekmiwmm9zhZ7yS8k8u3DMiMWCJxjPcnvz3qOcRaczpgGZvndR8zBvTPpXoNhaaG8nkaQ0VwTlBKBkF/f8A2awri3sNLgkW1mju758mba4Oxl7g9/p0osByt1fqVla5YjZ8oDD7w7H0NcRq2pSNdCQyl/LTZub07KBXR+I/EekxW6yRqj3LttWLcG59xXl99qkl9rUSyKLeLG/APBPoT2qGaQj1NfX7XR/EAj3RlZMYSWNQsv45+9+Nef8AiTwxf6DKPtCiSFgCJY+QM9j6GvQLRJm1dLqZU5+UybflP407xzrtlYW22OR5rifdG6gcbcdeeopGsJyg0o6nkFJV23thebxDhJFGQpPB/E9KqyI0cjI4wynBGc0jtUk9BtFJRQMKKKKACiiigApcUUUAJS96KfCjSypGgyzkKBnGSaAPVfjPeT2V98PLyymkguYfC9hJHLGcMjDfgg+tcjc/EHxZc219bzeIdTeG+k8y5QznErYAy3vhV/IV2fx50q+t9V8BaVLATqSeG7K2aFGDHzAzjaCCQfwNeYa5pV5oer3el6pCYL60kMU0RYNtYdRkEg/hQZwStqXNJ8Ua5pGsS6rpuq3ttqUwIkuopSJHBIJy3U5IFIfE+uG4M/8Aa1/5vmyz7/PbdvkGJG+rDgnuKf4Q8Lap4t1J7HRYYpJ0jMrGWVYkVQQMlmIA610+n/B7xjqG0WtlZs7TNAqfboQzFSckDdyvB+YccUDfLszg7q7uLsxG6nlmMUaxR+Y5bYijhRnoB6VBWr4m0G/8NavLpurRpHcxhWPlyLIjAjIKspII+hrJoKVraC0lFFAze01WNlGQwHX+Zop+lWN7NYRPBZ3EkZzhkQkHk+1FP6rVlqov7ilYwHYs5Zjlick+9NpT1pKRIUUUtABSUUUAFFFLQAlFFFADlx1/pWtbJBcWggAlSZugUbgx9T6Vj1Zt55IHjkgJSRDkEHmmiJxvsdfo+ny2saGGdI2YbMfwscnnParoklmeNL0ja0mUwOXYDB5Hf+dcyms3Ny6rcCMbPmBAxlh0P1qxDb31/fRRhnWV1G1y2Fb3z2oOZpp6nc2E0EsatcSL56Eg+Wf4fQirkl00CGNpRJGeVYAcAHuKxW0eGNY2MpllQ/vl67m9c9+K1UaSAmK2Mc1oyrhSQeT29vpQZMcha+j2tLHBGTuDMvDen0qzCl0JGGwyIRtOOQSOx9R3p0aWgEcFxCttLglWDkjPpiq7xTLD5aO8wJJKZCuD7YoEQu0kbyyN/o5Pz709B2psuoGU+W5RfLAb5B98Hrz61pxWzzudwjdUVRJuQjntz3NNn03iWUPbycfKCPnx0NMV0c3e67e2bboZSwHylM7QeDgA/lWjo3izUJ5Yrl7iUtI2x1U89O9UdTtEkuIo5YYMFgVYZ3E4PaqNjYXdtE/7l44XkKp649f/ANdFy7JnoK+PZ1h/s+RI4rZI2DpEAm78ffuaw/8AhIL3ULZIopFistoMIQ4OM/xHvWI8DgOLWPzZSpV3buv06ZqxZ6b9ms0kukDiRtqO4xlT6AdhRcXKkWYrWOeTdJtAZicqAQRng89/ei60qJXVyT5UoITc4Lcevt7VKhNr5lpIf3SYVUhUbWHbJ9MVS1LVBI0YdUU7wiYTKkY6Y7UgV2y3qEESwpaRSOsagAsXGS+e3tXmHiCaS71m5LTGYISoY8cCvTI9lzcxwX8I3soZGXnYueOK4XxRppl8QzLZRvJGGCucYwff8qDSk1GWpY8KaY76TezSJuScCONc8tzyRWTd6M8eorZQMrytjq2Nnfmui1PVrbRNI+yaXKTeueSDkQrjsfU1Z8E6dCNFvL+8dmuJgdgYE4H97NBXNJXmcVq2nPps6RSTQSsUDHyX3bfY+9UK1tWgkhQmRUYu5bco5X61lUM6IO61EooopFi0UlFABRRRQAtAq1YTW0LT/bLVrlWhdIwJTHskI+V+hzg87e9VaBHsPj+VYtV+E0zXYslXQLEm5OQIcSv8/HPHXiuU+NN3p+o/FDxDfaPfQ39jdXJnjnhBCncASOfQ8fhXc+II7qfXfhAun6auqXh0G38m1f7rsJJcZ46A/Me3HNcl8c4r5PH841S0lhuxBGHme1+z/aioKmZUCrhSQQOOi885oMou0kjQ+BWvafpF5rVpqeo2umC+t4fKvLuHzoUeKdJMMn8WQpFeyWXjvwda+IGubvxLpl1pk15OdPhjtWWTSw6SLvZsfNGQx+QcDeK8e+Aou47rxJeaFbi68R2+m79Og8oSszmaNXwhBDfIWz6DJr6F0mG1ni8G6TLpkEk6q093aIkT28G8XChwcb2O8beu0ccZoRnVep8wfFzVNPvdV0Sw0i8jv7XRtJg037ZGCqXDIWYuoPIHz4wfQ1wdbPijQNV8OambTXNOudPuXXzUiuEKMUJIDAenB/Ksag6I2toFLSUtBR6T4Q+IHivRPDtpp+k65e2tlDv8uGMJtXLsxxkZ6kn8aK5fSiBYRcevf3NFccsJRlJtwX3I1Tdjnj1NFS3ML21xLBMu2WNijLnOCDgioq7DISilooASiil/GgBKKWkoAKWiigAHXgZqYRMj7ZVZCMHaQQT/AJFJbFROhk+4GBPfirepXrXZVX2uYzhZcYJXsDQQ272RZ0yCS/cWO4CPmRXZSdo9vrXZWUIm2pZRmOSJRuduGOPT1rF0M21hbpNMJt+cbgcoQfQ/jXR20kdxIriFvJcA/KdrD3xTOWUrvQjvoGvZQu8xTOP4U2bVHfFU9Hm+2SBI2kVo3KEscB2Fa+pyXOnyL8skkWdp3DDJmmQQRPdylFZVQK0RAPzE9Sfegi+hFNdzR3DqRx02IMnPc5rUt2thEEMcrxA4Xev8XUniqkluYZPNiDvzg7m6H346V1PhbQX1I3EtsUDR2ktyxY5+VBkjb60CbRQtnWNdjy5Cc7QdrL9D3qO7uvtVwPLjEkI+YDdgg9sEda2bXSV1CHzJJ7cypwoCkZyPp2p95oNxZ2VtKvkG3lOySZZcbR3yBzVWIurnDarfrMibyUmDcrgYyBWUZ5XiMrLI7Z5G8BV5/UVu63ptpH5qiXehOULDOT61xqu8KOsM4BY7N+4jOfXipNU0b1vDZANcJLIZGO0R7/l68/SrE97JbzrBa27Op+UhWz9cn+VefiVreSZY3lR9+DgcMPp655qxHduSHWdldSSVkPBOOBjigtwZv6ley2Ef7j7R5Rc+ZIGDcc8CpNP1RJUJETomRuyu7twfpXNNqX7llV3L9CHG7f6fTHtVBJ5YCDG7KR1IJGfrQUqbZ6GdUlubRItIuXSQNgybMD3zWF4jhjlgleO5ElyJQHCjBkY8ZxT9G1AhYYppkhV1+SKLr25PpXQxWBhT7VJbhduRAzggZPUjPX8KDNPlZz+keD5Vu7eTVCq2hAdwDz9K6bxheMPIjsUSG2C4ABxlRjt2q1aeHP7QI1HxLqji2gXK28S9PQE1zHiK6gfz7qFCIk+SPf1HPamhOTm7vU5nW55biaRpJUCoQqovcevFZVOc5Zjnqc02pO2EeVWEpcUoGfpUjyAxIigYX25JPvQNsioq/wDYFTSzdSyEMxAjQDr75qhQKMlLYSilo6mgoKAaBSqMsBQB7N4mmhivPhJNdapPpMC6HEJL23JEkKiaXJXHOccfjXM/G/S00rxmkcN5qV3BNaRSxtqFyLmRAc/KJR8rge3AyR1Brqvidex+Gbv4Y3egXUWqxWejKYbhoCqz4mkyCjcjqRXJfGQ6vH4is7XWdKg0ZILGL7Jp0EhZLeFssAM8gkliQe5oRjrzI2v2etBtda17WZrq91Cyax09po5bK+Fm2TIiEGU8AYY/WvVdJ+Fml/bdEQal4ptbmWNpZNQM5jjmQTSf6NGcZEvy7/Tqe9eRfAiTUH1zVrGx07Sb62u7Bkuxq8rR20cYdG3Ow6fMqge5Fepiz+It34n8I63qNxoY1C2dorbTLm9aOSfLyDe8ZHPBIDD+EChGdR+8eM/F/T4oNX0vUrO71O5sNWsVu7f+0p/OuI13shV378oSMdjXBGu/+My6pH4phi1K1sLW0jtwlhHpshktBDuYnyWPVd5fPvkVwBoN6fwhRShSQcAkAZNJQWdRooU6bDlCT83P/AjRXceAvhl4p8Q+E7HVNLsYpbOfzPLdriNCdsjKeCc9VNFZuUL6zj/4FH/M0Wx4+etFDcmkrQzFopKKAFpKWkoAKWikoAKWikoAWremTtbXUcqIshBwY3GQw9KqVpaTbLOx8yJ3TOMoM4+o9KaIqNKOp0Edx9qs2eGGOzw2Nitzjjgr3ra0uKWaOMSjBwCJNvyt9RUWm6bELyK4lhBVkAIByrDPX8K6c2RmRRaRiMEcNnO0fWg4m7GfqEJlhZY5WldMNtbkr7CtrRImhzP5Ijt0jGR1B9xnp9KbfWvlWkcW9YApDM+Thj/jWraah/Z6COVVndxhGRgyn+tNEN3RasfD8MqCc3lqzSLkRy8qRXQ+CbaeGz1HT5bSydQZLiOYoTIWVeIgQc7W9K55IlPlTyKsakFmAOMY7kDtV6C8uLVhcackUttLxuYk/iD1FOyITaG69BO+p3V2WWxM0nm/Zlj2hSR0UdlrAl8qYyxywStKvTygV3N6nPatq+a6vJUivpYbyPfktLIQyj/PpSXen29tKsrNGYimVjiYt+JBosFzkbmzYxuIgQ0RDPE+ASOeRWKbW3Z96JtnlOScBiwGOMdq6fzS1zNcMkjQAgGVEwBVbfa3JllsrQ+Uq7mV2xn1LY/lUmibOXl0G1mWdo3W28zkfvAfmP8AT2rN8UeFZND1C9sb+GQ6na8TqMH5yoIx2IwQa9B8OwWtnewXt9oK6rbpu/0QFow4PQ7uTwSD07V1HxnCX3jK/bTtLg01oJCLi+WXzGvCY0IOCPl29OKC1K3U8C0/QLiWSEX0BhjkHykjDH0wK3vEHhuw07STlZWmUZJHyqn58k1XvtT+zXSytcPIyAqA5Krn1B71h6hqn2vP2g4RjkrsJz15yTzQX70mbOglLe8hNpZ2ocEcyHcwHdj/AEFegTf8TK28y4nNxNnAJ/hUdh2H4V5jEkE14H+0C3SJQyYGWOPX39q6C6vZ38lLdpZJHIUMwxj/AGj2AoM2rnV6zbW0enRteXclraIN3lk4Mjf4Vw+uwJqVrI5xHBHk26JgF/c1tRW8N5pk0kha7lQbfNlf93nHaqcdq5sCtrAn21xtEwXOBntmgI6Hm5GMjvVy1st8kf2lvKjcZyT7+lbF1cWmlMUt0336kBpSPlrDnuJ3uPPmbMvUE0HXzSntoLejy2WNSzRgfLuGPxqO1ga4nSNByT9MDvViwsnvWkkeZIokxvkc+voO5rX1YQ6RZLbW6RtJMMs5GWxjv6UCcuX3VuZGp3rXAjgUFYIBtRScn65qkoBOMH8KSkpGqjZWQ99p+6CDmmUUtAwo70UUAez6zf6fpafCDUNas3vtPg0stLbofmcC4l4H44rn/jr4o0rxb4ssdQ0Q3hjTTYIJjd/6zzF3ZBPc4I57mu00+9Gmap8ELxkgcx2jYE0oiTP2mQcseB161zX7Q7XM3ijT7nULjUVu5rT59P1Fw9xZAO2FZlABDfeGOxoRjpzIxvhRq2mWVzrmn67dmwsdW057J7zyTN5Hzo4YoOWyUx+Oa9e1z40WOoePPB139puIfD1m5kv4ja52SjeqMGxu+7tbAPfFecfAmSwiHjZ9Wt3ubIeH5jLDFKI3kUSxEhWI4PSvWvj8dROnamNI+wL4fNmX1L7S37sXeIvL2Edbjy9uO2MnFBE7c+p4T8UNb0zUZdE03Q7lr2w0izNql40JhM+6V5M+Wfu434684zXD0daKDoSsrCU8ngfLjj86aanW1naLeInK43Zx2oBtLc63w8gOj253Y+96/wB40Va8LqW0K2PP8Xp/eNFZtamiOCNJVjUIY7a/uYIbhLqKKRkSeMELKASAwzzg9earVoQgooooAKKKWgApKKKAFpKWp7W2lupCsEbSMo3EL1wKBN2Io0aSRUUEsxwBXW+F9EuJZYnBaNuchh0Geo/wqroumRtJFOqO218kk4249q9X0nS1uLX7T5asCm7Kvg5+lNI5a1XojI0/TUtJ1aEl0DfMuSArV0ckT3FkzplUTG9EYbh/jWda25DSySzAkHkFdrgfQ9RXJeN/EElmPs1ogCyD5j6fSnsYJOTsjQ8S+MbeG1ltFUzJt2hhwVb3q18MY47m2N1evLGVBIdgWGPQnsPevIDIZJw8jF+eSx619R/BHS4b2yOopq2mWq/Zbu3eyZ/nIMR/eFf7ozn8DSuazp8iSLUOlzLKZM7EZcxNGN+4EdjVG80zULBJHbfFEzErOwOD6/L0qW/lTQpmht5bS6jVYyktqpEMpKg8emKlhuYr6OQz3lurMm8Rl/lU+nPer0OYwILG9G8ynz4nyVa2kB2/8BPIpk9zb20lgbXfNJsP2lHIID7jjafQjH41NPMmfPe2iadD8jwbuR/tCptIXTdSMkVws63bywxjKDZtZwHJOeMA5FIZlalcRXw/0W3ZQcD53xtPPYcVDexqYljFzCzkACKIED8T3pdftI9F1zULZZBPHDcSxxkpyyq7KCcccgA/jWH/AGwYYcR+XHGMkrnkfiaRduxrCWXSIhcT74lPBTaWz9KxZru5vDO1tJ5Mr5KmX5z6dD0psdw+ttmULE5HUtwQOnWre0QW4Nu/nOTtMkinA+g/qaQ9jjNQ0RkEklzOGu35y/A68/SsODShIfKeYNOSCiR5bK9z7Cu/1W0jeFRMVmuHHykgkKO5JPevP7i8ms5JVhu1cMSCsYwCPc0GsHJ7HdaZYaDpFmZ7u9t5JvLyI1bc271rntS1wwyL5QhMMhxgksMA8kiufFy5tWjgCqTyQiHIH+8TUEkjuESVgBHnamP89aCo03e7O88L38d1fLKSZkiUfuWwsQ+o703xJd3FxNcMJNjN/qoovl4zjJA7Vzek23nWu8tLEpOcK+1WIHU0+z1K+trpoo/KlUZ3bW3cZ6lqZHLqzLv4pI52WTomAxxgfQZqrMyvISiBF7KOcCtTX53lvma5Y5x8qoCFA/H+dS+H9KjvrpWuQYLRAXeR84IGKRvGSjG7IbazMGknUZQjKTtjQnv64+tZTuzsWckk9zW74q1aC/mSGxiKWcGVQn+L3xWBQyqab959RKKKcBmkaDaWrX2ZFgV3kJlLYEajJpJrK4hiSSSJ1R/ukjrQTzorUUUDrz0oKPb7vQR4mtPgvo5m+zre2ksJkxkqPtL1yPxs0aHSPFw+wQldOmhBhlF+16kpUlWKykDOCMEdjXeeK9+pzfB4+C1/skzWzx2S3E5JhkE5BLP6E5Ncd8coNVTVtNn1K60Ca0lhf7LHoUjG1i2uQ4VWJ2ktknsTQjBP3kL8CPDWkeJdd1iLxAAbO102W5Cvdm1jLKyD95IAdq4PPHpTvi7o+naTpPhq60Q3cNrq0dxNLA94biPdHKY1KscZGB1xzVH4M6drWtazq+jaBeadZvqGmy21w98cKYWK7gv+1nbivQbvRvGFxoUPgWfT/Cl/b2lwml2+o+W0kyLMRIJI5M/cBIBOOCcGgUpWmfPuMHFFdH428JXfhO/jgubi1vbaYMYLy0cvDNtYq4ViBnawIPvXN0G6aaugrokIOlRY2lvJPGeeM81zwrpVydIiCoWH2c8hDnoapGNfZHS+D4t3h20Py87+3+21Fdl8L9B0a98C6ZcXvim0sLh/N3W8kDsyYlcDJHHIAP40VleP8y/H/I6kn2PAzSUpHNJVkBS0lFABRRRQAU5ACwBOAT1ptFAGi2kXRR5IUMsKjO4DH6daZYSva3sTK7I2dpwOR68d66HwZdJbyFDDJyQct93p0r0IeGtI8S24At1tLwDKTxnAY9Rn0p2OWVVrSRx2mXEEymO1dXlZsuQMH8s12ei6tBbwhLlFt2C485WwD9RXH+JPh5q+hhpZbW5K9RcQ/MhB9cciksPDV3NCi3monyXBwATyPTP+NO1jJqLWjOq8Ta/BBaBXXzmXIEsRBBB9+teW6iJL1hc5nZJDkjbkLxxj1r2DRbaytNO23dpa3USfLuH3h7EelOhi0dLoCzS2EbfMULA4P40ExnybI840PwjHdRCW6nRSfmCZIPT0r0b4cXVr4dmmngg82XyJbbLE4+dSuc+2a045NKij8+VLa7iH3oZUII9NpHINYq634eguAwFx9mYnzY0yzA56igHOUjutEmEduIpzbzwsBtdjkqQAOKztY1Ifa5LVoo2CHLSELhvf1rnL7UdDdzDpd1d3OQNga1K4Puc1mXmma5coJEtTHCv3GMYyPzNO5HL3OlutSsplIeVRLjARegpmheJ5LG+NhaXECf2iotZy0CtiNmALKT0IB61ytnpjSSkXWni4dVyXDlCDzVmKCyhiCy6esMmMB/OOT+FJjSSNnx9r+ox3r6GhkurTRppbW2njRUZ4gxGWYfeJCivOtVu5ZjtgtWTsSPvL6n0/GtvXvskaqwEqshHA5BP0rGtb65uFVgY/IBIGFGT7AUjReRp6RdFtNaOeV1faf3crr1+gqC81SYWqrDHLNO64BD5AH9K0dNla3jZ7gW0Ak4C8kn9OtU7vSL+9gm+zpE8SgjdnYq/ietAuupzTOXu1fWJ5iVGNquML7ED3rFuBZo0wjEso/hfIAzW+fDrW7hkaKWUH7rLle/fvVC4sY105lWJzcRtghY+M/XqRQbRaTMMFlbcqkVM7xFwxMkrlssxON39akhSOOUG9SUr1wmBn86lcxW7gxWpDZypn6DuDig1ctStG0xjlSM4UjJUdMVds4ltYjNLDK7gAhThQOevvUmj3EaSSXV4QeCMk4A9MAdTVC6uWkuneKSRg3G5vvEUE6yfKaNjp91r95JcMSIFPzyMeg9KteJNZRrZdL08bbSMDec53Ef0pBcyWOgtbkEyyHJXtt9/8K55t0rKFDMfuj3oYoLmd3siOnBGIBCk/hXa+H/A1xdIs90u5epiU9vc1t3ehiKMRpbKu0/KgB20WHKuk7I8weKRCA6MpPQEc1padp6yg+ajluP4sAf54rpI9IeW+L3MiiTor4x36A+tdBZ+H9P0pFvdVmAkyDHCJBn8RRYznWbVibwj4KSOJdTuLNZEBBTzH2gH2rivHshk1PaPL+TjCHOPaur8a+LbqfTEt9JYxxLkkoR8ory6aVppGd2LMTkk9TTYUYyk+ZkdFJS1J1nrXjQWp8CfCP7bJLHbG2uRK8A3OF+0nO0ZHP41w3jy9ur7xJcPdWM2nRxgRW1nKhQwQD7i4I9OSe5JPevT75bQ+HvgoNSuY7S023JkmePzFQfaOpXuKzv2kklXxNYDUZZU1YRSLNZyzfaGgjD/um84klg4Jbb/D0oOeL95fM4j4Y6vDoPj/AEHU7uOeS3tbuOV0gXc7AHJAHc+1e5+CPivpmg6ZoLX+kX66XAt2s96LEFxI115kapKT93bncPXFeW/AqHSv+Em1K91meW2GnaZcXsE8LDzIpYwCGQHhmHOB61714nv/AA3Yv4R8PNcNc6Xq8skH2J5lNt5csiO00mD8sqljt4IG40E1XeVrHhHxR1OLxDHp9l4as9SutI0VJ2N3LbFHPnymU71GQoGSAc8gZrzM19g29xaXGkXV94e1G6l0+G9tDrE1zcLFJLawvOkisoPzJsCjH8QA4r5L1p7aTWL57EKLRp5DCFGAE3Hbx24xQXRlfQpV6LYkL4ctwynBtCevJ4avOq9GtEdfDNqTzm0JAzxj5qcRYjZHT/DmEv4M09stz5nT/ro1FaXwtiLeBNMOR/y1/wDRr0Vk3qdi2PADRVvVms31O6bTIporFpGMEczBnVM8BiOCcVUrQzQlFFLk4x2oASlpeMe9JQAUUpBAB7GkAyQM4oA1NM1GdZ4Iml2xhuu0E16bbvc20KXNvny8ZyjY9O1eU25jUASqu1mzuHUY/lXWWOpzWcccQXzIsAgpksAfbvTOSqlfQ9e0n4h6tZRiNniuYT1hfByPTmsHWHfW7+S5sLZLLzOWVRtA+gqLwylpcwg3jRJk/KQvIPuDWs1zBZzMseXUDrjt6090cz0eiGaL4fnUML+cMD/d+Uke9aP9j6FEUF7ZKWLfK+wkfXPWo7a/DRK6XXKjIUj5l9OKkinOoQMt5KkbgfLL5eT34yOlNEu7LNtpmix5kjjR+oaNpdykcY4NUTY+FIJd6ad5MzHLuJsqD9Ox+lYU7yW1zsa5aNQcFtm4VDdWwKt5vkkHpKuFb8BRcpLzOyuNYttPVTYtbm324Mbxq5P0pP8AhJNHmsCLm33ux/5ZSAEfhXHFUtLc75lOeiOmdw9jWJPfyQzlo4kMLDGF4OR6k0uYFBM6+4vbG4kVLZlt5BklpOgH1/wqrdXLsgheWOVF6tHGCfwJNck1y06xyl125yFUbsD/ABp11LbWsBkgv3S65+Uj/GlcrlIfEV1Fb7p0iu5uF5IAUflxWBZXzXF3uhV9hPzFUJ2+wPatXUdUuJNMb7Q6s+ASeBj3OKxdI1ia1kVFmUKx7R8Z9feg0S0OotmDyFYLKWeVjkvJPtAOfSte1s7q4HmtfxRJGf8AVpxt9ie9Y80szWklzburTyL8zEhFOPQVl2M8r4mukuZN7dIBlT2xnvQKx0WoyO1wXtoBOyf6xnyAT65rC1DUdUW4McUCxuxAVowCgHua6DT59KW2eOcXiyjkRkcZ7ZOarX+tBLV47cRvKB8p24wPYUCWnQ4vUbBbO7D3csl1MV3NsQgZwOpNZl/ezXs4eZ84AUewq+WmuGmubm5Dsp2+Wzct04wO1PgMNupmFvvVj8peMY9eDQbqXLvqzOsrGW5cnG2FRuZ24GP61owqL+8C2SLHbQ/MzMOvvU13qZltnUQSMf4CV+TGOv5VXs53ttNljIViW+6TjjjrihClJy1ZnX1xNeXMjyuWwTjJ4A9q2fBfkNqW2VCWAyo3deelc6STV3Sr17KcPFgMeCSM8UjWcfcsj3mK9hhsy0kiJEq52jgewPrXGXV/caoZpXuCltuIEcXG4e5rO0XUzr92INQaVbVMbUAxuHufSurkFgo8jT7Z3KDgLwqcd6o4uXkKFjpsSSQMWjlmIzGh6L9aw/GUcAnigEsc1+33vmIWMVc1u4m0+CWeWVFkI+Xd1APYeprj01FZPMCFot4IkncbnIPYUi4pvUp39z5cZtoZd+PvyLkA/hWZVp/mDJaxsYwQdxGW6fy74qtuIbOTn1pPU66astBKPrRkk5JoAJIA60Gh7Jrlvp974Q+D9vqt01rYyLdRzzAbvLXzxk4/Gq37QXhSx8PalpN5p1hDpUeopN/xL4bjz0jWNgqyB+5cHOO3Sr3jkan4s8NfCmOGOJr64gngijSJY0ysgA+XoeBye9Y3x60rVbDXNMudR1Gw1CzurYm1lsLYW0S7W2uvlD7rA9T3yKZy03qvn+pkfCDwmfF3iv7M0aTw2tvJdyW7y+X56oM+WG6Anjk4Fd78RPB2heCvCcelz6a95q9/Jc3UeoWjl5LRY9u2EjoyYbDP2561wfwjtNT1DxBe2mnaimm2s2n3CajdvD5qxWhT96xXvx6c16zJoXjzxDotrZNrthLomp7kOpQWufLhiKRKpdfuq67Tt74INCCq7S3Pm7e2CAxAPUZ61t+IPDk+jaXoeoPc21zbatbG4iML5MZVirRuOoYce3NaHxD8Ir4U1GFLPUk1XTZ96w3qQmIO8ZCyLtPI2nArkqR0J31Qlez6THG3hHTi0ceTYnPHX73WvGa9r0V8eENJIH3bMk7hx0aqic+K2R0/whh3/DzSW9fO7f8ATZ6K6X4Fvo4+FeifbbC7muP3+50mCg/v5McfTFFYuUb/APAO5LTY+SWAGMHPFBHTmkNFaGYUUUlAC0lLmjFAAMd6v2tvFNE43YckbcjH6/U1SRC7ALyamlimgUb8qOOh4Pf+tBE9dLi3UDW5TO7d1ORgfhXV+EZ3lQRXM0mAdqYAYL061yce+corSMTnABOcV2ek6PAsQZswTdEfJ2n3/GmY1NrPc7i0sHljZopDJjndjAFTEh02BVeQcEAnJ/Oo9AmntLZ457hgeQCFBU1B5dyzTSxSny8ZK44J9qZy9TVt7SBIQ8rESgYUOeR+NVY9Wv7GRkhwsefvAqc1jtcOkvmTXnlo3ABJHfpUV1JZyGQva3Lq3G6E70B9c9RRcFHuTahfyyMouJomLsVBUeWw/LOahiuCl18skdxFjDK6B8e+Kyn01nlSeGNZYzySZDkcd6s29tLCGdpBeKwP7voyUi7IsazesqwR2LQG2K8/OAB/wE1h6gJWeNpZXSAnBjgGc++3vSrDpouCl3azRSZGJc9Tjjml+y2R1FJ4Zp5mGflJxtz1IIoHZbFi2hlhhMUcs2x+RgKpB96rrprwyGSWPzZ2YsJSN3H0zxU8kdmlwp826VMDhWGM+pNWbi805YAgub0ZXcCVBJHGaAMnVrSeZiVECwHGcJnv0wDVGGy0m0eNprh5Js/ckXp+FGtT21yGjsJLkKedobCkfSuaYFMbwwBOee9BrCN9Lnfw2jPKv2a2tpAGwVkG7I/Pir8MbbPJgklQkYKp8qDj64rjNFtL5z5scIaHHHmMACPSupieykZVaaTeDny4RlR7fSgzkrMLItAZlkdZ8ZGVUkjH6Vg6zcTwb5Y7eSE5BErHjv8AdFdA10zIym2iSMZx+8APsSBXI+IL15n2NbGFRwN2STj69KBwjdmUBLOx2vueQ5KjqTnvUtzC1rGokljeQ/wBtxT+marwJJNIqRAljxgVs6jYxQ2ZIgG9e6N09c0G8pcrSMQs7j5mJXpkk4FNGO/Sr+l2Ed7KqyXCRAnAGMsxx0A/+vVi/Om26NFZpJM/Qu5wAfYUFOaTskY9SrNsTaigZxuJ6n/AVGQQeRitDSLL7RLvlISNeQScZOe1IqbSV2a2g3TIvEMrkAgsW2hR6cda19GvrljIql4oRxtZsE1ZjJhtpTAoDEcOR0rnL4yWyvJbrvZzuMjIdx9RjsKo492S+LLgltktx5hfkRqc7cHv6VzO72z+NXLaG5vrhzFFvdjyR2rQm0VLSIves24/dVOv1NI3TjTVmMnnto9MaG1Vd3DF2xuz9awzViG1luLgRwoeeeew9TS31ultMY0lEhA+bHY0MqFou1yt2o6Hip44C0LSMcAcDjqaiCttJCkjoTikaXR7TLf3Gm+GvhBfWdkb65gkuSltgsZiJR8mPfOPxrD+POsvf+ILey/sfU9Jgt/MuEt9TjCTqZSCRx1jG3C98ZrqdKuEsrL4K3F1PFDDHNO5mZwoQeaOrdq4n4x+K7PxF4gMOkx3BsLOaYpNeSCWeV3cliZByU4G0dhTZy017y07/qSeC01LwBqsV74o0TVYNH1mzmsXZYtkkkUqYZoi3BYAgjPFdRonxa0zRxoVnaaVqMejac9wj24nwsytIjIWXpvG0k+54r0WLxZo+p+MNFiaezb7FDHEZobpQZJzbqYHDPlV2kOpwMZIzmqHijX9Ai8OaYl9KsWmX2qzrLpO1ZfNdZFBn+0KMDactgcHdRYhy5tWrnivxQ8UWPiC9tbXQ7e9i0u1eaWFb0KZt8zB3B28bQRx3xXG3FldW9tb3E9tNHBcAmGR0IWQA4O098e1fRfinxLHocXiS7mvdIufFMVqixXCmGUFTN+4MWBtLpHndx3Gc1wPjbxLqniX4QeG/O1G1lttPuHtp7ciJJRJ1QqgG7btzkjjNDNac3orWR5VxX0XoGn2reCNBaSJcPp25i3f71fOlfS3hoA+BfDvIGdP7fVqcNycX8KOh+B8IPwv0baDjM+OM/8ALeSipvgdIifC/R1YjIa47j/n4korllJXZ6MVoj5EcEMeKbW74x1HSdU1gz6Bog0Wy8tV+yi4afDDq25uefSqel2KX2+PzVjk6rkE10I5uayuzNqSKNpX2IMsegq3d6ZdWbnzYn2DneoyMVJaWkzlWiSRozzujGSPqKdgc1a6KbW8gfaV+b071p2GnpL5SussU3XevPf0rVheCScrcqfMx8s6Dt6EV00Edv8AZyxEZAHyuRwe3NBzyqt6HKS+HxFHvmJk3cq6t/P0qrc2yJ+6IRg3TJyV6cDFbutmbTyslrGFLdmOVPfNRaZfabfSlby3EV30OxcAn1oJu3qVNI0eO62NHGrqG+bPBx0rq7e0WMqqqVh7oT39jVqxjhs0C48styGQZBHuKvWjiN94jEkQboBjrQQ5Nlm2Xy0ZYymwjG1+SKo6iNqFS0as3RlJAPtWvFdWxVtqAvnHlFeapXU9u0WGRI+2GQ5FMhbmJeW968UbWjxMgbLRsd35VCN1uoO9bdj3VSQT/hU93AWkEqkRKDkPB8wIzzkVm3jyz3bCIpNGo6ZKsPqKRaLElxdwI3kzQkdMkFQeKzVn1eadXgjibbnJDDk/TilTULQoRP5kJ68c+3T61u2tmXiW4tL+NiRnHl4P5EUDegyB55rYLeWXmvjI38c/1rLW3kF2c6egAOfkmJz+GMCtuJ7yeE7lSVVB4D7CcVii+uUutklg2wMTgvkY9zQJFi7s0eOJyjQJ2HmEZ98VYcyCPYNzoByFjPB/KsiR57qUNJpLKoO5GEo24565pWh1JV3XCtHC6kbFPIHrkUDKOriyhlb7XbXOWXIcjhuTx71k6BaxX1+u+2JXk5D4UenY1t6lFY2kBMkk7lM/K2RnOecnrz2rmNNvhbXQd2lVD97YRk0zWCbTsdyJ5LO2Nutlbi3GcMjZdj+XSsqLz5JC6PbQoSP3YUB2/L+tZU2qXUrFbKSXcQTu3Dgen0rOtbue2kZ0ZjI55wetISps7M3CRRSo93Fac4AYbmJ9AAPyrBfR9f1pjOLG5ljBwJDGVGK6Pw3cTWl0t1e2sOVbcrMnmMM+meldLqHjm61WI2IuJorcMFZIocEj60aEJuLukeaWWg3sN+N8MMix8tvb5R9at65JeJAyNJafZyMeXFHj8cdT9TV3XlgsVdoJLhA7Zzn17mude9mEYRHeRScFmQAHJ9etBScpu5lruH3ep/OlG5jkdfX0q5ZWlxc8xLsUHmQnAWqbDkgZY56iix0ppsWKIu2ARkc49q37dorWxZkJuJUf5EHAGRk9OwxXPgBcfNyfTtTvMkUFQxwRggHtQiZxcjqbHX38hlmMTPjPyjAA9PrU8GovdARt5cMTkBmJDO35VyCKSOF568DJrq/B8ltK5idpBL/dRdzt9PSgxnDl1R1+i3GnWMfy2fmvjl5Fx+QpupxW14wkMcao3/PQjng9q1LjS4bexWWaMW6twqvJmVvr6Vxt8kk9ywjmZcKNo6+vamYrXVEdzNb2iNa2ls0sznGFXP6+lYkejKsnnXbbVJzsz/On3RvIbgIsrhVcZ3HAH4+lUtSkdkGCWB6gH7ox0/nQawv0ZrR3dtGAkUMGwNg5HsaW+voZ7V7ezhjaRztO3jk+mOtY+lr9oBhVQu4EMzMQOnU1qwJcaHd22pabcLFeWkqzQNwdrKcg4PWgTVnZnW+MNPlu/h98MrM+TbzSLdRfv28tVPmjBcnpXpupeDPDOgX1/ajQtFvBetplsrhjMLUShlmcEN8jZG5Sfr0rzr4xa5qfibwB4D1nXLj7TqVwLvfLtCcCQADaABXNp8VfFUEuoPY30dmL+1itLmOKFSsiRpsU4YHBwTyOaRShKS08/wAzZ+JXwysPCnhmDWbDUtTuVmuBGIp9NaONVO7/AJbZ2sRjsOab4M0/RLv4W3l7qdpKbmz1m1R7xiWWK3c/MqLkAZxznrXm9xqV9cWqW097dS26Y2xPKzIuPQE4Fall4t1yw8L3Xh22vWj0a7mW4lt/LU73Ugg7iMjkDv2FI1cJONrnbfHLw/Y6Ve6PeWcOlWr36yhrfS2zAiIwCN1OHIOWGetdJdfDbwtFfqBBqPkC0Xcn2gZaYxA7844G45xXkPizxRrHi3U11DX7w3d2sSwhyiphVGAMKAPx61MvjHXTIpn1S7cBdow4B4GBzj2H5U0yHTqWSTE8b6HF4f8AEk9hbyNJCESRC33gGUHB46ivp/wTotrP8PvCkmZvMlsPmwenLV8m3t9c6peNc6jcvLOVA3uMk4GAPyr7E+HxH/CsvB54z9iIP/fTVUPiM8QmoJMr/BCwjPwy0n5IjiS5X5iAeLiUUVpfA1kT4Y6WraUlwRNdjzDKV3f6TL2/SiuKUtXv+H+Z6MVoj4plA+9kEknjuKbFI0cisrEEHIwaf5bPJtBGS2BmpLu1lhEYmj2MR6YzXUYXWzPSfCHiC1ltlt9XiSS3b5SzjI/Oux1L4XLeWLav4QkW8iPzPHEwBHHoK8N0tZHnVFnCgjO1s7T7V6j4L8Xah4TuY5rOXy9vLKeVYdKo5Jx5ZaFWw0m5jkeNAyOhw0EqY5FQ6lAwuF82J7VwP4eUPTqK+g7LVvB3xLs91xt0rXivyyocBjjjn/GuD8Z+ENZ0NwuowC5tD925g+cEds+lFuxHM7nnKwyz25gUJJnPzbhz+Bpmn+G912Tc5QbgfmXvWzH4ZF24lhl3Y6bDgj6it+3gNr+6u3LgAAHvRYTl2IIdBXbG8cJlOeDHJwK0prb7HHHHNZy5YcNt4H+NZrW9xbz/AGiyvWKE4MfSs/V9avoJVE0k8gI5jVsYp7EWuSXcsENztYSAk9h0GfzrF1bVYWKhrhGB+ULICGzV19XupowU81lXOBIoPf1qGBoJ3jOoQzIuPvdQKRaVjBe4iW4Z3uRGzjCqjkED6VPayPu863/fMR/Cqlv/AK4rc1XTNPeBGS42sfunbwfaqMemXUJEqoFUDJcKDj3yKViuZMzZ7eG8J80QyFsEho9rdK1bWykyPslykQB/hkAYe3WseeVo7vLzSOuepjb+Yq/FNdx4V5xNAwyA0e4r+lFgLUtwA224umkboN3H6iqM06yTPFbNtIH8JJpb5IpYWC3kkErdSIwRis3T9UntLjYLuWXtg4U8enHNFgLbiKByLgK7Aj76/X1qpqz28vltBqItJFGWz0YcelSXZSSNrq5Z2ABKmeLnqehHX0rFurhDdxPBDFHboAWd4g3Pc49KdiluV9Vc3mxI74TsDyQhVM+2ayzCLOdRcBiucnYeo9M4rV1i8WT/AFV4WIHISMKv5jvVDT9Lur4gohEQPLSHAx/Okaw0WuwlxPDOqR2NsFc5yMFmOa6Xw/FZ6dZf8TKzY3DcgMOtN061tdB3SzXKSyt8v7tdxHTp7VbfUZRbhrcSjeOCcL/PmixEpXVlsLNrk0jvDbxJaABiWnwq8eh9aw1n1TVcpZuyRKcFw7KD9anniuroxtqcsjhWztjTuT69KvxWl0wT7BLOi5wFXBHXpTsSmlsNl0q7EYSSSCQH7zI5eQEe54HrXP3dgsVxGjuEiJwTI56Z/nXazWt4LUm41B7WFRyTCMnj1/rXI6rLpzEx20kkr5y1zM2eh7AUhwbvoF8llHabIbuVyF4AOF/GsN3Lcktz6mgueVDcfoaagLOACAfUnAFB0why7jaXPSlCOQW2nAPJ7A1PFFbkDzJ8MfReB+NIpySG7WaPLsqhiTyefyrR0PVrjSQ8tuGVjgb1Xkd+v+FZ7xKH/dNuA5yeBSy3UssJWR2Yk556D8Pyp7ENcysbMviO6u7ktc3DxJyWIJZj+JpkuvlIylmhXK4Mjklj17/jWCTkk96TPHWgPZRNW2jutRby7YSM2RuYscVrf2Jc7x54AjA9CATx+tZmh6oNOyWDtls7V4zXcaPdnXhlt0cIOMdOKDGpeL8itpun28aOixRJyM8ZJ47etPurOGKNpHjjGc43LjNXr6BIHxboyIgxkHrVS4vIjuWZ8OMqQxyefSmZXub7+Grvxh4H+FOhWU0cVzdvfIjTEhVHmEknHb5TUHif9nrxhpFitzp5sdZQNIsv2KbmPZnJO7HoRgc5rsPhuVCfBT955RNxqA3sQQDvcAjP4ce9eqfFK8sF8LWpvvEGnW6w6zHMBP8AuBK1uxMyqUDZZiCRn1paGinJPTz/ADPhdgVOCMEcEHqKv2ujaldaZNqNtZTyWEMqQSTqpKK7fdUn1Neo/E7xf4T17wXFBo/ljVpLoTyD+yY4XUEuSDODluo+tVPBd7APg9rdjceI7SylfVrSWC1kkPmIQwDShQPQ5/4D9KRtzy5b2OE8W+Fda8JajHY+IbF7O6kiWdEZg2Ubocgkfh2rPGmXxZV+xXWWXeo8puVxnI46Y713PxjgtbTV7CDTPEOn61psURSBraRnkXBG5psgYdjzwSOK9Sk+I2hi7tpYvEOGgs4baNsN8i+Uiug46feFNK5LqyUU7bnzYUZZSjqysOCpGCK+5/hbpguPhj4Lk8zyz9kxkD1Y18g/EW/sdQ8XSXelSrNE8cZaRARvfb8xOe9faHwhUn4X+CTk8W44z/tVUPiM675oJsx/gmzQfDfT4vJlfZcXg3Kowf8ASpaKg+ENm0ngO0bZOf8ASrzlTx/x9S0V5k0+Z/1+h6MH7qPkCy0e6uY/Pjj3L5hGD1wD3Hb8a6JZZHtWtLu1ZVxjL87fxp9pf3moy3OrXs5a9u7iSSSQIFDsSMnA4H0rUjujMjQ3CI4HdV5r0TzZSbZkQ+F1lIeObcvUDGCKsXdnLaIyNIw7gkcda1tOi8t+ElMI7kZ/Stffb6kNmFZx0yOaLEOTRydpvth5oEkTDnfG/Nd/4P8AjBe6OY7C/wA6hbcriUdBnvmsF9CuHU/Z1XA6oRVaTw5CZA8i+W+c4bp1prQTae57pp154G8XQgxFtF1Fhw6dz71o6j8MZLzTyLe5t9QGPlkjIR/8P1rxPTtFkVUYBw69HUY4+tdhp2u67oCmS3vC2zAz0JHp71VzPS5U1XwvceH5WF4k4iz0uoiM/RhXIaskdyxktkmTnu4cfhXtOifGZL8NZaxYwXGTtIfC7h9OlQ6/4Y8JeIYTNpr3WmSvzsjQFc/0FLfYp6M+fdRFxMAI38sqRnPRh+NUZNPuZGBS/dG6+WzcE16h4k8DSaSMwX8WoIf4XFcnPp86RNDLZT5LDCiMOuO/v6UrWKUuxm2xvo7Yos5LEbcg/wA6fHcXcTAtOqpnklsZqO40a6UBla4hXPC+Uc/r0q7Z+ELzVGVYLhGGclZ8xnPrn0pJDbRTm1iyDILhrjLHlo+R9Se1U5brTwTJ9tjKnoCcEit9vh/rNtgKojj9RICD+lX7D4Z+ejNdT2w4I5Xdj8qfKxKUV1PPrq7huCi2qSO6n70anAFSf2bdXF1CbZLovnILMQo47iu51D4f22lgyw6hbPgf8smZCp+nes3zbuycIlzcLH93jnilYfNfYhPhu6ktF/tGN5Nv/LOOfGetOjs7GEeX/ZtwoCkFmYHFW4J1l5uAZj/z0L7avSala2y7ETzCT1Djj8KCbvYxbTQ7AMtwsbyrjo7hfzqrruo2tpD5cdmYWAwCoMg598V0W+1vI8TyzQ5GRgAZqtLYWrKfma6GTkFwM0Anrqclommz6jehlkmkk3ZXc4CY+gr13TPh7PPp0c97Z2u1Y8iR5FT8RmsHSbdbaF3e3t4V7AHn2rL13xIYUMUEc0iJwZN+TTBtyehc8RaAI52ihhtHUD7wJlC479hWA0Umn58kTPKDjdDFgYqOLxVAeGS6mBwCQp/xq/ZS291I2+cwLkcM2SR9BSGrowtXs5L5WDTTbyORJl8/hniuU1SwjtcKUYuSBkH7v4flXrl1aWcygWcxdscsqE9q4rWreFLhkRphKON/BYetBUJs5XTdMjuWJuZlhXsufmNa11oVrFAfspZpOu+Rvujj0rO1NbeAbIBJuI3FimOtQHUGSIIJGfjJ6Yz/AFoNfflqiC5tU37beY3L9CUjO3PoD3qu8bx8PG68dxircss1wmY1ZIU5Yg8Z7Zx3qrL5oOJi+DzhieaDWLfUSAISTISB7DNakxsFtEaJN0rLzknIPPT/ACKyVIByFJ/GpUlJXy2yIz12jnFATi2RknJCqQfapIrSaUjbG2DyCRgfnWjpl7FbTBY4Ffn5S9WdTu5gEjmLkDnaq7UA9vehEupJOyRFY6bEWAuZlB/uqe/1rsbbVLDT1FvZg3NyVOEQfoK5250LxBBo7X50PUI9O2h2upbdhHtOMHdjp71iQrPc3SpHu8zpkZA60zLlc1ds17nxLLcKN5ZVI5VRSabatdXH2mTzSjfNg8Dp/KnReGp94edQsZP8JwB/jXSNapaxIplVVODzxj60hScV8JpfE+yutI+EPw0t7mPyZ8XswCuGwrS7lOR7EV5I8sjLh3ZgTnk5r0/xzh/gh8PHyCRcagvH/XavLKR0Utg/GlGT/OkooNQNORGZWK4woyeaZS0APjHzgGv0F+DdqZPhV4OIYfLaqf8Ax6vz7hzvAHTOa/Q34IHPwl8I9/8ARF/macXqc9ZX3/rU5/4QRFPAdsrKxZby+BIQ/wDP3NRVz4VXNxF4NjSO5MSi+v8ACeXnH+mTd6K4JW5np/X3HZC/Kj5v8GaPb6n4Gg8vat0lxNkHvzVGfRrjT5yW3K+cbj1xUvw61WG10lIWAEqTuW45wTXolxe6dqtvsdYSwGenOa9Fao8mTcZM4DTJXjkYTSIyenStuCOxvMOgcS5+UqeAKytY0loJ2+zuojb+EZyah0ySW2kAK4QEAFev5UhPXVHZWrTW+xQyNHwN2a07fSvtY3M6uuegIJNZGl3LSgqskRl4+X7prpdIlm3KPs+7DfwgbgKtGbKFtbXVhKUjj8+FePKY7WHvWld28OoQMz20yTY/1ZXbj6V1NpZDUAFupPs7MPl85M/qOlW7rSL3TrcMbhJEwNuQGQ/1FVYR49e6QhmOFdWU8Me3NNstaudF2JJslhPGUO013mpyziQtIIo1HUbAQfxrivFdk96Va2Ven/LI5qWrbFJ33NKXWNI1Cz8xNSNvcKMhJV3A49xXOSeP7/RZZIQ1jc2rMQCyZH+IrnP7KmaUokjrKOoaPafzFLdQNbjZqFmZVz94Lkipuy1FHZWfxgRYBFLpdtcx8fKRux+dFz4k8Mau4kWH+zpz1CAgD1rzG5itYPMOnrL5zegxjpS6ZNcLCftqyBc7ckZ45xRdj5Eeg3F2YU/0XUFljXpwa5+XXJonYJLMxY8cYFZS3cES7IHy+RjLED/61W7SdmbDQMuTzkBqm4Wsa2m6rkHzkkmIGSGbkVeVUW4FwLYpxlc/MPyqjYtblttxdSRgEDDRgDp69a3I4tJeMM94u/PIDN+XWmiXuZVz5eozyCOOKYjghIyD37UlpYpZkLdQqiHPLxMAD9cVOJJLa6H9l3MzKeuxen51fuLnVWtWVLmSaMg5VuOMUAU7mHSwuUa0G7qPMYDGfSsy5uNPtY2a2ht3YZyYo3bt61zPiWe7F0sUkL4cfMyt8tZ1tY6rNG3kXN1bxnPyLKOnpjNFylFdzQ1DXoGkI/ehegAiK9+tS6XLZ3CeZLYy3GOcMSoI9KNHsI7aXddxmYqBy7Hb9MV2cFxazQCCK3tYkPG5V5pDbsrHFXV0ruFt7PyI+gQLnHPrWbK15CJNiBhnuQvrzXsGmeE9KmCyT3Nsjnnc7Y7+lXLnwToTxP8AZ9S8185Cqm1QfqTT5WJVEjyaLU9T+zeWNkSlOuzPNc5fSXkszb5p129T5AA+ua9bHg+1eRgNQWNBzgsCcfniqOq6dpFpGEOoG5PQrEePx9qLAppbHjUkE19PJ9mgkmcjGACSD3+tXrTw/co6tcRqRgZTHWu8+3Wuntsto+N3AJ2j8hVLXNV8mHc5dGPRIwAPxNI155WsjFk0ZcRvMsShBjkbQPYjvT4PD9jLM091J5oILBFwoH1Pesaeee5lXzW2oenr+ZPWiS4kgVFguUC/xMzcj2680Cu+5a12zttojtIIl5+8OCg/maxB9ktwAzPKxGT8gx36E9qluLtmG9GDuODI/Un/AD6VTud82JyVxwOSBz7D0oZrBPZs1bXU922C2t4+mAxUDB/wrYurG2WDfql2pwOUj5rK8Lw2lzqFnbCIS3lzMsEalsDczYAPYDJFeiaz8MPF7rEbXRo7hG8xXNrMJjblDgq4XhT6Z9DQjOaSfY1PAniTVtd8H+NdMvNTvrjS7bw+4giuZiyJiSMAgHpgfkK4WzfTdLlFvo8R1LUTw0oXKA5rrPhjp0tro3jpbmfIl0CZccngyxZ4qxo2halfwyR+GNEkaOFgsk6xHCE/3j245z6UIUmUWjSHFxqF4ZGIBKmPZsbuAMmstba31XUUZjI6b8cDGa6LWvCd3oF5ENdFtci5Z/s88E4kikKhSwUjuNwpsYitUR5dkIzwi8d+nvTM72MPx4ir8DvACgYK3upL/wCRRXlFesePDu+B/gcj7v8AaWpcf9tBXlFSd1L4RKWjpRQaBRRRQA+Fd0iiv0P+BgZvhH4SPpaD/wBCNfnlBgSr6Z9a/Qz4D/P8HvCoyebTHBwfvNQtzKau7Fb4WR7fByhkbIv7/wBP+fyaik+GqbfCpVVOBqF+B/4GTUV5817zOmn8CPlbRNHfTvtOnanCn2y0u5I5RFIr7D1+8OCOa6qwsoXXdGRInqG+YfhXh0Gq3ekazPPYSlG3sCp+ZSM9CO9dvofjq2nIW/H2WbplB8rH19q9JM82pSluju76ykEbMh3Rep4OKyLSNTdANlFLZz1/On2+vpEykyGSLHXG4A1OZI7m6WaOQx5+8COpp3MtUdhYaGssKO0cLDHyspwSPQ10UFlEkJ8y0niZeBLE+5fxrj9NvLm3YLbMXQ/KQBziuo029vopFe01CNWY5Nvcpw3tVozNKS/vdPtx+9E8JwSMZxV3R9etJYwk0AdmHXOMZp3222uUWO7sDbXB5M0OCjfUVnzaTZXefNmYr2e3O1h77TTEXdckWUAwxhEPBEqZH51yV/DaNJk2qLIx4khyK6KS2vLWApYah58IH3X+R/8Avk8Vzd5ffZpd0iTQyf3l/wAKTYHO6nCyufLlzgcLMnPvzWa8rKGAK5B5Q5A/WuuF/b3k2Z4YZpMj/WJg/TIrRfTrLUrPaYEjmz2bpx71Nrjvbc8X1yzsLh/9V5c38Txnb6d6fY6MrlUTVQOBhZycH8q6bWNBW0uXihlKruyQ3Q4pLfSJbZt32EScDBR88VJpzaGLP4UvbaQM1vDcoe8b81o2Gn+QP9IM9u3QKwyAfTNaS35h3LJHJEM/wSd8e9R3OrO8DfMWj9CwoFdsx7+e2LBGiEueOap3cKpPGI7Xyyx48xcikkjEzlxdrFGckqw4zitRVh8klrqKY9PlOTSK2LNrBeJCjqluPlzwDVSbUbuJsyyQo3TYoODVRmuDITC7QqDjDPVO8eWZZVCq0xz1Y5yRzTBIs3GqTvKrNBBKM8ZU8c1bjuokQyNp1mrAHnYfw71wl7bXVuwd2mYZ5EbdOvUZ5rLub64LARy3Koc56/yzSKUU9juZtWWS5ZfIiKHg+XEePwqaXxHbxQpE0L4YjDSLhe/UV5zZ3paQlp3TaDklmIK/QelWbeZZniitU85l4LiMg459Tmi5Thbc7hdWDRiRJpmUZ4RcACsPUfEXzEp5gOMkySEiq6LK+DM9yqAnIVgq44AzUV+ltbWxEUcSFQTk/vMn1oEkLHrwk5ub4KMcKsJ/nVO716HyNkUUkh/vMxA/z0rJvXtntY2V7lr4yN5u4L5YTA2bcc5+9n8Kockdz3NFzojTT1ZqxazeIWdGRTnqRUd7qs12m1yd27O4Mc1nrtOSxxgZA9aDkt8vHPAHalcv2cb7DgvB3Yz9eaRFBfH+TQuTxu4NOSN3YBDuOCeOw9aCtixJbv5e47o4+6t254qukLODsXdjHT3qQxzbGd24P948mrtjex2seJucdBGoyPxpszu0tNTqfgcsVv8AF3wv9vEccf2xQwmwF5UgZz74rU0zUdd0HVtTjh1C+sWF5J5kEcjIzyBz98Z5PbmuIfVprW+jktYRaywSCUOfmdSDkHP5V9A6FZ6d4sgn8caUkUl/KA+pWIfc9rMB88yqedjcNntkjmlu7GVWTtdm/wCGvGOs3djfXHimxs5NUmtXtLS+EKpPCCQyBlHy7FYbsdcgV5b4z8ceO7vUobbXdWmikhVvKntf3CyocbvuYDcY4PSu3BLgMdr9+DTB4ebxTv01445YNpeRpG2pCo6yFv4cdavlRzRm7nHHUYNP+CjTADzf7eJtCwx5ii3Ik2ewYjPvivO5Nee5LNczFFIGFU8jpjPtWh8S9Ys99p4Y0GdZ9C0VpFjuFOftUzEeZN1I5IAGOwFcNU7HZGkpK7PX/iJDZRfAzwINMvWvITe3jSMYjH5cp2lo8Hrg9+9eQdq9P8SEn9n7wd1wNWvgfrhK8wpGsFZWCkpaSgsWkpaKAJIOZV5xzX6G/AI7vg94WJ/59j/6G1fnpbAGZNx2jPJ9K/Qn9n7/AJI74Xxn/j3br/vtR1M38RY+HNrKfDT7dhH9o6h1OD/x+TUVZ+Hqxnw7NvA3f2lqIPX/AJ/ZqK4p25np+f8Ama02+VH50aic39weM+Y386rnGOKs6mMajcj0kb+ZqrXaiUX9L1S406VWiIaPOTG3Kmu70XxfYzBEuCbeT+6/3B9D/jXmwALAE4GetIaLmc6UZn0DaX8U8Ie0uYynbnI/MVq2OoiYiC5kVuuecEH2r550rVrzTHLWk5QdShGVb6iu00vx1DKFTU4mibI+aMAp+I7VSZyzw8lsexR6o2msot5y8ZHKvzj8asx3636ttlaGfHG1siuB03XLK7XNlOoZTjKtkH8K0jJdSshsXtmkA4wdpqrmDid5YazrFkuyaBLm3yMMxB4rorPUNH1WFo74WtvdYwFkyoP0ry2PV9TtV338DlVxgjPIz9P1rfsdX0/U4ljugwk7bsHn8aakKwviNIdPunFlB5pY9Ym3A+1c6/ibUYAEaK8hTnlhvU/hW9qEP9lrviBCHkSRf4VSXXLgxurLbTgYP7xcPz6UmCMRNSiuJv8ASLje56LyuD9DUsstlbsJVMqDgblBBA/Co9Q1eF32NYorbh8xAxVu1vl8kt5Ftt75J5FIorTzR6nEU+0sx/20yVH17Vh32ipGGMc3mEn7rZ6e1b0mo6ewYNFDbOCclGIzx3rNumWRgYblTknGHz/+qkxptGAdKlkiLGWRG29FGf0NNg2WkZWR7pAOr4xzWmEuxEAtyqjp0yB9ayJpLtZWYXELr/tNgY9/ekXqRXMyyMpgvmZl+Ybkb361nnzYgZHuY5geQqIwxWh9vnRgJGjIB52AFaw7/Wo13x/uy27oEx+tBST2QXt9bLaKcw+byGjIbjHeuY+eV3MUOAW+6oJ/CkuZvNfJJwTk857mhLqSIHyJJIwTkAN0/Gg6Iwa1JYJUt3/e224Hghsitmz1exgQRiEDk5KLgfX1rBmuHnwZcFgfvd6iViv3SwP1xQN0+bc6G817cAsdvGUHTDHIrFuWllxI0ewFuMdKiGUcnhjVrMz22MxOmRxn5h7frQHKo7FNXADBhuyO56H1ph5qV1wCW28Hbwc1Gdu3oc+uaRqhKDRR6UDHLjOT+VWbe6W2YNCpJPXd0/zmqhPtSg+tBLinuWbm7muV/fSHGfugYFV847c02gk0DUUtEOGAR39q6TwX4r1PwprsGpaNdNBNEMbs4Vh3DL0YdeDXM0UClHmPf1+NHhW9gE+t+E5jqbZEg0648i3PPBVTkg46+9cd8QPixe6/YvpGg2qaPoJIzDET584AGPOkz82DnGMcHBzXmFLRdkKjFO9gooooNT03Xst+z/4U46a1ernP+xHXmbqUdlJBIOMg5Fel6xz+z14e/wBnX7tf/IMZrzOhExCkoooKFNFFOUqHUlQwB5BPWgB9txMmPWv0H/Z5JPwc8NZ7Qv8A+jGr8+bdsTqSep54zX6Cfs6kn4OeHMnpG4/8iNQZv4je8BhhoU4A4/tPUf8A0tmoqbwOg/sSf/sJah/6WTUVxzXvM1h8KPzo8Ww2Vv4l1KLSrx72yWdvLuHi8tnGeu3tzkVkVb1cY1S7z181v5mqddhK2FoopKBi0UUUAPhmkgcPDI0bjoynBrcs/FWoQSKZWE4A2/MMH8x3rAFFBMoKW6PRtM+IDJFskmnXPAWQ70Xnt6V1ukavbakN0F1H5zLlsHIH+HNeGU5HeNg0bMrDupwadzGWHi9j6N/tu8gj8uZIWUnAzyBWVdXp3FnESknlo26fhXkFj4o1a0zi5MykY2zDeP1rV/4TVpVAuLCHI6tExXP4U7mLw8kekJJb3cflyMGGOAeop81ksMXyxzqh6mMbs88V5/b+LdPEqsYbiMjABz/hXcaD4+04qsZnGOgRxyMe9CsRKEo9CL7aYkaNLqFwOcSw8/rVGeS3ba7zW4fJ5VStdtDPpurbZUkt2J9cMOlV77w7YXKnAsfOxkBMAZ+lOxCkjjop5VTFk6OGA6HkfWue1G1vr6eRZp0RG7bK6y58JImWmkMSg5HkOAe/NZP/AAjMFxlBfXU2OxJGP/rUjRSXQyY4PsdmUIhkIf7zrnJ/zisXU4ZJmd1hjAQHcFjGOfQ9a0r3wpeRHy4ruSSDJbZluD3P6Vm3mg3katIYpmOOSoJLUGia7mFKuzg49R75pivt7Dj1FWbuyuIMeZbyoPVhVYqQSCMEdQaR1RaaJnnEiMPLiToRtWot+OmB9BTO9TJA7dBz1weuPX6UgskIz7zzz6VajkMkexjBEgAOdozV2x0W6ugrRKU6/MWPTHbipE0+S0GwSWMr9PmI+Tnnk0zGU4mNMpErchj1OBxUTHec4A9gK0r+RWXEotyyADEZ9u2KoSeUVXyw2ehyevvQaQldbEWKcOxzj39KbRSNANB+oNFJQAUUUUAFFFLn8aACiiigApKKWgD1nxVe2l9+z34Xay06Ow+zaxNbzeXIW+0SCCMmU56E8cDjivJu2K9KvBn9nTTD/d8TTj/yWjrzWgmIUUUlBQp9qO1FFAEtv/rV6/hX6Dfs8FT8HvDu05/duPx3tX59W3+tAAPPvX6B/s6EH4PeH8dkcH/v41Bk/jOp8FgDRrgc/wDIRv8A/wBK5qKk8IjbpU4/6iF8f/JqWiuaS1ZrHZH5oX8y3F7PKgIWSRmAPXBJNQUq9/pTa6QClpKKAClpKKAFoxnpSUUAOK4AORz2zSUlFAC0HrSUUALRQvWkoAlhmlhYNDI8bDoVbFWk1fUEGFvJxnn75NUKKBOKe6NuDxPqsJXFzuA7OoIq3B411iF2ZZIWz2aMH8K5rtSUE+zi+h058aatzzBz1+Sq58V6qcjzUAPUbKwKKA9nFdDQudYvrgky3DEH+EdB+FUSxYkkkk8kmm0UFKKWwoOKsxXs8QURPtKnII6iqwpKAaT3L0mq38hG67m4G3hscfhVImkooBJLYWkoooGLSU+b/Wt9aZQJO4tSO6NDGixqrrnc4Jy2fX6VFRQMWkoooAKKKKAClpKKACiiigDoJPE1w/gSHwuYIvssWovqIm53l2jWPb6YwufxrApKKBWsLSUvakoGFLSUUATW5/ep1zkcg4r9Av2cZBJ8HdAPyjCyDj/ro1fnzH98V97/ALLv/JGdG/66Tf8Aow0GctJJmXe/HHwt4N1TVNB1aLUGvbS/ufMMUIZfnmdxg59GFFfLHxz/AOSv+LP+v+SiuaWClJuSqtX8o/8AyJpGei0/M//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An endometrial polyp measuring 1.9 x 1.2cm is clearly visible. The stalk of the polyp can be seen extending toward the fundus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Steven Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33425=[""].join("\n");
var outline_f32_41_33425=null;
var title_f32_41_33426="Patient information: Upper endoscopy (The Basics)";
var content_f32_41_33426=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15732\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/39/37490\">",
"         Upper endoscopy",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?19/50/20258\">",
"         Patient information: Achalasia (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?24/2/24610\">",
"         Patient information: Acid reflux (gastroesophageal reflux disease) in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?13/29/13778\">",
"         Patient information: Barrett's esophagus (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?19/31/19954\">",
"         Patient information: H. pylori infection (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?36/33/37393\">",
"         Patient information: Hiatal hernia (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/57/28562\">",
"         Patient information: Nausea and vomiting in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?5/53/5971\">",
"         Patient information: Peptic ulcers (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?37/30/38373\">",
"         Patient information: Acid reflux (gastroesophageal reflux disease) in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?21/0/21506\">",
"         Patient information: Upper endoscopy (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Upper endoscopy (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/upper-endoscopy-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H1479918010\">",
"      <span class=\"h1\">",
"       What is upper endoscopy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Upper endoscopy is a procedure that lets a doctor look at the inside lining of the upper digestive tract (",
"      <a class=\"graphic graphic_figure graphicRef75392 \" href=\"mobipreview.htm?36/39/37490\">",
"       figure 1",
"      </a>",
"      ). The upper digestive tract includes the esophagus (tube from the mouth to the stomach), stomach, and duodenum (first part of the small intestine).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1479918017\">",
"      <span class=\"h1\">",
"       Why might my doctor do an upper endoscopy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You might have an upper endoscopy if you have:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pain in your upper belly that you cannot explain",
"       </li>",
"       <li>",
"        A condition called &ldquo;acid reflux&rdquo;",
"       </li>",
"       <li>",
"        Nausea and vomiting that has lasted a long time",
"       </li>",
"       <li>",
"        Black bowel movements, or vomit up blood",
"       </li>",
"       <li>",
"        Trouble swallowing, or the feeling like food gets stuck in your throat",
"       </li>",
"       <li>",
"        Abnormal results from other tests of your digestive system",
"       </li>",
"       <li>",
"        Swallowed an object that you should not have swallowed",
"       </li>",
"       <li>",
"        Had growths or ulcers, and your doctor wants to follow up",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1479918024\">",
"      <span class=\"h1\">",
"       What should I do before an upper endoscopy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor will give you instructions about what to do before an upper endoscopy. He or she will tell you if you need to stop eating or drinking, or stop taking any of your usual medicines beforehand. Let your doctor know if you have trouble getting ready for your upper endoscopy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1479918031\">",
"      <span class=\"h1\">",
"       What happens during an upper endoscopy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You will have an IV (needle) put in your arm or hand. Your doctor will give you medicines through the IV to make you feel relaxed. He or she might give you a mouth spray or gargle to numb your mouth. You will also get a plastic mouth guard to protect your teeth.",
"     </p>",
"     <p>",
"      Then your doctor will put a thin tube with a camera and light on the end into your mouth and down into your esophagus, stomach, and duodenum. He or she will look for irritation, bleeding, ulcers, or growths.",
"     </p>",
"     <p>",
"      During an upper endoscopy, your doctor might also:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Do a test called a biopsy &ndash; During a biopsy, a doctor takes a small piece of tissue from the lining of the digestive tract. (You will not feel this.) Then he or she looks at the tissue under a microscope.",
"       </li>",
"       <li>",
"        Treat problems that he or she sees &ndash; For example, a doctor can stop bleeding or sometimes remove a growth. He or she can also widen any narrow areas of the esophagus. Narrow areas of the esophagus can cause trouble swallowing.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1479918038\">",
"      <span class=\"h1\">",
"       What happens after an upper endoscopy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After an upper endoscopy, you will be watched for 1 to 2 hours until the medicines wear off. Most doctors recommend that people do not drive or go to work right after an upper endoscopy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1479918045\">",
"      <span class=\"h1\">",
"       What are the side effects of an upper endoscopy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The most common side effects are feeling bloated and having a sore throat. But most people can eat as usual after the procedure.",
"     </p>",
"     <p>",
"      Other side effects are not as common, but can occur. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Food from the stomach getting into the lungs",
"       </li>",
"       <li>",
"        Bleeding, for example, after a growth is removed",
"       </li>",
"       <li>",
"        Getting a tear in the digestive tract lining",
"       </li>",
"       <li>",
"        Having redness or swelling of the skin around the IV",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1479918052\">",
"      <span class=\"h1\">",
"       Should I call my doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Call your doctor or nurse immediately if you have any of the following problems after your upper endoscopy:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Belly pain that is much worse than gas pain or cramps",
"       </li>",
"       <li>",
"        A bloated and hard belly",
"       </li>",
"       <li>",
"        Vomiting",
"       </li>",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Trouble swallowing or severe throat pain",
"       </li>",
"       <li>",
"        A &ldquo;crunching&rdquo; feeling under the skin in the neck",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1479918059\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/2/24610?source=see_link\">",
"       Patient information: Acid reflux (gastroesophageal reflux disease) in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/57/28562?source=see_link\">",
"       Patient information: Nausea and vomiting in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?5/53/5971?source=see_link\">",
"       Patient information: Peptic ulcers (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/31/19954?source=see_link\">",
"       Patient information: H. pylori infection (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/29/13778?source=see_link\">",
"       Patient information: Barrett's esophagus (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/33/37393?source=see_link\">",
"       Patient information: Hiatal hernia (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/50/20258?source=see_link\">",
"       Patient information: Achalasia (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/0/21506?source=see_link\">",
"       Patient information: Upper endoscopy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/30/38373?source=see_link\">",
"       Patient information: Acid reflux (gastroesophageal reflux disease) in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?32/41/33426?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15732 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-A20BFA4EA1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33426=[""].join("\n");
var outline_f32_41_33426=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1479918010\">",
"      What is upper endoscopy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1479918017\">",
"      Why might my doctor do an upper endoscopy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1479918024\">",
"      What should I do before an upper endoscopy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1479918031\">",
"      What happens during an upper endoscopy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1479918038\">",
"      What happens after an upper endoscopy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1479918045\">",
"      What are the side effects of an upper endoscopy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1479918052\">",
"      Should I call my doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1479918059\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15732\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/39/37490\">",
"      Upper endoscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/50/20258?source=related_link\">",
"      Patient information: Achalasia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/30/38373?source=related_link\">",
"      Patient information: Acid reflux (gastroesophageal reflux disease) in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/2/24610?source=related_link\">",
"      Patient information: Acid reflux (gastroesophageal reflux disease) in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/29/13778?source=related_link\">",
"      Patient information: Barrett's esophagus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/31/19954?source=related_link\">",
"      Patient information: H. pylori infection (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/33/37393?source=related_link\">",
"      Patient information: Hiatal hernia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/57/28562?source=related_link\">",
"      Patient information: Nausea and vomiting in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?5/53/5971?source=related_link\">",
"      Patient information: Peptic ulcers (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/0/21506?source=related_link\">",
"      Patient information: Upper endoscopy (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_41_33427="Imaging medulloblastoma";
var content_f32_41_33427=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F55787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F55787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    MRI and CT scans of a medulloblastoma in a child",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) MRI sagittal image of a posterior fossa mass causing compression and dilatation of the 3rd and lateral ventricles. B) CT with contrast: Axial image that demonstrates a large posterior fossa mass causing compression of the 4th ventricle (arrow) and dilation of the temporal horns.",
"    <div class=\"footnotes\">",
"     MRI: Magnetic resonance image, CT: Computed tomography",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33427=[""].join("\n");
var outline_f32_41_33427=null;
var title_f32_41_33428="Cutaneous squamous cell carcinoma - poorly differentiated";
var content_f32_41_33428=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F75816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F75816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Poorly differentiated cutaneous squamous cell carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDiZbnOVU4GeBTFyxHzHI6CrZgSJTkEn3psJViPlz9O1fPKL5tT320hLe3LSANyByea0hFHEhPy4PNVVIV85woYcfhTLm7zlUxW3KoqxKu9RkkwL8McZ4o37D83XJPFVkQlsngdeasiHcVI53dKyvZaF2bHCdwPkX9KkjErA7j19qsQwBY13df51JtbeNuAPWhcz3NNFoSW1ugzuGfxqRgocBakQIiksQRTUZTnAp+Q0uoj5ztHfmnrCzEAkhfWk2ndnt1qQlkbJPA7U3HuMtwwwoMtyR7025dCm1RgDiq8Iy28gnnvVhIS+cjH1qk9LRQrdyJVZY8nNTQoSoBOc880+NIipLt9RmoX1BFOI13HGKHBRtzME29i5GkiLkHioi0YbMrj1PNV991Ou0IBnv6VYtdFZwGlbJ9BTWrtEb03EkvY0P7nkseKbFPdTH5V2L9K1V06KDHy/WphHHjqFzT5JX7CUo2KEdlJJy7n25q3HZJGMquX9atGVYyEUZNTCbCjOAfpVcqM+ZvYrLa/MG2ru9atJDjBfH4VE85ClsYqtJckqWKlfeq5kFpML+5SKRUiXczcYXmkgkWMj5Q8h9e1VVV5G8wdPU9asKEX7pzjvUX1uVyl+FGcZkYKvXAonRFXIckdhVdXyQqqWP1qc7jjGMD1rSLuK1mLby5jO5doqGdwxI3flSkbfmd8YPGDzT0ZHALcemR/OiSurDVrkMKjkYJq4oICsMj60iIAQVGM+tStEQoJBP0oirIG0OPzDLMoGO9QqxVjtUtj8qmSEN0Yc9KmWLb8uMnqatGZnPJdEAKqoB0ApyQTM/7yR92c4FXEkjMuxMs69+1PdSWDMcE+npStqF0RGFyoVcnI4q2isEUKoGO+KRAAAFJ61P5oj65NXEhu42SOSReQSfaq11J5IKR5aQ9Fqx55dOGKn0qAxIru5Pz93ptdgRHbRmPLOVZz+OKu2pK7sgknpmqizRLlVVpGz1UZqcNI/LR7VHYmhPsN6lgZOcsdxqvO/kriMgseNverRYGLZHH8x6MT0pkVmyybgu04wWPOatrQhPW5HZ2/lskjsGbrgdvrRPcTPGY4otxBPBPFW1tdirlsZ9KZPtWQKGyO9O1lZCvrcyoLS4lkLTgu4/gHAFaaW74wAMKeNtTlo8YIcAY7fepm0upCKRz07ikoJD5rkE1o0IMkzKoI4otniCgg7t3G7Oc0yeCSaORFmCZGORk/WmxaZHFGo8+RsDjA7015ITfcsNdW8BXEjE46dKgnvCAGaRFB+7uNTCG2MJVgpYevU1DdWMV1FGWQHHfHSqtoNWLDXdxPColnjKBeBxxTVuYW2xOR5p44ySazvscUW1l83A65bGPpV14o02m2iDSL95s80RXcGiyI13ARiTa33sVcRUMCoR8g6cVBbtGAWcEKcfxE496YZQw24c/7uavREOMuhZu4RlW27SR681mTKY3Tf8zk4VAOoq/bxRnBk+Y9iW+79aFhSNmKkZz94VE0mODtuV1t2BMszZYn7o5AHtSvG8ke2LAz3Iqy0bAKw3Jxyc9aFClN2SOcAdDiklqO5lw6SY5PtFwTK2cgHgYrVh8gzLgeUp5OTxSkgOFbEg7ZzimSFIU/eNgKeFANNJRehMndalu5kgLr5J3Mw4zRXPTalLJIy6dbSpzgvIuFHvjvRQ5hFaHhssu9jngCnRThWyGz2pLe1kmG4k1ZFjsIya87lUEbK7IhvmA2gkDp7UqQep5rShijRDyahlba2BgHsaymurZovISGLJHt61aO1QMD/wCtVdZCWHFPmB2dsn3qb2KSLHnoCoHI6e9DFnIKjj3qK0iUNnHBOeatkkIOOaabkVZLcaqMeCc4qaCL5sAZJ9ahR8NywHrU326OE8YLY4ppLqP0LkVuTg8VXuykMgVnHPbrVWO8nkLbKatm8zB3JLelVzK3urUSTvqW2vVWPbGuT3qv5txKSATtrQtNPBUbhzmry2yopwOOlO05DujItrFnbczHFaMNlCjZVc5pZ1ZY9sXJNTRo6RDLcnqKcVpZi9CzGUjIPHHpUj3TADBxUUSBgBzj6VKbTzCAeKtKXQzdr6jNxkzlvcYoZX3DAyBUskUcIVd2T3pgulQHAyewo5Sk+xJEuGXey59O9Sb0O7LcCsiWSR3LM/Xooq5BFiIAgljzihNbDsXgYlQ7jn0qhcv5vyIDjNTNBIVGwd+fanwQlZME49qpt9EJWIPLkIVcYXGBzSLDsdd/DHpmtaOIL1HNN8tC2WGQORntQ4XDmI4YdigAEsfWrPk4XlTuqSCQgDavFOlLORlsH2q0rGd2U44Qz4PHfB5q8LeNNpJAJ4qjOWV8IAT3PelLlIyXAwBkkjpRGy3Kd3sXz5asBnJHTFKZMrgcEVWjdGt/OEgAxnHtQZEI3M4Ipt2JSvuSHcRljj6CmRqZ0kZZBtTAK55NIW81SikBD1Ip0caRofK+YnuetCbvcNNh0SCN9qLx19zU65ZjjA9M1FHGy4J6H1NXGEeQqdcZPtTSb1E3bQgJI5GAScYp4RWOWU1MMLkkDPqaVZ4xIod/mI6daaiTcixtXiNc+9RG2kkYi5kBH90cVYe4BkJX7vYnimSXRIATr7rVXWwK4+GNEX93gY6mlBDS5fHIwBUW7cuGfGe23rTDbiXBfonCkmheQmXGIXJ34A6j0pjTFJBufC+o5psaxEOrySBh096hWOME5ZiM9+M1duwvI04pIJpMRMWGOd3Y0skOGyQq56ZPWqcSleiBT/nvRFb4LFyJAWPTrntVJ9GTaxMzoV3ANkHHNMSbdu2fLg9W71KEkBEZTOR/k1HcRthVxwB1obZUUtiu6RlmZm+Xrx61YiufLVhGvyDqe9NiWMMGZS6jg5pXt3nut5ZYIV6IvU+5pK+47x2ZWkJkJKAcnI9qVTNuOChB6Kammh8s/uyXA55qNoSzbo3G3PAxU3aKumtBk6yGVY3KxocbiF6VSaC4jWSOG4d0J+/tAJFacsJ4Lkk55wM00vcSugijjjiXjOPmY0avcFK2wmnw3ItupEY65OATVssFiA3MN33kAxVmFWdcOU6fdNQ/ZVO5mYKD0ypyR7VdnYjm5txTEEjjkU43dA3T86atxb27MyzxtIT9zrT3tyI8xwjZnnfkEfhVWcQWymSaGOEfeDev9aJaEpXJLm7LEP5kZYjpnpTWuGb7roxx0HWqcN7aXKlYrdn5/wBbggZqnqupGGPybSyuL6Qcqka4UH3PpUuVldlKOptTymCEyGTDYBABpts9xfzERB5JQMttXJWs7TtOmvR52pSBSBg28YwB+NdDHBFZwBrUqrlcFASD+JpxTb5uhMn0RGqva20s2oM8MeMAqoNFQSWLyMpu2y2MrufI/Wim7dBI8QVxGoC44qCRyz5I79qcqFyeMCpGRUI2jJryW3I6lowDOy9Dioiu48n2q4sbtF8o469KWJEQ7pGQEUnC7sXexEiEdvyqZLcHLuR6c1WutQjXiPls4ziqwnnnBIyE7VUkob6gryNUSww8llwO2ao3WotI+IRxUUdm8j7pDjjsa07azRONo571PPdWSL5e5mxx3E785Aq/BpzDDNycd617a1ACsVPt71KUwBjqentTVN7sOZdCvaWHAY8celX4I0Q5HXoaWPzAmGPNNKBUZ5Gwo960SXQm9ywZcDCjNVpC/UfKKS3vowGwCSOneo7udnTKqRn2pt3W4RQ9QBIoLZqYSRqGyRmsqJpHk3FsEDjFP4Z8nJP1qVO2xXLc07e9kOQiYTPepJZJmOSwX1xUVspLKinaAOSOuauwW25xv5z1q4ty2ZDSW5RTc8h3cnOM1aEBwSSMelWLiBY/9WMHvToYSwBzn6nrVKNnYHLsZDQSSXShARGvJOMZrYiypHGKSWRIlIGPw+tJHJuwQAT6mnazDWRbjYFueTTHyrkquR3zQqOWBJApZlUdZQGHYmrvdWJSSYnnMW5HAqN2YkoON3GfSpEaPsu40o5z0U9qizDR6E8CusSoGJx19arXExhfanLt0A61MpCY/eHPTimeVGZDJy0g7+lVJ3WhHUdGoVSSVBPUjmoZYhcxPFIfkJ5PtUysApUKBk96RpgFB+VR0wKfQdrBHbJGiheQoyA3apdkaHAXJ75FVXv4oSUzubHCqMkmqTtqFwwKARIecd6Tkt2CTNlJI8c8Y6UryfvFIckDOQoqha2EpZWkkdsener8cUinBUFvenFt9AdlqQi5Jl2ICZCMKT2q5FugiAXv1yec+tRWlsys7uMyMePYVZSFlXJxzxmqs0S2mRSsSvIDZ560QIUyuME8Ek9qmEQQ4bB+lTSIEGeOmcnsKLMOZIjKZAIwPeoZTIHzEhZvbtSNcIWUISWPTHSiGSRiQEYgngk4oZKuWoowGAKMHIyTmnrsJJfnHA5piLkgYbHTg9KeVBOY0GPeqTsGjI2YCUM0eRnt2qSNlKtsjwwGAHNOXc7YWPcccj0qSEbs+ZtVPUEk043E2VlXdxcuN2eApwKuwzuIxHGg4/ur+uagmkiBYqnTGDjgUsLSAHZ5SHkAsen4U09bNiaugdpPODsWPGevSpHBKcjk9MVAIwAC8xdz3qY5CgoG4HrzVJgIm5SB+p4p/lEHO4jjqe4of5gGVfm6euKgkkWBAfnlfP3QOf8A9VCS6hcuSRSRqAJQSew64pC1vHH+5jluJ+gV/lU0xLmNiY2ZlfAYkDgegNOWYS4CRliOQRgVVkhatjNtwyrLNGiSDIG0/KvsKcs4jfiEE9yzfyqw4laLcHJUfeGehqKKMlwjMihucg5xj1pW1HdEsl2doIjQZH3d3JFLLNIxwrkAdMDOMelRTRyMrrDJCj/33ORtqwh2pnEIUY+Yg8n2+tVqToEplmiYi4nLY+Zh2rNj0wQqSoBmY43u+5gDVyUGR2B2Hf1KpU6GS35WFGA64XI//XQ1fcS02KAgbywso5U8ENgCnwBoAJV8nkkbTyakmnnc+bJbqijAAUZFSK8eSyFgx7bOPr9am/YrUMJPvkJC56LjGPpUtqnyAAEjByNvNMlkY8RZaNfmG7ila5kkwyzEsPl+Q4Ipp3dmQ0yRnCP5eRg9yMj86KzWs/MLD7dcITnK7sCihu4JM8OhRy3QgDrVoCOPlzyD64rLm1A7sR4Cj+dQAyz53Nx7ivKcowVup2JN6l681QMdsIzjgZqnDDcXbZJ4Jqzb2oXB2/nWlbwuV4A/Kou57lpJFCOxSNlJ+cg4z1rUSMbQI15AqxFbqBuJG/tTkdYyRlQPUiqjCwxsVqSAW6mr0YjiBzjOKoz3hUEIefrUEcxdvmbjp9ad0tBWbNyOdfLHIPXiqctwAeAM+9QLKu37pyOlMlZmz8pqpT0HGNiz9qZ8KCAe9QHMjHexYdMUyCJslnPHvV20gyMgAA1CbloNqwRABQEjwfanvCx5OauxRIpyxAHoTVotEF+XGMelaqHclyMeGyxluc/WrL2wSMN3GMAd6lzlicgD6UE78be9JRjsO76ElltWLe/3yauLcHnaO+M4rPjh2yDLZHenX0jRxqIgWZjj5R2q07LQiSvuWrtmKjceveo4gxXG4haRQxiVWHzdTk1YiTaACRmndt6D0SsN8lWOME5qTyhGp3nbipkKDqT9QajYqTk5I7k9KrlVieboOGZAAucUwxKTgD5jTPtqrlVIqNZGaTd1pXVrBZp3Lo2IQrE4FRzXEanEalseoquVOzLDbgdSelZsMkt3c4txlVPLZ4pOfLpYdr63NeBXDNI78kYCg9BT2EvLJmpbVBGMyPu/4D0qTepJwMjPHar6EtlVbVzIrE5z6CpWs94AfJHfNWQzkjYQo78U8RBgWZnJ7A96ErbEuQyK2jUAIqrgc5qRFjHU4UdAaI4lLAFtuc9TxQksG7by3OBk9aaFdlhDGqZBp6yDO4KSfWo1fH3UBB/SpFJ6Yq7t7EipI+8YTg+tOmLlh5YwMc4FRuX2kAgD1AqF2l3DZsPrmi+lgsPcygD5zj6VCfIK/v5FYj+DPNSS2z3G15JAqjsDgVJCqQIVRVyQe1KzuF9BlsqlgERwOoJXA/CrQi2DcU5PpTSZApIJJ7EnpTZbYzx7bpy6nsPl/lVNaBzXZM0qthY/Lz3K1XkikchZWbywcgA1YitoIEKxYUYycDGaYUBYYDEnpik7rcSsO2qF+RTkdM96ikuI4IwZGXcTgAnk/hUqw/eZ5HXIxwM1HBp0cTmRFyx53scsfxNOzC62ICstyiNA6xq3J3LyPwqazit7RZASzs3JYgkk1cjiYsCMA1CEBbDElemccYo5UncLkqyxuVKICR/z0HT8Kl3IxJbAPZU4FMDAbgSgHuvJqTCttYEjA7cYq0IqyBlIDD5O+DioJfI81Iv+Wkh4+fJAq6YTM3Dp06n/AD1pi2ESsXYKzHGSev4U+W+ocw63tlTKjh2Ofr9asGMw/dUkgHGRipkCqx3yLkHr0qUGF2XdnPqz1XKhOTKxciMllyD0B6VBJerEq7o0j99uc1oTLDG5MZjI9DzmoZpA0pfEfqfl4yKVydTNfV4FR0MM0jAcCO3J/WiLVpWh2W2n3DOG5LQgfqTWo8o273liGDkqOCDUB2jIhMhHoQOfw9KcnroON92V4bu8d5IpLVYwMYZiBlvwrQeQMh/cGPgbvm4Jp6RQxxrJvmDMDuUKMD3pEKO42tIUyMBtoNC0VwbTKqRqWIw5GONrDGfeq11e6fZRgajPFCzNwS2Cp9MVqXbG1y5lEfoSVx9Ky2ls5ifMMc0oOdzAHHv+FDBXepBP4j0yGIxx3EMsrDhQjEkH+VS2lzOzBm06RoivHKr9Oam3QTOioIXPdtgAYVZjijt0KxLGuR1X5gc1HvdSnYm3xSNHIuxXOMxj/GiojHtKnymK9QVT+dFUmQz5/ttO+UEjcT7Vfisdg+YDHpVhrmGPpj0zVC51Au+0V5bjGO7O5NstSeUgx0I96cLtFUbm7dqy5vNlGVzT7a2KygSNwe1SpO+iHbQtyXTMpWIHHrimL5pG05+taaxRIpCLuxx1700QHzM4wKbTY0VVgfb83TGeetOtrRXJOSRV94CykM2M062hjhVhup8mwJkkduqYyop8kKg5ONtJ5oBwoOKgnMjrhcDNXokTrccdhk2AgCpo5+fkIKjviqKRGPCscu/erPlBcqrHPfihaIe5eXHVh17ZqdRkEIMnHHtVa3jIdd7AjpnNXGdEIJOM96uN+pElroUispbD8Yq3bqyjJwRVW7vNpUW6byTyaR7uSThNoA7UNJahq0XdiLIzE89uaV5o49pYhSRWZI+wDdKM+1Q2haSV2ZCVzhcnNHPqPlutTWa6iBBxuPXNJ9tIDFVGT61WSMuSWIA6CpowkQDMM+nHWkm72BpIlJnmUHoPQVB5MrHDMTntmrkQkdfkjOPWhLOTeQ3HvmqsxJroRRwQxnLcsOgq0J8EGOPg9OaifyYQyvJvJ7LREWkJMce1R3ajYT1I72Ke7BjZxFF1IXqfbNPt4IoYwgZgvQKBxVhI1xl2ywPpShwj5VMkj+I8UNXdwTsSQKcYxhR1yetTLgnPkjPUVFl3ACBV+nNTRiQnDGqVrku5PHv2novtUbZVGd3AAGTz0FAgLHliB6ZqxDaxKeSuRzyc1olchuxnRCW7JZSYYemf4mH9KtW8FtA2QhLf3jyas7oEfl859PSmNPHyACR64pcqiF7jhKMnC7gOeTU0UwIG5CF56HFU45FJ+WI8nAJpjXIUnEeGBp8wON2W2nJx+7GPWlMm8jjjoOO1ZMusQQHLFBxxvbGfwqNvEPmFdojVhxlVzxU8/mPkZt724BVSOy4pkjSD7xTcP4ayU1GZvmSN2HqVOP5U6K886YR4QtjdjJ/qKbdwSNhCZcLu57YNTEBHHnTIh/uk9apqiqo2sGHXIHQ08CN88qcDqRVK27Ia6EjzwFzsfP0pfMAQsEO4fdFRqqkny2wBzgAVOB867WLMe2OlF76DFjkJU72UGlbzpsjztinoFHIpill4LJsP8W3OKkjURkqrZX1J5NVrYnQfCpClXlIAHINOIVnHcdcgYzSZYovzKQemRRG7O+NuSOMCjyDzJHePAGxjIe1OUADbhsY5wajYlGxHEXbrknGPahJLjduXyI16ZwTinYCzvRCmEYL7Ch50YuFjkdm69DxVYNdhiDOmP9wjNWownk5J/eZJZuau9ybWFjcScFGAxyO1PcRGQNsA3cEKefzquSvRWz+BqzFLjkYDdCeaExSdgdYlB/dgA85Z+lUZ5QrsoWNlZh8oAzU9+/lwtIxVugCL8zEmq8FhM6hpjHAjfwJzIR7t2/ClK+yKja2pMxRWjjmWJZj8yqcEkfnVuJgwC4iTuw8sDH0qubCOEt9lijhY9/LyT+JqZRu/i5XIwOufU00geq0J2Yp5kkJU7flGACfyqGeJmb9+RluQGPQU5lIiXDS7m68dT7UjQhn3yysHx1YEnFUyY6EEttaibdLbRyBQBlWJ6d6lxA0YaKKGHBK7C2Cfp7UBYgxC7+emBSlEwWbzSCDz059Klj06CbUCkNIoRP8AlmCSKIpIhEuwMG5zlcg/ShXjBwXm3r90j1pDOyAnIGRgkr1FKwEsTucpGz4PfbzRVeO2uLmVWF7tVRuWNABn2Jop2b6AfPyoWTOetPt7fMmTirYtiFBqaBI0OWHPrXkuN3qd6VkRrFzgKTn1q7ZWgeUCU/nSxzRqfl5NNaaTzCRxVpJO7FuaE6QxcDH5VUmuVB2gEc1GoZ+WbJ9DUMgbeQoqnK40u5fV8xgkkKaiZ0LALyfWlSEyIFLnA/WpFRY8YUcdzQ09BJpEsCnbkk4pZFUIB3I60yS5jRcEgn0FULi/beqqMZHGaE0hasurGZLlpGwAvAxT5rpAhKtnBxWOJJ3ABY8+lWYLWTOWXkjvS576IaXcka8mlG1FK+mKltxNMSzucrwamhjkTaRgHoCKkgtwHJ3HLHLc0L1B26DRDg5Lgk96kSNmyW4z1q0yIijb8vuaMrgEq0n0ppXYr2RVcLHCzMAMDrUVojSssgJjQHgDqanuIvtTRkptjT+H1NWkiVF3Hk9AKVveC+g6IL0OCPU1MuN4UEfgKZ8xQBFVQe5pCJDHsEzLz/CK1WpNy2ryKpyyovqagaVHJHmbz3waSOFdxLKWPqxoKZc+WFUHuabb6E2RIhjUZVF+uKnWdc4BJz/dFVjhQqFgPYHk1YhijByCXx2AxQhtCRJvfc65DdMnpT5SoYZKq2ei9KeYywyIyBn1pi2+5syFQR0qrWESeZGoJklAAHQdaSyuhOHcRSqh/vLgmlMAZ1weM/MyjnPpVsr+74G1cdAaeqJumQkltuxCo77jS5cyHIUcdcU8FU++jMfrSM8jsowkcY7ZyT9TTs+4r+QpRyhO/aPyJoIijx5hJ4yRnNI0qkbXlTOe4qG6ubOFlV5Q0hH3V5zTtdhdpDbi6WOFjBG0ko5CAY/Ws1ba6vBm6lZSf+WMHAA926mtQbJHBU8MPp+FWE2KuVUAeoJqWufcafKZ9nY28GdlrACP4mXcx/E81Z2MXzkL6BQAMVPvQnmSNfc1UubwhttpEZHPByNqA+pP+FO1hJ3ZZN40ShfNZRjGFbpVYzxySfKHkl6bUy7H6noKjgth5ge8ZriTB+ULtQfh/WtGGQIFVbdVRf4QMA0Xb+JlPTYgiSUn5kCE/dzhj/hU8bqsLI8MjuB3fgn3FP8AMMm5jGNo6KuRipRnoUQdDx2rSL7EOK6lGKGV5VN1wi/djiO0fjWjCZFAaNOB3wSc+nNRScuTtLLnkp0/E1ZQGTCLC/P3RuxihKw3sI7suDIN2D8yelNmu5HDeRbhmAwBI+BTyiBtp2KScbmOf5U5mjUdQTnk4zQQylG1+5JkiiTPUI+QP0qe3mm3BXgQ54ZlkzUxRGDbCF3evFQndgmNkHTtUvQq9+hfUbjtYKD145qcvIqBGjXtxg4/Gs+NHVNkktuknpkcD3pZZduNkiMcdAOfetFLS7JtroWnuFDndIucdFBNPMy+Tny2Y9MKlQxb9u5pYk44BOSc/TvT2JICo/K85VqL6XJZJCz8M0cioefu7anLrwFQqDyTnjrUILOjPs3LjBJOcVG11FbKDcTRxJ6SOB+lUlYVrlgvulAPljA6nqaUgFduVC9eBVRdRtWU+TK8jHp5cTN/SnQNFJPmQ3LNIcZaJsDv36VW5NtLF2SJcAbyVHPzNTFDIpZGZVHYHpT8PE3ySEpnG4jkf/WqDU7qePTrhonUlY84IyeelJuw1qTxzJPEtw8rtkZTg5q0iRjDeazD6HNVbZDHDEGZSyoFG3jnHNW4pAwVeSw/2+tUnoJqwjbBCJMttJwDjkms65QuV3M2xDwCuQc+ta+/dK37rdG3J2Lux7VBIsWQMSgnOBjHNG4k7aFJVIJChQOu7a2celDxysu4btpPbt71cHyrltzHHOX6fSopSwjYJGihscZ6/UVLXcpPsVkZtkZZdp5G/aOW+tFQyTWao0dy6bSeVYjH5UUr9mP1R4pJO7ZKgECqhYecN5wpqVCx6YApGtA7gkjJry3qro7yVWXaNvGe9OiLFtoBY0qRRomXYfSmSXccTAxj56OXS70C5qWyk7lYqD/KifyYzwwZumKyTNLPLtDcY5zUqx59STx1qudWtYXKyy9+UTaox+FVWuZpiVBz609LKSVgcYz0zWjBZFABsJ+tZ80qhVkiglu8jDGFyOpqzDpwchpFyw6CtSO1KqATgHtU5jVQdpPJ7VcYdyOYqQW8UKltv3eOTUwkDAbUPTPSpkiRBlud3XNTp5aBcAnHTNaJWJbRXjhZyp2hR71N9mAIO7OKbNM7qUjwmRgkDpSW8CldrEtj+8aT5dtw1eo8pGq87jzx3prEn5QmD6etTbo1AGMkelTBlK5WLB9WoUb+QbFXa4A+XIPOKVUORgAY65q2dzLlyvT+HrUDQxtwSW780WC/cbGY92GbefQHpVkED7qY9C3amRRKmAq9evFTKyorfK/FUiWRO25gG47A01Y2c4UHcOC3QCmv5k1wh27IkHRurH1q9lmRdyhR29KpK71Bsht9PRZNz5LerGtJIlUZOPzrPOF5Lc9zniqslzG24EySY6rGMk1ako9BNORrvNEp2NIh5/hNV5JgXKQLxxlvT2HvVGzEjsywweUcfM7NyB6Y9avo3lpsXbx7f55p3ElYernON2B2A/rUu0F8YXB/GoTIEHzDj1qOS8crthRQf7xOaWi3DXoXHjY5J5HTmo5AFyvyhgfTFV1uJGXBbGPQYpCpdSctkdOetCa6BZ9SrcWu+YkStjPIx271Ziiij/5ZngYyBio/L+b5ix79+tOaJJCwlJIx0z29KIxS6GjbsLFdxSTFUb5em0DOPxq0UbC4ZiAM8cD8ahhSOMBU2heygVIZUReVbjoAO9FiJPsHl7AS59yagmcKdwGFPAY/0Hegyy3ChAvkcHJ6sf6VJbrHC27yiWHVnJ6UwVyILMRuSILnpI/p9P8AGrSMY2Xdk8Y6daRJBubO1AecKM4qF7ksP3Y3k8AHtjuaNFsPUstc7VOELN6A7cmkjuXMJEkSLKepD5FRQZViZDuOc/dwPoKtY8zb5v3cY6YxVJticbbjRPIcIGIUnpzTyskmFU8/Xn/9VEhG0AMwCjPzdPrVR5ojtADE44VOc++amTGlcv7PKBbKgHuBnBqaFZnUTDc0Z6kjNUbZJJWHy7l7qBx+dSMFI2EuexUEgfkKrpdisWFlWUZj2EFiuQO4pUPJDsuTwcDNQpDFEiqqgH0HT2/GrEJGGACAjHfFF22JoMLH2I4wRgZNWIoQFDNtxn5suOPwqFE8yTAKr6knvUsBt2maNJVLKMMwBAH4mqW5L8h6fLJtCK4zkEHFWH45eNW7nJzioVeNEzsiPPVgTkelOicHH3CvXaKrQm1xDh0JIJY/wqMAim+RCJd/2dDKgwHKbjVgKcjaFC9cbh+lNlkUnEVpI5PH3x1oJ2ZPFMEba7Ou4YG3jjvxTnvreBf3twqezHqPp3qpDZzyRsbxpFBPCR/KB9T1NWILKOMBookQnqQMk/jVK4NK5IJInjVgzOHGVG0gVE9s926pcM0VsrBljjBJb0yfSpooXMhyXG3virXkoMfNx14Sq1tqRs9A+ymRyBEzoOT2Gae9lGcEqUHUcc/zqKSIbidrEe4wKl8qRUDMJRk8bQCD6Ypi17jBhCBvdcKQM55H4UiFWjPzS5AyCCP61LGkpj/eNKobj7malEkKAKZMqAcGSDOPqaEJuxl3EdxNE8LXE0JPdVGcfWqa6JbzPmUvO4HLTzt/OtvbGzsFkVRjh0Q8+1Qn7PBIWe48vjI5Iz+FS49yk9DPi0mxiIaOyhQ9flQtn8TRWmkyMmIthx3wRn3opKKQXZ8+CSCIfMwJz0qvcX67sQqc1UhtHY5cHnnrV+OyIAwK8pybWh6VrGeGuJpMNwvatGG0BAJBLVZjtnC5KjPYVoW0RCgPyRycUoxvuFyhbWDeaXIx61qJbJHEXLAY4x61YVPlA2jnkZNTwQhjuZc561pGNnoQ5ENuinkKcnkZFWNjMenT0qYusYAXp0qKSbjCjqap26k6voOZliU7m2/71VY7uN1YhT14PrUTwM7kkMxHqaljhCL83Tvipcm2UlYkR2/hOfwpUWR1O4HParCMgGdh44GaRZZnY7Ywq5+UmqS6slyfYRbTC5k6dxS4UH5RU6pIyne2PpR5W1iMj8KLW2C93case4jOT9Kl8khS27gcZpgRWPGT+lDBHPIz68mqjZbibZN+7CjBB4xSqCSCMDjFMDBQBt+UelOdztHCqPrTv1EOwSchifT2pVThjwD7molmznJOc44FG0NnIbJ7mqTQrEdzL5RVII2ncnnaeFH1p6C5fJcrGn91PmP50sUe1sjH0FK7FhjGM0PuNeQwwxIQ0g3n1c5IptzcLFCEtgHZjg7RgKPWmyBucfnmoGBWMlcHB5J6Uue3QfKXFm2LshQIp9eTmhpHYlM8nuBVC2LSsGhzKR/F0Rfx7/hVlBOyv5kibj1KKRgetCbkVZLYkXBkAbLHHQ9R71KGRSMnk9gKqQWphLMrkucDcec1YYHdkkKMfdHaqUe4NEzuqqmMkHPemSzsq7UQM3UA9BQX+cBsninhRgkgZ5znt/jRr0Cw23jeQI1xLlz2XgZ7VYSHblsIT0waZEpCkk8nkdyalYkj5VIIHqOfwppW3I12RHcMIImkc7E/n9PWmWYkmUlo9g6De3zE+pHYVFLEGmWSV9zIMpkcKfYVLHHI7Artywydx4A96La6F20Js+XnDKSD/DzSSysyE7QMj7x5NLbCFcbySfQDitS3t7UIzNAJT1JY8AVrGDaJlJR1ZlIoZcAMQMbjjGKVkWMDIzg87gQD7VOyOv7qI7Ecghc5z7UtrcRMGWJt0qttcvnk+xP9KOW2g79SKPZv3lNvGT6VaM6Biyo0h24GT3qaeAKEY7GkY8l+g59P6CpDavbAvKFEh6MV5HvjsKrkaIlJNGRLYz3T5uFLwhc+UPlT6n3q9Zx+WmFVFHGAF4FWSHLMS7lducLjHriqs10XPyMQe2e39KTpqOo7uWhYxISI0Z2I+UALQIGL42OWU8oKijWV8tukLEgkqcY9TTZ2MLtEjfNwQ4zu5pJdRa7IkdfLxhWU544qIySAHOevXBz+VQ75m2xeYUwM4zyakki+ZEAUsDkN1PvS32Q1puPikY4CFgvfPerVtDI4AYKSeQAeoqlaQN5m5nBboPT6VoGFy+3YpGOozxQo6Jim1eyLhjBRHYEZ5JxgZpY48kgyBc8jFLCJDHu5IXkDPepEmG5hIpGfQ96uyMG2KE/d5wSRyCOKeIQDhyNx65/+tUDXV55XlJcHy+wIGKt2zXDlWaVCw7/Liquris7ALaLaWDRsScZOeKkKJGwCoEBOVwT0pfPliyTKMH0UGledpDtd43YDpyKd0TZizOmw5wFHUseM023khmYgOm8dgP196ikRZo9ssW5ehGcZqBdK05sn7PtOeCXbn9ad2Fr7msI1kj525IzjGOKZHbfu8JlQMjg/r1qmZJI0+QvsyBg9cfWrUAV4xI7IyjrliP0p3Fy21HLCwbb5sm1ePvZpXE6Z8qQnIwQ43/hxTtqgHCjB4684qKLfCVfYfYqSN3sPegRSa31CXdIbsrG38McQXH41Ja2sUDArDEzngsSWY+2T0q4s4kHMcqMPcEGpy0BBSR41LYGWQrg+1JQ1uNyaVivJHN96I7R12q+T+RoqdWReDJHleAA3H50U2hHz9BZvxvxnHT0q0sKI2RxRJ5rKQgC8YzTGDAjL5bHNeXax6VySQqHAyM1NEVBXAz71VOxG3OR7HNTm4jRMJk++KSdw8iyuMEkcjpUkcsuSMnHtVOJ3cEkECplkKqQcKB6U4vsLl7lsREruOefWob2aC08oSZYucACoEusqSCxweB61IsSgtJJgkdyelVpuKzLEsoJG1Mf1qS2UHJOfpjvUCup2lRnPp2qXzmAOBg+pNHW4n2LBBUbVUDH8RqFJFDv8+7acECo5HLqFLE/Q0sKogGFPHOfWiTT2Ek+pZExIACZ+lClnBJIX6Godx3fKoBI71KkGF3Ocfh1o16D0GscAbm49BTJrlYEPlRNI/YAf1p52AElhgelRZLthcrj2p6oLJkhmZiMLgnnntUwZQvzEE+9V8EHJOc9AKdkMegGBz70bDsSB0GWZtgHrUa3qvkpGQB0J70mdzkAFiB+VIBvBJGGHYelNNsVtdRVkc5C7jk/n9KesyN91T16g5pqBSvzFS36GnxkjCjj2AoSdytOgr3IRDiIu2OAO9UkS5uG8y6XMecJEPuge/qatCLe+SwB9c1YS3MYDSDbnkA96uzYlZEaOzRAAEKPbGKkLDau7gflScKyb2DKf4B0J+lVp9QDXTQxxgOuN3+x7U0h2u7Fk/vAFGDzxxgLQIhEzCSQD9ce9QxSPtOeozxjqaCJJDuG5s9/WrUWVyDopnmlmWFceXyrlsBh64p3mOcH5cgdzTWtWBBGSWPPYDFIiSB9xZQRznFNRd9R26l0MQw3gIWGMHqaCwDBiVUemKBH5ioApLk8kdPqasJp8rYCbRuPU8YquRszdkUTKnnlCVC9SQOOe1WGb58B2c+oXrWha6Ihfa7LtP8QHb/GtO3sdMjARhM4HPDY/DmtI02iZVYo5pIpHbeq5I/D6Cuk0bSr/AMn7UkeI84wSD17irE+o2cNuEtrIo5wMkhiB3xVSPXGitWiWV4oVYlQRu2H0zTSjHVszlOdSPuonv7SKzuWicK7BctIerHuAPxqnEkUTr5aqp5AYnOKq3GsWRmBurjO5SSVyxHPpT3nL29vJGoEMzBUlJ2cev0p88BqnNWuX55ljVH8sFiQPMIwEAHOKgvJ9myWbnOCgzgEfTvWXf3LCNYjcuQSThhww+orLmkSWOM/MAmCCSfl9s1lPExjubUqHNqzb85pkkWFtpIzz9ajVFWMc7j3+XvVC3u0VGjJV5EGFIPWp3uIfsgluCEk6AOdpIHt60lXp1OpUqTjoTeecbSZCP7ucfnTt6FTnao+nNRW7LKB8wyx4AGc1PsZCOo5xgc0+V7kOy0J1bYShOB6IAAfxp6RPhSpOG7bgM1AFYfKgBzz1yaVFUE+Zsz2bnj6UmZvyNBrVnKqU4IPBanwJIqMZJkjZBtzkce3vSQIkkTEqshGMhyR/Wn3MaBQpSIADdncT+HtTt1Mr9BhuIY9pM6nd2Q5J9e1aCPC4Xa+4ADjdjPtxVSK1OWjSFcNjJJ/lVv8As13YFYwp6EFsgmjVg7bDw0jAKYsHoNrAkVYW0ZgfMjRSMYA7/WovsvlEDBDqe3tTXiGNsSum0/eZuKq3czeuzLckBQ7hblMjPGcY9RStGqBnOAcZxnJqm0UzwFHLnB+8rcj6Uy1t5LdCFlnUlcneuQfx9aL6hZ9y3K8aEDewbjG4EA5p0EoyFWU4HfB4Peo2aURYZJcAcnORj1pqZj+Yl+2SePpTFYfJs2jLEe2c1BFJukOwMgXuTk/lVliznvtHqRzSIoVQCyuCvTkVWl7AtBfIZV3oOW7bcZqSIblJDDYTyA+05+hqSA7Dg+bgL/Cc4pWdNzZDkg/xR8H607E3ZCrGFso0mFHI3buKdzMdjSL838L9DShYuZA4XAJPlgr/ACrP0XUL++0iS5QwRzTZNsrjfwOhfvU31B+RZtmglTzLVopUyVLIxKkg4I/OiotH1G4v7Lzo4oY3DMjxKuAHU4OPXminoNN2PFl8xjgN8xGPaomUmYrnBHUgcU2W7IX93gHsazpJ5BiMMVZu9ePKS0R6SuaQ8snauTt4OafLIkEG8/gM9abZwERR4j2A9Cxqa4g8qXazKwH8Q6VXI1qK6JY5QyrtDc0sjEuS7cdgO9IpiHG4sRSO+CVUYI703e2rAYrAuAmTjnA6k1bRGZR5rAc/dFVLa3Cu7AvlupFXoht4WMdMZNOImP3BE4VifWjqBuKjPvUUkkm35VHuc1JEu/DfpjrVASqY4wOST7GpFk35CKAW55PSodoXAO3346UklzHCu5Q0hzgBRSatuBM0hQEZHT0zikQsc/MWJ/vHpSM7MCyqF+vrQI5Nu55FGewoT6C6XHFwOg+9xjFIxMgwrkA9cDpTljCkluT14polXzXGxvLUDBxjJ71SE/IFUIp6sV/vU5CSM7hz2AoRTIRIRtU8qGP86kCFCAw4PPA7UFIjA3A7WYN144zTYIFRmZs73OWZj/SpiyjhjgdMdxUJdMkc4zjB5oGlclMoVTjHHQgUJPGwYEOMcEkdT7U2PlW5AUH0qZLZnYKvzMa0irjsupEZXEjeWMA9yOlOYSSDYSCTznOf1rYtNDkfLuCsa8Ekd6ux6ZbwEKceZgjazcN7itlSe7JdWC2Odt7Jy4BO3HOTVmPSGjZmC7A5LZbjcfWt26uYLaymZoGjkhcfPI2QPY/4Vz8uvxvbKY42M7EktJ90DtgUp1aNN8rHTVSpqkXIrdFlVpE3qv3vLOSR3pL54xJtgyFUjYDgZX/GsxL6eTIDEJ32nAq/Ys7s5OdhxlcZ4B61msVd8sVY1dJx1kXpp4pXVCnlryAW/wAKWOOIswYcfdz/AFrMvWmZZZLRWkiRdoO08c8gHtSaSJIo991C8KE7wXUlX+p9K3jP+YXsvdumb9u0cUauBHnJDYPQD+pq4zwu6lUZVbONy85rCt5hfSy3CxeVBk7CGILDpwPT0qzLcFVCp5hUDqx7+5rT2sVrc53SvtuTvfrE4SWMwKhyDj88/nVWTUoijSykRAKdhYDMhB9KztVuZY0aRFLAr7dqwoI57y6c3chJzw2e2KxlWWyep10sLFrmZ3EN1Hdp5sKhNyYZBzkeprO1hnEZd9u0DAGNqqPYVT0wTQT+UATFjsODWxc+XLAySFcAdDUL3zNxjTn5HCXKpeShATGenH+eladrYQxBQszsqjcRyRVG9vYbW+KRhGLfLvYZ8sZ6iqD311cTbQGmJbjYpxgVklY9d0ZziuiNbVtehtomU4nkAwAeOnTmsi216C6AG8EEgfKeAf8A61Zd0IbmZvPibcOjKen4VFaaAyXTzeaAhwRgY/MUnCL+M3hhqMIe87M6yON5ENxCW2owBcf3v6VW1O4uryWMyMHkQAAFR82D39T9ah+3iyiKRyOysdzr2J+lXtMvre/dgo8uZeMEf0rjq0G17mhzuLiudx0NnTdSt4bO3WYLuKku542t6+wq0t9vji8pg5b5tuME/Suc1DTGRuNyL1wD61nvHc2+XiLOqcnAPyitoYmpTSjM5fq1OfvJncWV0JhmYqrdlXqfYVZLqq71Cn0yK5DRdQMtyisV2t0bvmuuZFLFtx2Hoc816FKarRvHocNek6UrDrrVGaNIkhRdvJPrUNrLftGRgyKSS2QAOe30qZ40Zc5zx0JwaVIxyoTB68cU5xk3cxSSWxbhlcqokgiGejc1fhaVWAkX/aCo2P1qrZW5lZkjiQ4OSckYx2FXbSzffJGYJXPUbZdvH401F2MZWY0ee4zDLtyMEMu44+tPjFzHESzwcYzuU5+lXBZtEjM8Tx4PJyD9KHlAjYbmU+j+vr6VSXdmXNfRFOS4KsA8ceCcb4jnH1HWp45FZdqFSOuVc8/nTUnjdjEksUjqMkDBb8cVZGRGAFQt3XZ196S1KdkIYW8sYMxB+Xhv88VTmjLfJ58yj0GCVAq9GyHDDg852kA0yVUQMwMpLH1qtLE7FD+y0PzC9vGbqd0mP6VNDZ3MDApdOBn7sihs+wPFOkkvEkTyLdPLY/MXfa2Pap2ml2hWtAq8EHeCfypcq3Qcz6kzySkglvn6fOvSjDlRIrRtnghTU1vI4kUh4QrDncpyDR9mzKP3iMhOSFxkCqsTcWOGWNC8a5UDqzZx61ws9zp1uXS01i9t7PewCRQFlBJ5CP161391bwS25jVFKlSCC3X24rj9LhvLCxS1bQopBDlUkMqnjORnI60ehN77kuj32lLYQR6fK/lJnILneTnkkHnJorZtYp5rdDPZ29vMSf3ZAwMf7Q60VLTNU4pHhn7qP/WDODWbFE5vJHYfKT8gParcUZcg9AD1arYi+YFSxPtwK8x3askd/LrqRRebKQCzEe3AqxfD9+ogHA4IPNSxxbTyu4emasRKoYnGD700hPcjEQ2oVLZI5B6inLGir8/BParWwdyefTim7UXOA2c9TVW1FzMgBZsBBtHTLU8JIDhmyvtTwx3Z6jsKbMjSrtc4BHIFJpDHrGiLhsZ6gnkUId8g8vO0ck5xT1jCgL2x6ZqVQtvFuTPP4Y/CmlcTaGbSXJxgEknvTRvQFVUYJ4JPQVHNcXBykEY6cOxGPyqk2mPcnN1O8zHtuwv5CiWmwk7l17uCIEzTx5HbcKrvqlpwqToSewJJz+FTHSLOPBit41yBlWGTn1zT/saxrti2q2ew5pe8NW6Fb+2Ii5CpK8hHCiM9Pxp8V7ESrGCdnBxuKcKfar1vp8UbMw3O/wDE2alaLZIfLQY3YyaaUhaXuETqzA5y3YY4pZcYx0z15NKFdSAHHA5BPSnBVeLcpy/cHtTWhRTCKv3h1PLHmnbAPulR3zjgehpzfI5w+49yR+lEUcoVl3EBzkjtj6VUVqabLQmhhM0gCAkZ6D1rfsLI28RkHlvKCSQ7cA++KWwjigtlK4YYCuNuefei7u4pJFhci3RzsaQJkIpOM/Wu2CUFdnNJubsht5rlyt3Bam/s7UE7SUiOBk4ySTWdb3V7Nq5WCeO5EMmxHII4B5b0C+9UXvo9P1O8mhgaW2guBEDKwzKBnGfX1FUP7SlPmx2fmQ2jszlS5LFT2J9PavKr5hGMrSfyOuGGdrxWlizf3t5JczWjsk0CzMy+XJlS3t61SihPnBJ4mUk/xDr+NWY08gIYl5xwTV2Dc8YcjknnNRy8+vU6FJQVi3YWquc4AA9a6GzFrCuTw3dAvXjrmo9JtlS1Dykj5c5J6VamxPBm1G+ROAN3X0FehSpcqPPq1HJmZPGqs4i3KjnB28A/hVS58y9me1lZjDC22X5s5x/APb1NY17quq2EjpcWy7mOVYjPP1pNL1S9uLhmuECggcqNo+gpu3Xc6Fhp25tLHRybcjaQqAbQOwqjd3kEaRx78yu4RQRx1/wqvqjyTIvkhi2eAOScViW0cok3yR5ZX3qSen+NJpoqnQThzN6nUlImwvLfxMq+n19ahEMKMRGOOuW6mpbKOSVCzhcfe4PWpfsbSgjJHpilyvexlzcrs2Rv8ilsgA9Kz9VuJmtLhIpNgkUq2BnIHPFXpLFwu47sdA2eBWPrUosoVHmOHcHdx2obZtQXPJJas4hITeO7tLIuw9NvJPcVrW8kkVvItruRHVVkw33iDnIPaktriKR96llU8+gJrQs7H7XKGtmJZT8ynoPQ0r30Paq1bL3loYkZ8uXMqFk4A+Xp7fStnUIY7XR2dJF8+VsCInDY9R7V0E/ht3t5L1ngL5w0K8cYxu9K5DVrCfUbOCKyldbtJCWBUbEHQAHuTTcbbmEK9OvJWdknqYss8UEJecnB4znGKo2V5eT3CPp0cjSNwNqli1dXbeG72WBEuoo2LLk/MMAj2rb083PhyNja3ZtkXLbUwcH6000tLaHRPG04pqn70n3MrT9Ruzata3EUi3UBxypB9cYPertmkk4cTLLHnhx/eHpiss+IM3kssWWmlYvI5HLH61dg8QxsCJEYE+2T9awqUlN6HHOE0rxhYvPoL2gSdEAhYZTccEH6VfstSS0jEdzlZAcDdz16YrFl8VpFqUZjjEzxDCLIMjGO3NVbDfd3SzSKGC87OThe1FOKw8lydTF0Zyi3VO4guFlVvlYg9WPep0mlDABcduBn8ahsBu+RFLcjtW2q2dsh+1yKH7KDz+Yr0Wm9WeRUkouyQW006MJD5qlhyFIXg1ItgkkbmSOcPnPzSY47VltdIzsqO2OB3IIrUsb6FMJIuQfm3eVlgfxNRdbGUk0roDAkmVcMSAArFgMYqJNGhBDSRRydRy2f0qWW+RwfO3CPJPCc/ialN3BC6pBOz+jBeo/Kk1HqS7rYLeyihVmRYU7ELx+tW7dijFVVt2flIIINN+0yMFxMwYHGW78+nQU2SBw5bIOF52qD39qpW6Cu3uWVjkbICY287XIBz149aewAjzJAU9TkdKzZtNhuXDMJS/QHkAfSoho9mHJMbkkn+Js/nmld9BWT3NQsxcu7MgHOWzwPTFOQoznDyNg/dJxVeONooSsMspGMYZs/zo2SJHnfIDkDkjafwppifqWZiFLMkRyTwc1AsoWQpNC0cjHhyBg1cgmaNcLlgBjPl9D+dRCZiCj8qWxkoOfbFXchNla90621JYxco+2Mll8qYxY+uOtUj4a05gPLa6XcPu/bG/lWw8d1EgSzlRIlGCjxAj9TVfyr6Vz9qlRY24VoYgCB6c5/Oh6CtqSWunrp1kttEm6MAkedlm5OTznmioNKm1O2zHcx27xgnBUuzjnjJ78UU1cabPEVlUMAigD2qeH5jjbk+tQ7TuO0rke3WrduxkKgqSfbjFeOm2epJWJkiXHzn2wRmpYhsdcKTgct0pIAQrlm4HTH+NG1WOcsT6g5rRWIsOlY5bbjn0pVQMuZDhs5BNIp2AnJXNP37YwVyO3v9aa1YbDBuMqeWOD98ngD6VNxwQefU1Grhox0wTnryamjXPVR+FGgO5GCW+Ygt2GOMVIsZLDeCCB1JpM4GB0J6+lMBZ5PkBbB5Y9BSBEm3acjaFFODbVI+Ubju+tL5fy4JBx68VDczfZo2cqz4ICqo5OaaEyd2zndtVsemajjDg8sSeox6VNuXlhwG7HnFMj5jYFWIPXPtSldsE7EyhdnQA9ueTTVSUHJO1T6GlBKr8oCknODzxVZ3kkl2g75SM4UYCj1Y9qpuySDlJba0ijfAhJ3Dgnr+Jq0Qqrwq7ugGagyoRQzEgjnk4JqOMrggk5PtVRepXKRXEJmYKHaNQcfIec/hV62tHCRxIrnHQNyOe2TVVEJlGVAHQAHFaun3EUMbO8noT+8Bx9BW9NX0CTstDfGnx2mnmOYuCR93djBrhdRvmt5CksISNyVDkZ+bHGR9K2dV1i33RkzFdy7ccZ+ox3rkdVure41BjB/pakFQ07MuwAAg/XNTjWuSyZeDpy5ryW5Jdk31wHkEce1AEWMYB9M+9WoUIjCRgYU9+5qtYR/ezliozjaefqe1bNiqSvtzljnnPSvnMLRVSbqVFvc76tSysnoUkd3kKkMF6E9MVfttUjXbCqlQvYrnNOv9Mla3K24UvnPXNU7W2vVl2+XiTHDHjb9a9ijTcbtkWhUjudjZXdtd2rRSMFDqRmta3jstNsnW027h90scg/UdxXH6VbtPOzyOyxqdxCDr69K1Z7+yhZraZ1SEEvFuwSSOgJr0YTdtTzqlG8uWOpY1CFbsLcXUqPFnOMY/ADsKpyXlgQFxlF4JQgE/UVhXup3F7A0flvEAc4znNZyaUBGs19cskD8khec9hWUpXlaJ1QwyUfflbtY37TUdM09zdXLSuqA7FTjLHpz6VzF7rDxT4ieMqV/gXhRSyxxfu/LlM4ZNysw2qvPQ/T1rLW1RZmdy3rgc5/+tUyu9Gd1CjTjeTdzc0vWpLhid+wR4BbGK6Cx1fz0AVw+3j5e1cFa7ESZQPMBPz444+vrWpo8CgPdecYwsigoF+bafapjF3JxGHp2bR2NxPcNECpOwHcQehNcprVuZJw4JZR0RuetT2V7fyzOJmZbdRkgDrnpxUb6gQZNgRo8fdY/pVysZUKcqUvd1IrS1+0I8UEe122lgOn/AOuunjtBBZyXBQW7kCM+Wu3zARyMf41yt/4ilWNBaQQx7E2jacgn1571TttevLsFb4yMjNteQDgDrj64pRlHpubVKVarG70OmvdWW2sXSxlYnG1y3oewFcZaa6bLA8vyo2bBwMdO/Nb+naOk8Ye0OLRhx5mTz6+3SuY1PTis7rJKskKt1PUH0FTJNWcjTDxoJum9TuNB1KK8t82x3v79TWR4zF00CBY2PPKYPNYVjLNaMDbSMg9CM8V0mneI/tD/AGa5jV2UdfUUJ3jZnNPDuhU9pSV0jixbXK83GIcjoP5gVd0/T5728isoJ0tVc/6+TICjHrXTXk1nIu+UBjjhQcfhVGDWbK0ZhLYC5gLAFA5VuvY9vrWcasVKx1fXKk17q1Mf+zY7O6ES3EV4efMlU4Gc/wAOee9dPptl5FrFNGVMTuVw3Xjn8RXNalcobqD7Fp1xH5krErI2RyQFAI9O5rptO03UlRRdCOBEZiuyTJreMeaV2jHE1XKCbdjbs79hzGzZ+78owDWh80mBIURx3ZgKy4IlIywOPXkk1OkZOSIy+D1z1rZzPJmlLVGvamEsqDPycqyIW579KtqpdtzxyMwOPnDA1HptxcxxZiktEZcEGQnI9qVL27lndmvIw5P/ACzODz7GjTqYSu3dFuCCVgGXcoPO1Xx+hqxaQhu7d8Bm4I/Ksf7Pc/aH8u+aNivJMnH0GKgXTjv/AH0olbGSdzNU81tLE2b6nTmW3hB8yWJDxgFgQfzpUljnRnhO9V4BBAx7H1rNsbSNWCqkSsCPmKjae/U1oss0ShpJIuVAAXjP5VormTSJkU8naoyPm3HGaGiAYDpjqFbgVHCZ2OTErdSv3v8ACpzcB1dsbdvGTwQfagTIJvPQkCXcW5JIBxTUW4f5PMVj1+70FTJLES0h3hgMnZ0NPhuUaQsqTbj2xwT6ZoSC7Q2JHUDDfLjketDSpEy+bI4IHGznHtRNcpFIUFvKSoywVh09vWoxcicbIVcMMcMBmnp0FqNa9t58eTd7sElVckNnHAxXI2l4L63s7S8upHiiMl3qIkJBUjgITjp6AV2Ye2VHFzEZgAR90ZGPQ1ztpf3U11YzSy7be+gmdYREpWIDhcnqxHU5przE97Gh4aj1CTQo5BLsQu3lLJy7RbjtJz7UUvhrUPt2nKZFR51do3bgK5U43A9gaKW446HksUOFGSigcZPaqzTFLgKpaQdDjjihhyRu4PpzTrKJxITsye+7sK8q60SPVt3LZyy/LHhh156mpIFdwQWUeo6YqeOCQYBcKOuMVNFbiM7kBYn+LFXy3dyG7ESqOigHjqBzTZd7qUAYjoR7VcLrDGAzAE1DC+8sY8sP7wHH4VTS2JT6kEduYwMrlR07kVciYlOoznkDtQVLuoIYAfePQn2p6pjGFUc84OaErCvcieHcWAyamjxDHggkdvQU7zlR40dgGfoCMZNJKNo3B+vGMZpuLWqFzX0GrJvJxxnnOKgnwzDALEdzUnlszfdJTHTNQ7PnOSp/h5NTdstJIVX2ncABn5dqmnGRY42lncog/vHAqibtWlKw7ZHXgnIVE/3j/Sp4YomYSSSrNMOjYGE/3R/Wpux2uSrO9xl4mZMHAYryfoKfFEkKMF3Es+5ix5Y0gkfzDgMAOnTrUgOcs65J457U077hazGyAhfvAA54POKheN5MKs5O4dhipZJE86OMsgY8gZ5xVuF1/vBfl6kZNVFXZV7Iy10SAZlIMjDqxZuP1rpdL8PWMmwIsQbGfm4z+ZxVa1jikOXds524KjB9Ku3t7EkPlSQpLGB/ANpB9eK7KKS3OerKT0Rz2q6PZILlI4leXON5UqE55AOap29pFp4CPCkbRrtO5fmOe/Nb0zWpto4nvCgZlbMqE4A5JU9j7VgXeofar+RjtIY5yQfmHQE56dK8zGyjSlfqdmHcpqzNG2lR1KqCKkVvKOI0bcTyQajs76CO1fzgeeQAP61i3fiOGK5CLvQqTjK9qiPM4pt3NYxc3aKOi/tK5tt0cJQvjuB096rXV/eywM1ssTHHUnAPrXH3+qiafIlfdn0/lU8dzd29vseOQRvyobpW9JtHSsKlZ6X8zf03XL5dyyRpGNu0FT1HcfSoNTvYZLgyzEySlc7mHJPsKyba6ufMYxtyB0Iq2ZzLlpkVn4+bpit02kW6SjO6X3Fm6uZbxI3dyuwcEDGaqLfXV7NHbSvGq7gu58hVHqTWhpunNPDLNb+YzQoQYnfjPpWWEvbIg3iBCFy4bmriurKi4apLUqyzSqXKSKHViMBeHHYj2PpSW8F8EeR4sKeMjg1ZWMamwnXCFZPkA4AHckVvwRr53lOxZWGCOp56YqXFJiqYr2at1MBEbbJ5xVDncV9u1b+lzIqRTwrFlT96b7vpk1BqWkJFK4kmUocFWB6+oNPeCwtrJWe9ijgVgrRb/nxnkqKuMbHPUrxqrQv6lqkFpBKNPhhN4uSZSfNRzkHC+1c40zy3JabBMp3NhQFz3xjpWpdaTYDTHn07UPNnViFh2YDDqpB/n71zB19tJllW5tPMY8FNw6d6U4yujTDRi0+RXfmdPqGgQ2nhpL55kaeU5IjO5YE/vPjpmuIj1VrqVEtvmRThh0BJ4yR9O9aE/i+1a2mhtI54llAzFj5CR6+tM8PyWF3ZvLcjN67/ADYGAoHTGOAKJPszSE50YSlVV30O4sYXGnokbAqqhSB0Ax0xWTNpMSRTqtwSSc/N/Cary+IIoE27xiPqVrB1TXHurgx2jFFzkueWb8OlZVJpvTc4aUaiba2LUWn3a3bxYCO0bOksjhFwOep45qszQJqMizTwSTx4DNE3ynjPXv8AhU02nzXkCRRC53N1aSQ7V/DvTbbwb0a4u3O7khBjFU4ynG1jpWJW83YilliMysZ9+AcLjAznp71etrmzeYG62RLjaqqMliPb+tTp4atIV6SOvTDPmr9ppVnG24QYx0IGcGlChyu7SOepXg9Fclk1WOTYYFSJV4RQCcc9TVqC7zMriJt3fOakW2t/L3fKuParcMKBVDqQvrjrXS5yWhyPkfQmhl805jiIOO/Q/Sr1pNbmdY5pY4Xbq0qfItQxWoK4eN9h6cc1fKRiMARg7xy5XJPakm3qYza2G3l1Y28ZjkvElLDIMYJ59gP61HFdCRFeMpE3o2WY/h2q5baPEFysUpOM5+UfjTksmj2qYu/XjFJub1IvC1iUXduX2i2kcBuNz9DU4vTGzL5bKzNhjG/b3qL7KWwVIUjggAY+tOmgYAM7kuDyFGc1S5t2Z6diaR5ZXPlLLjjl5O3vikAvWlRRcFiByuQcVNGnnbTIxzjhQlWI96DI3BScNhQCTVJE3SIAs8aKzSS+YQed3B9qQCZ0yZEUjgKDjFWIlJlIIAQjIUmp/wBw6IigF84G1BkH060WFzGeqMwIkYlfZwMfpzUbWgKnLuN2ekhHA7VougxiRFyoOVVhxQGSSHIjGQM8AHJ9aOUOZmYlqsMeIwfQZfP9aftkDqmGJA5I7VPKVklSNVRC/OSMDHrmpGfAEY8tQp/hxz+OaLLuVzFNFlMpVXkVh0HUflXGXVvpd1MJ864kMLMCkKtsUn7wHp0rvEuoySjEBjlcZGcetYtnLqmmWsVnFZx3KREpHKtwqBsnI3KeQfWqsmRK/YraNcaYbeOzsLeSOMKWiWcMvmKOpDZ596KuadYXMc+mxyBHitDLPLIh6yPnKKPQZoppdmCk+qPOo4wR1LHHXtmpbaPyixbbljk5/lUIk2Ly5x2PrUAlLv8AdOPUmvLulqj00mzT3q0m3cvHPFEl4qgKimRz0B7fU1nKGZs4+XuegqxagsSwjJUdzyKcZsloteWqjdPslY9MdPyqRRO7EDCp1wOAKWSDc3yA+vAxTXlVGEe0K7Ank8Y96cr3uyemhOuxc+YygZ571MAHUMgOB1z2qjG+ZBtwSeD2xV+KJhGqO5HrhuMVcdRT0IiG3h1wo7HGKcwC4OTu9MdaW4BQFbdQH/vMc4NMd2CjDKxHVvWhvuSrMc5Uk43Dvk1WuLVrgbVd1B644yPrUiucFt5PsBQkwYkDJXox/pSjJditijZ6XaWyFY7aMKGOC3OT3PNSLaQM24QRKQfvKMGrcjjghQU7e3tUUszhAER35+6PX60tG9CtbainnJ5444p3yrGCxA7HJyc1SP2mUZkdIgeMJ/jTo1WPLDJ9M8k/WovqWXUhRWJC4Y9CKlERRiA5HGc1W38H5mI/rTS74IRnPqAtaRsI0o3GzEly+F+Vdvyj8e9X7iGNoguJRKEGAwB6/Tmuait2MvmTymU5yFbAVfYAdT7mrkkzbCRu3hfvs+Tiuyk0YVIu9zN1Jv3fkMQjbh8rD5j7gnpWUsZO5lJLb+FHQr65q1q0s8lsxaJ5SGysu7p7elZdrqCmNip5xwMcnHSvLxmHjKtzvQ7qF+WyOmtViWyWS43RoFyCwGf1rm9ffS3vEmhZppV5KqflJ96dZaHq+t3BS5u3RiCyxKnPHf6VmXeiPYkiK5Wd25IXg11JWjZI6aMKcZ357sfGz7knyrdcIAOlaFzqjyRxIQDxjpwtYf2vyFVJhtcjjIxWhaahbthW2SEc4zyaIxV7nY431tcs+YgO58o4wScfLVnUXtkigW3cysEDSv0Ge4A9q0dIa1aZZGhtyp+VWmBIj4+8V749Km8UWdqbeG10bT2ZVx51y64Mp/vAfwj2raya0OSWIXtFFmbBf3jNG+lhprrGCiDd8vvWN4ivr1r5jqHmCRlCnap4/wBkj+tdD4X0u70Oaa6WZQ8qYeMLgEGnXcP9oyPJK+xQcDjrxUS0jvqQsTCFXRJrv1OStNRkg7EIeuepHpXUadqkc5VlLAdMHgiuelW20+9DOA7oeO4Hv9a6CPXrKW1zHH5kmcfd56VnFd2XiveV4x3Lmozs7eW8kagjJZe3/wBestbe1jYhI2muG4ZpBk/XPaop715VPlrFHn8TS2t1HDCU4Jf7xY0qlWN9zkjGUVoSPBxkbRj7oUmqktnFOvzLE5Oclz0PqapT3RLFbQM0h4AB4FNg0W/1Dc08wiQ/jTjLm0Rfvx12KlzHp1kroF82QdWB/lWYs8kj+XaQsc/woCSa7Wy8IWULRvNNLLIvJOeB+FbMFrbW7gwwohPG4LyPer+rtu7YLE8u+pw+neGr26YPcgxx56MefyrtNN0CyskA8rfLnkmtEOPlyx9MEUPJIxGxMAgcgda2hCENTGpiKtR22BESFAEUBR1J5NRSsf4ThR3BqwY3cKyBd390A8CrUQhSFxIzbcZwqZLH09qpyuYXsZqhQ+d+Txwe9W4rZHBzIcEEhSTSQ+ZPOCIDEq8l2cZ/KtS0jjiYhbd3JGPMMmD78elZ3uEnYrWkEcZXaqYHIckgfr1q3b2x8z7yAHnnmrYi5ARJF/ur6CrP2fzUB2ygnlizAYosZuVitHGIuZFLDHC4J/HrVmK7UMMRcgYXK8n8O1OZAVVVjXJ655NWFgYBQqxgHktjnPpVa9DPR6snivUZFVgByMny+c1Z81GX5inPI2x9qqGKUDDLzkZcH8qtJbqpCu6hiOqn/Cri2ZSjEpX+pQwwKlvZ3FzKT3IVR+NNWeFoVP2eVWPPHIFWnt13Ha6lQeSc1XEkcski2+HZerKTjPpmplcqPLYIZMrj96cDHUgAU6KYSKyncQOpGTg/1qx5b7AJMFAMCNGOBUsgkhjCW0CErzzIcEelOwuZFOO0G4NgFCTwCQaspboCdiYUdy1NheRlX7VCEZSfmjbr+dPRY1bc7N5ZycY60JBdimzIiB2Kp/vbjzUT2kTEgBF/vANjJqdXCD5O/wDsgnFSjPlffTAyR1zinZCu0Zw0+CQlJEWZgNu7PapU0y2jHEYQn5cZByfzpBd7pGCpKiA4Dj/9VWEG7aW5cjrnOc96NOw9e5H/AGcka7YViD4z2HNcPbadppi0251BiUlkkt7x3cqY5MZGfSvQTKuxlkRicfKMHt2rnbb+1tTsPtQmsgk2c2/2UNtwcYbPfjvVIh3Yvhq2ibQowEYRJJIqSIceYAxw34+tFa+lrcx2qJdbJZVyCI0CjHbA+lFLQabR5AltLMAGyBUzQojbMLvOBjtVmOZIkChgG9uSaGYEBiGGfXArz+WKPQbk9BEjRDubLn3PA/CpDKmwKGXA6gVWlmHIBwR2FMjDNnzN2D0OKOfsNIuby4+RiSPenQwq53Pz7Dmq9tGPlDucEZ5Perka7d2CxWhakvQfIi8YTP16U+NzuC4BHUelRCdEQYjy386gimdSSgxk9D2pyaXUTV9y68mXJYqo6DA5qEn7oG7JzQC7IScA+1BMqkZZGB6cHNDlcFoRPHIylVyBnaWJ6D2p0kYQBIwAB6DNSh2dstuAUenSmiB2Zic889cVN/5Sl5kfltgDt7cYqeKMbwF6+tPiHzkEBccfMal8tIwCTknpjtVRiJy1InhzwGAI6nFVJJYFm8oOJGxk4Gfz9DVxwCu07Mnj3oS3QDhcDHUUnboCbRVG1Q2cHHXPSkwBgxlgMckZ/WrskeP4OOv1FRwqxBJiC8Z2k8GqtcrmSIVKmIocqxPTbzUEkpi3LGGYYzjI/Sp5RICu9sFumO4p88ChY3R8MAMpjJzVwb6CdluZFzCTunDyKW4EQc4B+nTPuaoX2ixmFZWxFJ94sDjBPvWxCJXu1WJWlmYnbHHjLe+ewHrUy6TKpea7nSSUcbFOVQ/1PvWitNe8LncdEzmLt9aaZZ57ie6ZV8sOcgBR/CMdv51QmvbqEj9wwxxxXcS28ssBj83MakAgknB9qwLm22hiDlhkn0qJUo97G1Ou30ML+0o5YMTQ52noU7eu7tViO7sgFjksQN/PmJjp7e9PudNMxZmUlDwMdCP8KibRHAXIJyOBuzgDpUqMlsbKs3u7L1Nq28QWNsgith5MSjG0jJx9aS88WDAWN1IHTcfyrmJ9MdUCrjJ7kHK1SfT5wSqpO7dPkXijmqrQjkpt8zOg/t0yyFzI7t6jkmmXGv5jKpkYJyPSsuDTLtbeVDC+9iOS23GPbvQdDum2gxhcDqCM/jWThUs9Sl7PRJGfdXIll3MC4+9zwKsWt7JwiIWOflCDitjT/DoUh7mB2A5JLjH5Vu2elW6MBAi5HOFHNafV3LqbyxULW6HPw299cDKpsX3NacehyMMyyb1A6ZwK6D7KEPy9COueKsLFgZZTgjjIq40IR3OWVdv4TKTT/JjKxFUJGBxnFW4IJkjPmsskmeWAxV4rvUFNtLbo3JbJBGf/ANdbcySsjJ3e5UG5umQVHIFSLE7El3CjHGO9aUMCYDNjBz0qUWwTaVBJyeOoIqW+5PMihbwyxvkLyRlTnrV6KwYj94NoHepfs0rPiIso/wBoDIq7DA6bd0m4kYbJ7elCM3MopbyKCo37R26VYis1Z1QkoD/ExNW1hmlkUYBB6A9ven3BMDqryYIGAuRk0Wsrslzvp1IUsljReFznB4OfrVyKKCJDJJJyONqKSSKgIuJVyIXHfzHbAz9KXZdCP5miXP8ADjP40JroiZJvqThoGwwR1Pqc8CrKpHtJUhlz3bmooUUxjewbHJI4FSnyx8w2nPXjFVqZtEzxDH/LE55B3dKhke2twvmvAWPOM5wKmVEwA2ATzxzigQxK5GyPPY1XoLXqQR3MTMscO2Qbh854FXQ85kODCuf4gB0ohhjTd+6j9mIPP0xTlPlkYiJ9uaEtBMimtZLlCr3LNCOfLJwP05qRIUt0VY0AwOADj+VTrJM/yCCJUHpwT+dR7iC38OOvyjNMnoKIztJVwA3J780+MsBhZWIzjd0ppMq7WPBJ7KKZchpAFWeQKeoBAINAyR0Ikw0rkexxzSFPKO5VdQejZHNVIongARmaQg5DSOST+NWfPDY81RkcYxxSBpogLuWZnc4XoS3epDNEU27lAPPQmmyMuAiFGHOD0rNWErzkpk84GfrTaaLVmXzJhiTICQeeTUiSRrGd8q7geBu6VVCCVdqk5B6nJz+FM8tVxudBzxlsAfnS1Bq5pNdBFJUqXxnMi5/GuJ0x/DskG/UrmT7aWPntvlAdsnkY4IrY1C/uUVF0+S1l+Y7/ADXbH4EVWOoayg4tdNyoHQtTTM3Ev2MlittAmmXZW2LH59zZPPIyeaKLTzpoY/t0caTgklI8lcZ45NFJ7lo8yedS4EKtK3dhwoFO8yTYxkCKOwAz+pqvHO7qFeZIwvBVRVxDb7S5R5MYwSa8+19T0HdbjomWUDceeowetTytgKEVc453+tVTcO0n7pVUj+72pVDOWLuF+nehSJsSlAq7wzKep2mmGWbO3dvX34/Ono4VSAdw9T2qMiSRwFGxD3/pSab2Gie2WV84O3J9zVqOHbzvUEHvgVURyBtZ1yOg5p6CUEjaASMjctEdGJloBY2ysuSf7vNQz3MsThIbaSZ+5yFA+pqxE2UYOUUgCm43HAfoCSe361o2rXRG5OzqYwQvzH7wA4+g9aaGyoCr17EYxVcSE44THZqQTMBlgnH50pVOo+UtbUyWZQWzxzxQu7zNuNoxxikgXftYNgkgjjrVjySRuLDgc/8A6qFdq4n7rsRGP94GcKCR2HFTA5XCg8elQFwDxjg4ORTpPNKhoZgnBAAWhagx78g4XlflyaiXO7Hys2ePpURszOR5jyyEdMnA/SpktlhUrEgVuhPr+NK92O9gJKyE4HPGQMmqt3LPsdLdQJMHaX5Ue59avIu0DcrA+tOIRSA5ChvuknvVpvYRl2FjPDF5j3KiVz82F5f6nsPar0VvKB5n2hCwYYQpkmrvljI+YfQCnyY8vCkNk56YNVGKQnJ9SjJ50i8vwehHFUZdJS4/17Egc7FGc/8A1q2zHlM8hR171GxypCnb2POTiqduok7bGMbNVCBTgf3c9KU2ahcBWVs/xHjFaS26Y3ck56d6kEKjkj6Z5pK3QpyMWTTlB+VQdvOaDb79qlMDrkVpzpOqsIkVVbrkZqCO3vM5dojg9ChXNPmtsNPqV47SPYxZBk4+ZvbtTBZljlUIB5wPStIJMVzPE+B0IG5as2kYJLq28kYIx0qlLoJzMtbX5cEE54HYmpLO2Wxtpo7WIKZGyz9SfatdUyTkAN0I9KcVIdSoHIznHeq5rk81zL+yyEKxGQT+VTR2mcFsg+9aCQkEhict3NTEL0UA47ipSutQcylDaLgkDI6naOTUkdsIUfYMnoM1c3BduAc4zn3qVFyMuufYDpTsmS5MzILeZmy7ZwcqFGBVsRgHhQQo6Z6+9XljG0fIw9enNPESFlXjPXFPk7C5+5BFCHIym5u/PFOaEqoJ3YHQ1LHcQJI6Rl8g/dAzn8aQuTLmRcJ2DU7WJu7iSNISzx5UkY3YqCDTojI1xIGMpH32OTVqNvMIYR/gRVhI9wUhDgjnBoSvuK9tEV0QAgbh+J4qVowuDvXnrgmngBt2Vyf7o4FC/u5AcJuA6YyKqwtRC1rEB++Z39FQmnbldgApUN3ZelDAtk7xg8ntS5XAyzH1z0FGoiYLyu3efX5RU7RQsoCb+cfeIAFVFKgBElIzzxnFNI28FsjrnbyfpVLTcm1we4ihn8tmdjyPVf0qQvEW5yQeyiokfIzIDgdiQM/hUi5HIKoOozU6laIkaQ7RlXJ+nSpYyp+Zlm5HUcVAwyGI2k4680hyuAm0j3NO9iWiwW53nzAo45NQT3EC5BugWB6BTj3/ABpyFwMFl4PQCmSxhiOCWI/u0xWGG6WQboYZG3cbmwoA/Gog88gYmJI26AtNnH6VMQWb5zjtjbzxTo5UwF2nr1K81JWxHD5wk/ezRMMdI+R+tPcblAMiADqAeTUkBG8+aGBHTatNFygVlXzxk8FlGKYasT52Rvnzg4C4xioBHG52uA3HUZx+VWGcrLgMSCMFiMUjuMgF0DDoDRcCldXsemLGWhaQOcZgty+APWqr65bfNttdQyTwRanmtaRwqb/MjB9N3pXGG/v5DYTT6vJEl6HwY4xtRuy+/vTvbVku/Q6e1lF/aiVEmiRjyrphuD+lFVvDV35+lxrJJJLIWdJHkPVgxz07elFFh3PLkSMAEtg5OBThFJkxpg5/izmljRnk3yt5YUfKoGM1J+7kAK4wASWLdfwrzX6HpSaHpalCEuLhVZs5UAVJwuDI7FiOp4pNipDmJWYkYDBf4v8ACsiZrppQcYIx75pSbj0FHU2W3s6BMktjGB1p5ikjdxNHIWBwV9KhtZJJk3lXJXGBjpjvU01xJNMS7yswJLDOOT16U3ZK41fYnt1USgjcP0xU1wyqhxukc9MHj86jhUxxxkRgHuSMgmnnLHEpOMZwCKFoiLXd2JAGY/MuOOdoomky2CBjsDzikZ5ASEY8+9KkQywA5P8AFj+VHkNIYWLbQT09qsKyRr1Y5H3ttRqjjIiJXJ5Zh/Kr8NuqDcxyQP4jnNVGDFJor225AcMzKe2c1aB2OAxwe+KNkmwNztzwOnNEaOSQoHPXJp3sQ1cXALKSmfQ4xmpeMnJx+NOdXZBjr0qm9rmfzHdyU4AP3aH7uwlqy9HGpGeAufuk96mEYUElQB0OKYsWIydpzweO9RJMBMyvkZ5rTSO5K97YlmTJOScdOtRLbIGydoccZBzUu5mOBg8dqfGi5IIzjkgfzzRuw2GQgq+5eD6Y60sgYYwfn9amVXAJJA9MntUMzKhAXLYx2pvTcW7Iykju2+RnH90DApy27jna2f5U/JY5VT9e1PSQ8gnnvzSdmPURI1HPzZzgnrSyIVBGdp9ae8q7AEGCKjdTImCSOOtO/YVnuGBubd19TTo0QDBG49/Wokt9pH3mz3Jq7ChKrjg+tEW2OWxGwVDxnGOcU0LlSYwTn0qw6cEgke/aq5kCRtvyMngDpTb6kjSpWFyqs8v8PGBn3NRwLcCTLNGqDgqBkk/WrltGxTnB56elSBN7jCknHJzVNXGnZke5lRlVSQR839KcAQV3BVI5HGc1I+IY95KAdsmqTyzTN+6QhR0L9PwFDvcleRZ3R7S0v7sH1pY5opsiJpcA4zg8mlt4AD85MjHlie/0qzwCQQMY4wOlVqxaDF2gnAbb33etEjO5HyYGM46U9UB2so/T/GopbKOViLgO2O27GfypsL2HJIhIwqr7k9Ktwldu0ordsnqaoQaZZKcmEqo9zVuC2hgT92hX/eY804t9UEuUW4d0XajKXAzznFRWs92obzkjyR1AqdYD1fDN2B6CpTGXJQLnA54p/ESmkhDcK3yqGyOOvBpYg5AVURfUjJJ+tUbmWNRiEM8p5VQMDPuauwiVEAkBQsOQDSuFiw8WArEg4OAAKQLuyqKCx9W4qrkjLMQAD61LCSUCqgAJJyQadyGhjC4BCl4lUZ4UZpiLJ1kkzj0TtVxFDk7FLepxUbyrGjBztX3OBQUpCW6jcNxy45GVqbJbO7O70CiqjXNvGBmbzCemzJpkdyhLBdwI7spAovYGrl7eEiDPGzMp/ibApBdM6MEjQFvQZIpkJBAI3KP90U1VVmG4MTj6cU7slJX1D7TIxCfMAOxNPB3EMWy+ccmmXbRW8Qkd4oQeoJ5xVEarbIR5E6PuzjbyTUt2eo13RecKGbdsOTkHpTlKZyrrwMkEVBbXS3C53bSP7w5q5gjG8j/vmnuMjjDKFJfG/ng/0pGhVeSQ3seKmIKIxJbjgHGM0xsgfuj8x4yRnFOxNxgjj65Xd/dwaaABjGSW54GBUpd4gqiTcf8Adpdz45CsT7Uh3IOI9zF0Ur1yucCuXbT4dX0Wc2tgyxvKZrdRJtLt03A/w554rq5bmGJ4obgKkk2QiEctgZOPwrloL6OyiNrp2vaeLNSdnnRbpI/YEdce9O1xOVma/h1YRpMIs4pYolJUoRyjg4YE+ue9FW/D32OPSo0tJHuodzM8ofG9icsfzoqrkK55M3lgD93vPsc5oklZWQrGqFR8oQYP40y3dSyvtKqDkgg5NWNiMw3q/PQV5iueq0upH5zIoaQbjjnPAzS2buhbygi98hc1NbwYxiJeD05JqSQ+UQWZeecAUuaW9wsuiEck7CWcg9tvU1LC0ar8gKu3BB4FRCUErtxjPHsasmFVCnexY8nAwKSlzapg7JWZMk6ygLIz4Byq9AParJEROSiBR26k1WghtM72fLdcYOasyhGICqwUeoxWibtqRJK9hYggLAABccj8akVYxlUjJGeN1JGN8eAoQHoB2oS1woYNhu4HWrV+hA+KL+N2UKTtI681YMiFSMgueSQOlVhDkAIrHHUtUsAEYBAXODwatNiaTFwAcsXJ6dKlt4Nys7rgDpmopbhQV3PtAGDjrUqksmU3MD6tS0uS0xw5LbRj/aNPYbhuLDOc4Hamm2HLNjf65qMzx71AYMwPARSfzNO3cXoSpIVQquTz2qPyu5A3EeverChDkK7KfXFSOv7sZ3Mfc4zQo31Fe2xRaKTcCku0DrgdakVhszuzzjGaFHz9CD79BUhjGwlgq8H8aF1ZRG0ztgYPPtSbAQQzNn1FSxxnaCxAXse9TxIcHZjB9etJJsV0tipDZxKBuck9eWPNWCkaMBxwOwobtkYPc5qFGBc7gNvpmhtLQNWS7V4KDn3pjEdGbbUsZAQlVAA5pFWNzl1BOM/Sq0BXHp8qqVYYPTIqUMEX7xLH0HFI3zABTgKOgFOjXrngYyM+tNaEsimmGMHc3HQCq6RkgPJuB6AHtVpgRhlY/T1qSMcHdQ1d2BPQjDbFIKs3PWiZpVBEKAsw7t8tSxqqEliKVgmAqkjJ5wOKq3divdlGK1uGbzbh1Y+nZfYCriLLjcUjJPBJJyacxG7AYlAOo61IS5wsZAA7nvQkgbdxLYMvUEe2atjy0xuUEkZPPSobeNkZmM0hLHoR0qbLD7pHTqeapaEN3EXaRksFX25qBrlh/qrZnJ4Bb5alQPkg5Ib2qw6DZgbifpTv2DQpu9y+BhFb0AzUyeYozIdw9D0qWO3xyep6gdqlEEanr9RSS6jcktBvmAxq2wbeg2nNKCxbdhTg9+1MkMSktISAOF9qibUInO23xwMFiKq/cnfoWDEqkt+7APHFNZRI2cg445qP7THx+8Uso796kVkI4YFT3FK9w1FjEeMHcSD0xinZUHJHPTrmnblyNxwo6A0LLbuvysrvnHA5FUhjlcBc459himGEFWI2887cVJGpz98cjj2oZgzAl8Ae1FiLkSxRqysAGIP0qR1LAgsMY+6vNQTzzKwENoZccAg4/OmpLJISsoNuSeFHX86GhpsmklWNgOCfzNK6tcKWdio6HaMURxoi7UQZHOSaez4Qkhj7CmJlCPSLXzDIbfcxwMv8386u/ZLZQoWOIZH8I6Uu9HVQi4PvUiYUbSGB9hikkuwO5SksrfPKDJPY4NW4IwqBI422g8ljml8tW35ZeOTu/pSNHDJGAxxx60wuOZVDYIwSOmf1p5iwuACwPJy1RRLCq/IPm9/8ac6gKrHBP8qAAwttJQEc8AntSrhQCJEDZwelCHL/ADKQO/vStEn3o0OT1pWFchkKu+XYFlBIYjOOK5+w/te9shcxwaV5b5MIaNgXHY+2a6YIVOVXORjHtXICVLbzYtLvdXFijMG8i2EqR88hWPP5ZppA2XdG1O5lNol9DCsN0XRDbjBSReqsD9DzRVzSNNsZWsLi0u91rBG3kRs3G5s7nJ6lqKLAn3PNYVPn4XBzxU0+ZVaSR8tyQEHH4+lQSYQg5+buRU/2zMSLGiRqDli3OfT8K8+6t7x6bT0aK8Eb7huLZ64zio5gTIwIyeT6mrTKski+bOq9TxzUvlFnYW0ZOBkl+DSS0sVezuFtbrHErlwrNx0z+FX4IIicvvcDnBzj6ZqOOFpowJHJK/MeNoH+NWgSoKSAZGACTVxgkYuTY0x4+QbY+5xyaVVRX/1m4gZp0RacbXTCqu4BTgY96Rli3ncAVxn/APVT5dLivYlEiAfIBz6ikYPKo2cA8VXiPzEIjsvrjgVYEpCfdPHA56U1K+4uXsK24IUYnI6nNEDjb1Ax0JFOU7uybu5xmnJGwQlTntnFCTuJuyGvEXPzncW6n2qeLbE2MgHp71JATgqSD+FRyxlySMDnn1qrcquib82jGzSHHG1hTovl9cd1UU1iQByCPYU5BsOQzkEUvNjtZEwkC5RiRjvjg1VvdQt4lAeTcx6Act+GKmzvTjGOnNQrDGGyI1DHvim5XQlHqxkN2hCsVcA8jcD0q15sUgCK4LelKGwy4JJPSpIkC5Y8ZPXvQl0B2I3Gw/Jw3eoFjRX3M8rsT3bir5USEKBipREu4FhjHoetPlb0QuZIpSxFsFlb2FCxgJhFx656k1bnKtnDc9iD0qKKEu2S/wCFDjaQ1LTUrebJGQqQlxnnJwMVcCgx7sKpPqaUQZYfMPyp4hZnO5s4HXtT5fITkn1IY3IGSvA6cVZXG3OeTTooz0QEcYyelSbCwxxk8ZxVRTJbRV8knJYk8+tI9t5jjcWA9Ae9XhAAuMjj3pVC5x0NNRE5dip5GwjOdvvUqRALjH41NIqj72eenOaGX5QRnbT5UJzZXchFOAQgFUptWtoW2+arSd1Q5xUlzY/aG2Su7pnkbiBV6z0q0giYQQRoDySB1pNN7DUorVmcl+0sgEaSbSM8KavQTXTgYgCDsXPOKtLAEX92PlHSpUiG3dkBh19BQovqJtFczSgZk2HHZQant5vOTPlsp77jimbV8zk5J79qsHIA2gk56VWvUm6HSMqoeM5pOSN4QDHPJoTAyXdQfQ01pi+dqqCeMAZxTEV5wGb5gOPxpVBUjkAY/u1N5ZLcfKuOgpChYgHPApFEMwjkxvVWI9R0pYEUSkqnOOMHAolUKfvDA+9k9qhtrlJX2ANt/vY4pdRrVFsxeZJukUED3pRHjGwED0AxUoUR7SMnPNSbztJxz6VdiGyFQc5zhvr0puQMqDuPbmpTGx+bcAe9OSJSeH/D1osxtiR8EfOck9CelSGAlidyN255xTTEFwFBLd8U24tnmXa08kSHsvH61SWhDKF3c2lkVEk2HOcICSx+gqrHcXd4QILd1Q9364rVj0y2t282OIM5P32OT+dTMPJbP8XoKlpjT7FC0sLiIrJLjcOhds4/Kr5ViQxPzA844BpRJ5oAOMjoSKhNqDNvd2JBwPm4pq3QV+5MiKww3PBJyaeqxFSqgHjqcU2NAhG4nB4prnygxVhnOAMc0wJAVaPZlQT3xTG2Kp8x8ADsvJqQD5ULtg9MAUxkZ89Dzx2pMER2chctlHRO3qasPLjACkg9M8VGqv8Ac2jOeMUpWRX25570LYGSM5I/uqQVPHT6Vz2nS6lpdnFY/wBl3Fz5JIjlhZQjjPBPPHvWnfajZaeFW/u4oNxO0Oep/AVV/wCEk0RXG3UoevBBP+FNCZY0Cw+y6aiXAR52d5HVOVVmYnaD7dKKpeFJVk0bzI23I1xMRz1Bc0UDS0POXjZ2O0DB5z6UJAMrvww6ECnSucleABycd81KJFRjhf4e/avPSWzPW94QQfNmJM7cFs9KuR4ZXOVdycBFbAH1qqnnSL8j5V+2MY571PmOFyyvhQOcDjNCXL6ENXCGFzlJ5WztIO44wc9qnEaKgLBmJ/GqYy5DDzJpM5A7fjmtGJ5cfdx+VOPLYzd0RgR5wwcqfwqeOaPYyxxdDgljSYjOAw75zmi5yYylsqByPvMM496EnuJ26ky5dcbBtHUZ4NSHYQcqMdqrxwOqqXl59hTzDIwyGxn+Lpiru+xNk+oPnPysFHfipomBwCT6nnAqFXCnBJ3DqwPBpxtY5Tuk3ODyFPQGkm2DtsSq6uWWFGYdSc8ChkZfuhefTtU0YIK5AyBgCpo1U53kZ9D2q+Xm3IbsVVDEqMLz1JHFPjiLDgMV/KrMhWJd3BxwKSB9332w3QAU+XoK73IlVIpcMcnPSnSAcjbgt0FTvHGDkAnPX3NNCZU7sls/jT5dLBdECoSQMcjvntUsKqZGVjwPXmnmMKrMTzjmo0lgMrMXB/Ckog2LLCpYBn/AU6Png4+lSAo/RvxUUqDAJAORxmqsK40RMGO0cEZpGlEWBjeSMYVcnNWQGkz2IqPLD5UwMnk9KdrbCvchMshA/cOAemTirMLy4xIgUemc0vlk8kBjSshVM5259KFcGLuC/dBJ9BTSJDhmY59KNnCqgwO/vU0Krk7m2jGORmndsNh0ZKocD5u/c05RtALbjxzikUBiRGp29M09YyynAA980yRscauSvK+9ExVCApLN+QpyYTOFwvfNKw3HLtgDsB1p26iuMXiIEgbscc055DsJxhB1B7UwoS2EJPoak8vA+Ynd3PrQNq4yCdZuFYgk9SMAVYX+6xB9eOtNEORu4ZuwNSiJVOZm+YjjHaizJbQ1yQnA6UqEuOCM+tJIc48sE4PVulMLBFXLqOeeOaAARIj78A/jUoOeFIRuuaVEGNyfqaYVO/PBYHqaAEIY/dJA+lBUjG5ual2Y+aSo5mCgYJwe1A7jSgk3BxgAdSKbFCqkfKAffpSySnYxQE4HTFEaiTBwd2O3ahbj2Jmd3IDMMLwPSh42ZQG6HjK09RwR3A9KRFd15BI9fSqsyLohSJUlbbnp/EasAB2GV59qYWChtqDOeuKVZJ2XaxVfTAosgepMF2pz970qNVOQzsAM9gTSAshGWOewp7twpBJx17YNPQVh/VOWAA6g96hYANkthfXOTUXlBjvZyST0JqR41U7jz7ZqbjWhMWG3ITA9c1GJOTuK89KURnud2adsAx8q7unJ6U/QQiyNtOYS2RjLHApUXYQc5PY44FS7W2ZOPbHNNUljg/hTAax4wEHJ6mgquwDAZuuQaRTIHxGikD+9zUq+YCzPGnsKVgGM7AAr8o9VHIpIwXUtuPXHPWnncy8gDHtUTHGdqMxxxk8ZpgOWG3JUywK3P3mUHGallt4Y1+S3iyfWNf8ACsnVpNVg043On+T50eWkjkj3bl77eeo9KhgOu3EKSx6jYMjqGUm0YZB/GglmwiIi7QCAecKAKKgsorzyVW8aOWfJy8S7FI7YFFBR5eT5QBMaO4yMtyfrVXZu3buSec9KuWbsXDkY2nOD3qaSAyDPTPYCvOtdaHqKXK9TM+ZVwJG2+gPIqVIW3ZwpU8Akfyq6tmAfm+7/AJ71ajjja1WFWxIudg7YHWqjTvuKVRIpp8jANJjPUJyxHpirjlY1UrhF6kFskfWktdMkbY5VQH755xVme0SMbN6AKxB5GRVKnLojJzi3ZFdSrjcN4z04xmo1R94JwoJ7mrVyqsQELv05HFUpVkaYeRsB4yCM49aTp9X0JUlexoxbQBvl3eoUdanQYTKJj61WR22DcFQdMnkmpkkiOACzHpj1rRWJY0bFbMpVQfWla4i5CyBgOPl6U6SJXIZ4wV7ZGcVJGmAB8uOvSizEmuo62lV1JB474FOZAzZwSBzzQW2H5AM+op+CyjkgnrVpXWpLWtyPBKvvIA7DNCFVU4x9RSS4IALdKVUXCsAqD0zxU9SiYIZM4kOR1p8YCrwevXmossqfJIRmhEODk5wc4q72JsSSbQBn06gZozGoAGAT0pqjJIJbA6Cp1VAucZOO4pK4Oy3DYGy5Oc8YHalwTnLHb6HqajPm5+UKAR1NPSIMP3jMzdzmqQh5JJwOcdgeBTH3gkJgEd89KljKKMRqvv70rZaMNke+BTsSNgeTaMtkk46VI2Nww2TmmZBPO4f1pd20gBRjrkdaLhYkcADp0qvJLLGwCRBieOtT7xgZJUj1pdysc80DsOj3CMM5AGOgPekCvtyWG3rjNRuAAeyZwDnk/hSxncOnfH1ouFupOGyi7y2496VjgYQE+pNNVhG4DBT9KtMf3QKqQCapK5LZmST3atstoPNHdmOBWlDJN5P7yIKT1wc0qNtHyhlA4welDyMQemPrR8wbv0Gldq5DZJNNZhvxkcdyKY0i+Zl2XjsDQTk7yCR6djU3uOwpAdyGY49M0KY4iFjUAfnUW8/MTxk8bVp4XftCgDHVjTC1idn5yxJz2wKY0KyrlncHtjpSGALk5JPqTUoiKorE5I9KCWhjlflGCT6jmnOoZcIDt7k+vpQ7N/FtHHYUzziE2gnHXNGg7DdrHAOcGokS4LhI5QqA5YBeT+NWVm3RcD5RTEG7ox/A4o0ew1dFjcxTbv5xUc+/IIY88dcVJEgC8jmpFjOQZCT25FOxNyokfH3mJ9jTyoB+6w71PhVYlVb3xTSCxznH15pgKBnoCx7YqTO1CJADkdTxiokjlVuZ2bI44pG3EjJyfegRIgxyuxR64zT1KiQk4K/Smxsx4wB9OlNUncTk5FMCTzJQclUC/rSMGIzkEdxUqEuQD0oKnd8qgbck570CGbmCYbge1JCfmPy59zTgNyqAGGKdIGXkglvYUCuhoUbztzjuamdWYYXH49aIGDouVcZP8QxT5Du6KBjpzyaAIVXjEjN7CmqcOzLnA45NS+VlT0Hueaje3yu7coPpTsF7blPU9UtdMhSW7E5V22ho4ywB7Z9KqnxFaY5tNS3HqfsrVNqyxpYP/assUVk3ylTnL57D1P0qC38Q6db28UZ+3iKMBQ8sDkYHqcUhM17K5j1C1SeNJ44mJAEqbG44PFFSLMlxDHLAyvG65VlbIIopDR5FGhhZguRk8Z71fVmUFn4IHAFQRR7lwTk+hNSMWO04BHcjtXHHRHpSd2JJ5hBYk7F67RUa+YjBw/zdOT+lE8zLuPQMMEE479aVZFlfLAqOvFDaew9lqWWLygl5A7n7uOAoHUVSLSST7UODn7z9vappSu1iWKkDgHv9KkgljitWAhzIx4Mh4XHf605XlvoT8K01I2d5EQMz+h5wBz7VYhk24I2bwep9KgeMrgO2SR91ePxogSAITcDj7oFEW76CcU0WgI3cGVt6nkk9BU8kixqnlLhTzgckYql5cKqVVyyLyCelSSNIYxIsYQNxuJ6mmtFcztd2LryMyAjOPemRzFXA3AexqGEBwA5b88CpzGrZOw9OtF29UOyLg2c8gn61XdP3uSxPcDdTVTG3ABA6Y7VLDGpB/v8AY1TvIiyQqQMWZiN38qlSJyEK7CPQ03eSMZzjrinMdnzqvDc5p2XUTbJHTGC2WbsOwqOd9i846dB1zUoyRjHy8H6U7YC3rg54FU/IV7blSOZnOEjkx7VciZudy7acgA6g9O9S7QTn5uRyAOKIxaFKQxs4w6kfWhGRcEjI9KZLNHE/luwyegJ5p1uVbGAeemaL62BDiyAEryT60FjwBkE9QaTyysnI3MD26CgcsMqc5pgNdMYBzu6g+1OiAY43LuHUZ5oky5wzY57UtpZQQuzRISzdSSaaSFzaErKFUBnGaaMIud24DoKsFQOXGM9M0/ylADBxk+1OxPMU5OSGKknscUgkmWQGOLfj8BV5IwEUEkE9B6U8R/dO04A65p6D5ivbpLIS7oqfTmplVgSJAcH3qVSACM4x3qNsSN1OR0xSZOrYxjtwcgL2yajwrnMoL+w6U4AAYkAJPpQoycsCPakO46GJSV2xgeualmZEA+YbfQ8U0OFDKWyc9McUojR2BdQcevaqsJkbFcKysD+PFIiAfKWGf0qeVE2dAMdsU0jAyFGAM4pDTuKGUMAxzn2pksjKuEj3evbFLuJHoRSMNoByST260CUddSCQ3MxwQqL7UeTsUlyXOMYBqzDvAO7p34o2kE+/fpiixXMRruJwQF9h2qaNCgyTzTRy+MgD19alC+YQGYU0Jio8xB2SBR6bcU/lh8z5x2pqBFBAGSO9NZyoOcY64qiSTnYBwv0qOJGSUBQxB702K5ycCNwPUipXmLZxGB7mk9dQ1QBMEnOD9aAuC3CZNM3F/lOOamO5VAwNvrQgGqM4xkj0HaoJQ7giJgpB6tzmrRLNt2t2oROBu2g+1MRDbxTq5aaYn0AGAKnfhAN+4j+HNPDdVIIUetHlqinHLHmgV9dRqNgfODg9MHFTB1wCF5pm/kAgE+hpFXdKeoUdeKAsScKMkgD60EqSuMtjrgGkZQqnkk9qRQWiOJiu7khaAHswGRuGSeAKcI3mOHbamOCRyaZFFGpByxz61Nzk7iAR0yapES3MvXLKdpdPu7OEXElm7MYZDt3grjIJ43DtUP8AbN/yq6DfmQ8Yd0C/ic9KZ4neWafTbOW7ktrW5lZZpI22k4XIXd2zVaOCTw9dJJNPPcaO5Cs8zbntmPQk90Pr2osBpeH7OXT9MW3uvLWVneVlT7qlmztHsKKqeFVMmjK7SNJ+/mwc7sjecc+lFSUtjzuN3aQgHGTjirAQGMqGzJ2wen1pPIXZwnA4BLdaspHGkYCRjnqBXHZ7HoykkUJomaQZBDdz61csl+Q7lww6ZPSpJ4co2CwHYCmKxEBCjD9+1CjaWo3LmjoS4EnKnDdxTkjRULuG4yVyODUccvOCuXHIPaoby/yoWaVU6hVz15rRNdSEm3oWDFK0YLY3OfvDnGaqwwO2AZWIBPyOORirNk8TqFdggPBbk1ZRFjcgfMx/Wp5U9WHM43SK/wBg8pgZTtLdB61LPIwIDABlXHNJNOzSBUyXx354qGWOQsGwSc/xGh2jpFCWurZJCWlY4ZifboKR5grKqI8nYgcDNOVXkJRpQgOQSOPoKnYLGy+Um7aOc9DR0E97iRSSEANGVB9gat2pMs3lxq7OcnBGOB1qGCVApwFLjqPSn/aI96gAE55b3/wqkktbkNt6WLEKlst37cUhkydrLz9aSOUyAnZjPQDgVE8UssqMj7QO2P61UttARZCgZxkqalVtkeQO/Wm+WBGQztx/nikAb7u44I7jpQtNyRx/fD58jByMVIzHbhcg9yO9RqArbdxyB09aMEtgMfpjgVSDcaUDH5lBNW4yvlgFhnrx1FVy8cfL/KfepYXRkBQDPfFCWtwepKx4GGP5UxkzjbkAd6jVnB6mpXclQM8daLkjRGOCRuOfpUyADkhcj3qELD5m6UEsOfvHmpI1jMm6PgfWhWEySV0wD37e9Mt7pZmfB6HBGOlNlXe2RksOg9KeAkajaCr5yD1ppgkTs/JDcZ4zTiM+o9s1DGSTk/gaezbHVccd2zQKwokAOH+X361HJNIpBgUOffjFKGG4/dAFJ5gznJ+uKBpCP9qYc+Woz0FJ5FwxBDKoPXipUY8sAcnofWpGaUDCDJpWC9iFreQ5Ky5b1FTRKyjDNnB5pgaURlXCZ9qaNxUknaO+KegXbLhRSp+baKjDxnPzhjjFRY+UMp60FFRNoA3etO4krEM7rn92D7n1pqySMoEaY7c9akdRgk49hTl4I4AqfMu9hyysifPgeueTTUmWRv8AVOwHQnih03P24pY3YuAMYFUImXdJzsGPSpo8BcgoGpkQPXdg+tBfJPK8d8daZLZF8+5sNxmn7flUkHPc0jbUG9mweuKhjvFMjKFkcqcjjikFmW0kXO0AMKXKhOSDn9Krhm6KPmP8qd5eMcr+NMLIsxCPhQw9TkU13VX+9uppAUDawyT+VGwEBmOT22infQkSW8SNB5jOfQKKIH8xQUiYAnnjmlMYLjP8qkLksFTJx6Ugb0HzMcFQH9cUiOm8YDZx0peHGNpz6k0zd5bZKg0xEkrKqAlRk/mKSCV5F2+T8o5zSBhjPUnqMUhlxxGWUHrSuBOeWwAobsBShG2luBxzVUkDkFixGcino+MAjdn1NNAkT7cJxz7VEZkWTBIB7jNNmhEqcsVwexqFbeKN88D6802KOpLcx213G0N1GJ45OqOuR9atMieWY2XepXaUOOnpj0rA1y7aMJEspRWV5pXThvLQZIX0JyBntVa6tLa30+3uP7PW0kYr5ssMx82HcQAwP8eCRkUIGblvbRwQ+RZRi2hDEhU6Ak5NFM0q7aax/wBKaNZ4neKVsfeZTjIHv1opMVjzpn2EKFJUetPhm2424AJ5qmSS5ye9JD/rV/GuPmsz0+VNF6WQScSMVQfn7VFMRvBVvkHY+lV5TmQ/SnD/AFdS53HGBfkdGVRuBGMYUYFNjgRWEoRN6ng4qvF98fWp24EOOOtUp3exDVtBJt85ZwAWPXAxz71ctbdlQg7QyjJ+aqcnCjHHWiYkBcHtWi11YPVF0Iw2uMYPA75oLSOCBwfbnFQREiM4ParUf+qi9waLa2RF7kQizGRyXHUmnhW2qXbPThajkJ2HmpowPssR77qFFJ2E2VZoyNxj+Unkknmn2s43CKRQrgcADr9fWpTyXzUbAZY989aUdyZvQuxliQGHy+gqxGMEnIVe2KrWZPmr9DU7/wCoH0qoiYjynO0MSc8GpS5XGQxJ4OBVKHp+NWISTnJPQ0Ju4NWJpC4A8tAMjqxFALiMeYwHuKZP/q/wpy9I/qKpMBoZS3zDd3GRUsbZyoO0d6hf/WinSffP0pAyaMDAO/ikaVNwCsMYxk0xfuCo7UAzvwPvVXQksg/e3MM+tIjAkZbp2Heox99vrU8YGI+P4ql7lB2yAcn0p+G2jryPpSn7tJH/AENNEvuOS3+UNnketSLtL5bB45HpTn+4KrtVMlDy8S8sVBxgAU7zlUDnJqqwG7OB1FSKBz9TSZSVybzCpyc+wzipI5iRvbG09OeahHMvNSxAccDqaSYWQMPNG/5gMcjFSDAVSE7U1zhwB04poJ8zGeKrYQryFFz5efTFCSB1XejD6Cp3+5VeQ/MPrQAMuTgJjPc0jFsAfLkcGlQnevNOmGIxigB44jy2BjvTBcRL8rSAknoo6VGfuH6UluihCQqg59KALXmLg45HpSsQfuDNMl4K4plr/q2+tO4mgYFmztGB61KmFGQqjsaqOT9oHJq1HyefWlcLEo2j5sVGZsAkLlvpRGfmH1pknUfWqFZEKm8dyCEWP8zVmJ3UAM+cCkYnA5ppAyam5RYMmQAWyfaka48nLFgo9+9Qf8szVeYBkO4A/WqJaRMdUtxkmeM+oBoGpRSjah3H2FVYoIg3ESdB/CKtqirjaoH0FTdjshY7ws2HO3sMU7E7sfKlUL6kZqaRRgcCpEACLVR1JehXCTRKWklLfhSrhiu4jJ6nNWbjr+VQoB5h4oYk7kivGiZaRV5475rPub0PJthG/wB8YFTuqsBlQee4qaJQNuAOlOWg4q5l31vJcRxTR7DcRE/u3HySIwwyH0yO/rWdHbXB2xpaai/lkGOK6mXyEI6EkcsB6V0cfVf96nxf638KlMTWpUsLRbW2SFiZH5Z3P8Tk5Y/nRVwdW+tFUB//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A soft, fleshy, granulomatous tumor is present on the skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33428=[""].join("\n");
var outline_f32_41_33428=null;
var title_f32_41_33429="Cribriform prost adenocarcinoma";
var content_f32_41_33429=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F52604&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F52604&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cribriform prostate adenocarcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 369px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power photomicrograph of an hematoxylin and eosin stained section of the prostate gland. The majority of this tissue section is taken up by a prostate adenocarcinoma (arrows) with a cribriform pattern, corresponding to a Gleason pattern 4 lesion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ximing Yang, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33429=[""].join("\n");
var outline_f32_41_33429=null;
var title_f32_41_33430="Lipid abnormalities in nephrotic syndrome";
var content_f32_41_33430=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lipid abnormalities in nephrotic syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/41/33430/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33430/contributors\">",
"     Jai Radhakrishnan, MD, MS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33430/contributors\">",
"     Gerald B Appel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/41/33430/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33430/contributors\">",
"     Richard J Glassock, MD, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/41/33430/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33430/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/41/33430/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormal lipid metabolism is common in patients with renal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. This effect is most prominent in the nephrotic syndrome, where marked elevations in the plasma levels of cholesterol, LDL, triglycerides and lipoprotein(a) often occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/1-5,7,8\">",
"     1-5,7,8",
"    </a>",
"    ]. Total HDL-cholesterol levels are usually normal or reduced in the nephrotic syndrome and there is often a pronounced decline in the cardioprotective HDL2 fraction. The mechanism by which this occurs is unclear, but elevations in the plasma concentration of cholesteryl ester transfer protein in nephrotic patients may contribute by shuttling cholesteryl esters from HDL2 to very low density lipoproteins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The concentration of plasma apolipoproteins in the nephrotic syndrome generally reflects the alterations in lipoprotein metabolism. Thus, there are elevated levels of apo B, C-II, and E, which are associated with VLDL and LDL; on the other hand, the levels of the major apolipoproteins associated with HDL, apo A-I and A-II, are usually normal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/11\">",
"     11",
"    </a>",
"    ]. A review of the functions of the different apolipoproteins is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/45/18138?source=see_link\">",
"     \"Lipoprotein classification; metabolism; and role in atherosclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic will review the pathogenesis and treatment of lipid abnormalities in patients with the nephrotic syndrome. The pathogenesis and significance of lipid abnormalities in patients with chronic kidney disease and following kidney transplantation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/6/6248?source=see_link\">",
"     \"Lipid abnormalities in patients with chronic kidney disease not requiring dialysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/54/29546?source=see_link\">",
"     \"Lipid abnormalities after renal transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Marked hypercholesterolemia is common in patients with the nephrotic syndrome:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 207 adults with nephrotic syndrome due to nondiabetic renal disease (mean proteinuria 7.2",
"      <span class=\"nowrap\">",
"       g/24",
"      </span>",
"      hours), the mean total cholesterol concentration was 302",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (7.8",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study of 100 patients with the nephrotic syndrome found that the plasma total cholesterol concentration exceeded 200",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (5.2",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      in 87 percent, 300",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (7.8",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      in 53 percent, and 400",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (10.3",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      in 25 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Over 80 percent of patients with the nephrotic syndrome also have LDL cholesterol levels greater than 130",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (3.4",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hyperlipidemic response is triggered at least in part by the reduction in plasma oncotic pressure, and the severity of the hyperlipidemia is inversely and closely related to the fall in oncotic pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/11\">",
"     11",
"    </a>",
"    ]. Spontaneous or drug-induced resolution of the nephrotic syndrome reverses the hyperlipidemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/7,11\">",
"     7,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A low oncotic pressure directly stimulates hepatic apoprotein B gene transcription [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/13\">",
"     13",
"    </a>",
"    ]. Furthermore, raising the plasma oncotic pressure with albumin or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/5/21588?source=see_link\">",
"     dextran",
"    </a>",
"    reverses these changes in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/13\">",
"     13",
"    </a>",
"    ] and produces a rapid reduction in lipid levels in nephrotic patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reason why a low oncotic pressure stimulates lipoprotein production by the hepatocyte is not known [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/13\">",
"     13",
"    </a>",
"    ]. This is not a simple compensatory response, since lipoproteins are too large to significantly raise the oncotic pressure toward normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Hypercholesterolemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enhanced hepatic synthesis of lipoproteins containing apolipoprotein B and cholesterol has been thought to account for most of the rise in cholesterol levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/4,11,15\">",
"     4,11,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, diminished catabolism contributes to hypercholesterolemia in patients with the nephrotic syndrome. In one study, enhanced apolipoprotein B levels were principally due to impaired delipidation, reduced LDL catabolism, and a trend toward increased apolipoprotein B production [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/16\">",
"     16",
"    </a>",
"    ]. No correlation was observed between the synthesis of apolipoprotein B and that of albumin.",
"   </p>",
"   <p>",
"    Somewhat similar findings were found in a second report in which lipid kinetics were noted to be markedly different in patients with hypercholesterolemia alone as compared to those with concurrent hypertriglyceridemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/17\">",
"     17",
"    </a>",
"    ]. In the former group, which had somewhat less severe nephrosis, the rise in cholesterol levels was largely due to diminished fractional catabolism. Patients with hypertriglyceridemia also had an increased rate of LDL production.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hypertriglyceridemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impaired metabolism, rather than enhanced synthesis, is also primarily responsible for nephrotic hypertriglyceridemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/3,4,18,19\">",
"     3,4,18,19",
"    </a>",
"    ]. The delipidation cascade in which very low density lipoproteins (VLDL) are converted to IDL and then to LDL by lipoprotein lipases is slowed in the nephrotic syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/18\">",
"     18",
"    </a>",
"    ]. There is also a trend toward reduced LDL-receptor-mediated clearance of LDL and IDL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    How these changes occur is incompletely understood. The defect in triglyceride catabolism is most closely related to the renal albumin clearance, not the plasma oncotic pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/20\">",
"     20",
"    </a>",
"    ]. This finding suggests a major role for the urinary loss of a normally nonfiltered regulator of lipid metabolism. Observations in experimental animals have further enhanced our understanding of the pathogenetic mechanisms that may be involved. Plasma triglyceride levels are higher in nephrotic rats than in rats with analbuminemia despite similar rates of triglyceride production and a similar reduction in plasma oncotic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/21\">",
"     21",
"    </a>",
"    ]. Thus, decreased triglyceride catabolism must play an important role in nephrotic hypertriglyceridemia, an effect that cannot be explained by the low plasma oncotic pressure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL IMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a large body of literature implicating hypercholesterolemia as a major risk factor in the pathogenesis of coronary disease; furthermore, lowering high cholesterol levels can decrease the incidence of coronary events by inducing regression and more importantly preventing progression of atherosclerotic lesions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/32/14856?source=see_link\">",
"     \"Treatment of lipids (including hypercholesterolemia) in primary prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/32/26122?source=see_link\">",
"     \"Treatment of lipids (including hypercholesterolemia) in secondary prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies to confirm these findings in patients with the nephrotic syndrome are unlikely to be performed. Nevertheless, it seems likely that patients with persistent nephrotic syndrome and hyperlipidemia are at increased risk for atherosclerotic disease, particularly if other cardiovascular risk factors are present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/3,5,22\">",
"     3,5,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Experimental observations in animals with renal disease and some observations in humans, particularly post-hoc analyses, suggest that hyperlipidemia may also enhance the rate of progressive glomerular injury, perhaps by promoting an intraglomerular equivalent of atherosclerosis. This constitutes an additional rationale for reducing lipid levels in nephrotic patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/6/30824?source=see_link\">",
"     \"Statins and chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Lipoprotein glomerulopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipoprotein glomerulopathy is a rare form of glomerular disease that is associated with dyslipidemia and lipoprotein deposits in the glomeruli. Patients with this disorder have elevated triglyceride levels and abnormally elevated apoE levels that are associated with mutations in the apoE gene. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/27/1464?source=see_link\">",
"     \"Lipoprotein glomerulopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;A fasting lipid profile should be drawn at the time of diagnosis. The lipid abnormalities induced by the nephrotic syndrome reverse with resolution of the disease, as with glucocorticoid therapy in minimal change disease.",
"   </p>",
"   <p>",
"    As previously noted, lowering lipid levels may both protect against systemic atherosclerosis and slow the rate of progression of the underlying kidney disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/6/30824?source=see_link\">",
"     \"Statins and chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The goal serum LDL cholesterol in patients with coronary disease or a coronary equivalent, such as chronic kidney disease, is less than 70",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.8",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/3002?source=see_link\">",
"     \"Intensity of lipid lowering therapy in secondary prevention of coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The therapeutic options include dietary modification, angiotensin inhibition, statins, and perhaps other hypolipidemic drugs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Dietary modification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of dietary modification is unproven. In a randomized trial of 20 patients with chronic nephrotic syndrome published in 1993, the use of a vegetable soy diet that is rich in monounsaturated and polyunsaturated fatty acids and low in protein produced a 25 to 30 percent reduction in lipids levels; addition of fish oil to this diet does not increase the hypolipidemic effect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/23\">",
"     23",
"    </a>",
"    ]. However, this observation has not been confirmed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Angiotensin inhibition",
"    </span>",
"    &nbsp;&mdash;&nbsp;A potentially helpful adjunctive form of hypolipidemic therapy is the administration of an angiotensin converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB). Experimental and human studies suggest that ACE inhibitors and ARBs are more likely to lower protein excretion (in part by reducing intraglomerular pressure) than other antihypertensive agents, an effect that has been associated with a slower rate of progressive kidney disease. As a result, angiotensin inhibition is a standard part of therapy for proteinuric chronic kidney disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/10/41130?source=see_link\">",
"     \"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The reduction in protein excretion with ACE inhibitors or ARBs may be associated with a 10 to 20 percent decline in the plasma levels of total and LDL-cholesterol and lipoprotein(a) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/24\">",
"     24",
"    </a>",
"    ]. The magnitude of these changes appears to be related to the degree of fall in protein excretion, but they can occur with little or no elevation in the plasma albumin concentration. Similar changes occur after the administration of an angiotensin II receptor blocker.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Statins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Statins are the treatment of choice for the hyperlipidemia in the nephrotic syndrome, if hyperlipidemia persists after treatment of the underlying kidney disorder with immunosuppressive therapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    an angiotensin converting enzyme (ACE) inhibitor or angiotensin II receptor blocker [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/3,25,26\">",
"     3,25,26",
"    </a>",
"    ]. Statins can lower the plasma total and LDL cholesterol concentrations by 20 to 45 percent, with a lesser reduction in triglyceride levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/3,25-27\">",
"     3,25-27",
"    </a>",
"    ]. Lp(a) levels may also be reduced, especially in patients with high baseline values [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One concern with the statins has been an increased risk of muscle injury, ranging from myalgia to myositis to rhabdomyolysis. The likelihood of muscle toxicity is less with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/27/25016?source=see_link\">",
"     pravastatin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/4/8264?source=see_link\">",
"     fluvastatin",
"    </a>",
"    , which may have less intrinsic muscle toxicity but also produce a smaller reduction in serum cholesterol than other statins, and higher in patients who are also taking",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/42/43686?source=see_link\">",
"     gemfibrozil",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/0/33802?source=see_link\">",
"     \"Statin myopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some reports have suggested that statins may have a renoprotective effect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/29\">",
"     29",
"    </a>",
"    ].(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/6/30824?source=see_link\">",
"     \"Statins and chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Other hypolipidemic drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other lipid-lowering drugs are of variable efficacy in patients with nephrotic syndrome and often limited by side effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/3,25,30\">",
"     3,25,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nicotinic acid has only a modest hypolipidemic effect, and is associated with a relatively high incidence of side effects such as flushing and headache. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/14/42217?source=see_link\">",
"       \"Lipid lowering with drugs other than statins and fibrates\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The fibric acid derivatives, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/42/43686?source=see_link\">",
"       gemfibrozil",
"      </a>",
"      , lower the total cholesterol level by 10 to 30 percent, but are associated with an increased risk of myopathy, particularly if given with a statin. Fibrates have a more prominent effect of triglyceride metabolism, lowering the triglyceride concentration by as much as 50 percent. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/39/7800?source=see_link\">",
"       \"Lipid lowering with fibric acid derivatives\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Probucol produces a modest reduction in total and LDL-cholesterol; it also lowers the HDL-cholesterol level, but this effect is less prominent and there is a small improvement in the LDL-to-HDL-cholesterol ratio [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/3,30\">",
"       3,30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The bile acid sequestrants (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/26/12710?source=see_link\">",
"       colestipol",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/33/36374?source=see_link\">",
"       cholestyramine",
"      </a>",
"      ), in a dose of 15 to 25 grams per day, can lower the total cholesterol level by up to 30 percent when given alone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/30\">",
"       30",
"      </a>",
"      ] and can produce an additive response when used with a statin [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/26\">",
"       26",
"      </a>",
"      ]. However, the gastrointestinal side effects of these drugs often limit patient compliance.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;LDL apheresis has been used in the treatment of drug-resistant hypercholesterolemia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/5/10329?source=see_link\">",
"     \"Treatment of drug-resistant hypercholesterolemia\"",
"    </a>",
"    .) Several uncontrolled studies have reported on the improvement of proteinuria and lipid parameters in adults and children with steroid-resistant nephrotic syndrome who were treated with LDL-apheresis with or without steroids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Possible mechanisms underlying this effect include removal of toxic lipids, reduction of the vasoconstrictive prostanoid and thromboxane A2, and reduction of inflammatory cytokines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33430/abstract/33\">",
"     33",
"    </a>",
"    ]. In the absence of randomized controlled trials, the role of this expensive therapy in treating nephrotic patients is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4348886\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Abnormal lipid metabolism is common in patients with renal disease, especially among those with nephrotic syndrome, in whom marked elevations in the plasma levels of cholesterol and, less predictably, triglycerides and lipoprotein(a) often occur. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The hyperlipidemic response is triggered at least in part by the reduction in plasma oncotic pressure which stimulates hepatic apoprotein B gene transcription. Diminished catabolism may also play a role. Impaired metabolism, rather than enhanced synthesis, is primarily responsible for nephrotic hypertriglyceridemia. Spontaneous or drug-induced resolution of the nephrotic syndrome reverses the hyperlipidemia. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with persistent nephrotic syndrome and hyperlipidemia are at increased risk for atherosclerotic disease, particularly if other cardiovascular risk factors are present. Hyperlipidemia may also enhance the rate of progressive glomerular injury. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical implications'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/6/30824?source=see_link\">",
"       \"Statins and chronic kidney disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The lipid abnormalities induced by the nephrotic syndrome reverse with resolution of the disease. In addition to treating the underlying glomerular disease, therapeutic options include dietary modification, angiotensin converting enzyme inhibitors or angiotensin receptor blockers to reduce proteinuria, statins, and possibly other hypolipidemic drugs. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/1\">",
"      D'Amico G. Statins and renal diseases: from primary prevention to renal replacement therapy. J Am Soc Nephrol 2006; 17:S148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/2\">",
"      Kwan BC, Kronenberg F, Beddhu S, Cheung AK. Lipoprotein metabolism and lipid management in chronic kidney disease. J Am Soc Nephrol 2007; 18:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/3\">",
"      Wheeler DC, Bernard DB. Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment. Am J Kidney Dis 1994; 23:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/4\">",
"      Appel G. Lipid abnormalities in renal disease. Kidney Int 1991; 39:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/5\">",
"      Radhakrishnan J, Appel AS, Valeri A, Appel GB. The nephrotic syndrome, lipids, and risk factors for cardiovascular disease. Am J Kidney Dis 1993; 22:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/6\">",
"      Weiner DE, Sarnak MJ. Managing dyslipidemia in chronic kidney disease. J Gen Intern Med 2004; 19:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/7\">",
"      Stenvinkel P, Berglund L, Heimb&uuml;rger O, et al. Lipoprotein(a) in nephrotic syndrome. Kidney Int 1993; 44:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/8\">",
"      Crew RJ, Radhakrishnan J, Appel G. Complications of the nephrotic syndrome and their treatment. Clin Nephrol 2004; 62:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/9\">",
"      Moulin P, Appel GB, Ginsberg HN, Tall AR. Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia. J Lipid Res 1992; 33:1817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/10\">",
"      Vaziri ND. Molecular mechanisms of lipid disorders in nephrotic syndrome. Kidney Int 2003; 63:1964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/11\">",
"      Joven J, Villabona C, Vilella E, et al. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med 1990; 323:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/12\">",
"      Kronenberg F, Lingenhel A, Lhotta K, et al. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy? Kidney Int 2004; 66:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/13\">",
"      Yamauchi A, Fukuhara Y, Yamamoto S, et al. Oncotic pressure regulates gene transcriptions of albumin and apolipoprotein B in cultured rat hepatoma cells. Am J Physiol 1992; 263:C397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/14\">",
"      BAXTER JH, GOODMAN HC, ALLEN JC. Effects of infusions of serum albumin on serum lipids and lipoproteins in nephrosis. J Clin Invest 1961; 40:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/15\">",
"      Vaziri ND, Liang KH. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome. Circulation 2004; 110:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/16\">",
"      Demant T, Mathes C, G&uuml;tlich K, et al. A simultaneous study of the metabolism of apolipoprotein B and albumin in nephrotic patients. Kidney Int 1998; 54:2064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/17\">",
"      Vega GL, Toto RD, Grundy SM. Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia. Kidney Int 1995; 47:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/18\">",
"      Warwick GL, Packard CJ, Demant T, et al. Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria. Kidney Int 1991; 40:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/19\">",
"      Shearer GC, Stevenson FT, Atkinson DN, et al. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome. Kidney Int 2001; 59:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/20\">",
"      Davies RW, Staprans I, Hutchison FN, Kaysen GA. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat. J Clin Invest 1990; 86:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/21\">",
"      Joles JA, Bijleveld C, van Tol A, et al. Plasma triglyceride levels are higher in nephrotic than in analbuminemic rats despite a similar increase in hepatic triglyceride secretion. Kidney Int 1995; 47:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/22\">",
"      Ordo&ntilde;ez JD, Hiatt RA, Killebrew EJ, Fireman BH. The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int 1993; 44:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/23\">",
"      Gentile MG, Fellin G, Cofano F, et al. Treatment of proteinuric patients with a vegetarian soy diet and fish oil. Clin Nephrol 1993; 40:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/24\">",
"      Keilani T, Schlueter WA, Levin ML, Batlle DC. Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor. Ann Intern Med 1993; 118:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/25\">",
"      Massy ZA, Ma JZ, Louis TA, Kasiske BL. Lipid-lowering therapy in patients with renal disease. Kidney Int 1995; 48:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/26\">",
"      Rabelink AJ, Hen&eacute; RJ, Erkelens DW, et al. Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome. Lancet 1988; 2:1335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/27\">",
"      Thomas ME, Harris KP, Ramaswamy C, et al. Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int 1993; 44:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/28\">",
"      Brown CD, Azrolan N, Thomas L, et al. Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome. Am J Kidney Dis 1995; 26:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/29\">",
"      Bianchi S, Bigazzi R, Caiazza A, Campese VM. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. Am J Kidney Dis 2003; 41:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/30\">",
"      Valeri A, Gelfand J, Blum C, Appel GB. Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial. Am J Kidney Dis 1986; 8:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/31\">",
"      Hattori M, Chikamoto H, Akioka Y, et al. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children. Am J Kidney Dis 2003; 42:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/32\">",
"      Muso E, Mune M, Fujii Y, et al. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group. Kidney Int Suppl 1999; 71:S122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33430/abstract/33\">",
"      Kobayashi S. Applications of LDL-apheresis in nephrology. Clin Exp Nephrol 2008; 12:9.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3114 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-7CA0D077E0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33430=[""].join("\n");
var outline_f32_41_33430=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4348886\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Hypercholesterolemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hypertriglyceridemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL IMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Lipoprotein glomerulopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Dietary modification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Angiotensin inhibition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Statins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Other hypolipidemic drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4348886\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/10/41130?source=related_link\">",
"      Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/3002?source=related_link\">",
"      Intensity of lipid lowering therapy in secondary prevention of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/54/29546?source=related_link\">",
"      Lipid abnormalities after renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/6/6248?source=related_link\">",
"      Lipid abnormalities in patients with chronic kidney disease not requiring dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/14/42217?source=related_link\">",
"      Lipid lowering with drugs other than statins and fibrates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/39/7800?source=related_link\">",
"      Lipid lowering with fibric acid derivatives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/45/18138?source=related_link\">",
"      Lipoprotein classification; metabolism; and role in atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/27/1464?source=related_link\">",
"      Lipoprotein glomerulopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/0/33802?source=related_link\">",
"      Statin myopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/6/30824?source=related_link\">",
"      Statins and chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/5/10329?source=related_link\">",
"      Treatment of drug-resistant hypercholesterolemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/32/14856?source=related_link\">",
"      Treatment of lipids (including hypercholesterolemia) in primary prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/32/26122?source=related_link\">",
"      Treatment of lipids (including hypercholesterolemia) in secondary prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_41_33431="Catheter ablation of atrial tachycardia";
var content_f32_41_33431=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Catheter ablation of atrial tachycardia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/41/33431/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33431/contributors\">",
"     Leonard I Ganz, MD, FHRS, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/41/33431/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33431/contributors\">",
"     Samuel L&eacute;vy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/41/33431/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33431/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/41/33431/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any supraventricular tachycardia (SVT) that requires only atrial tissue for its initiation and maintenance can properly be considered an atrial tachyarrhythmia. Although a relatively uncommon form of SVT, atrial tachycardia tends to be refractory to pharmacologic therapy and is therefore frequently treated with ablative therapy.",
"   </p>",
"   <p>",
"    Current catheter ablative techniques have evolved from open surgical techniques in which the arrhythmia focus was identified using intraoperative mapping and then excised [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Direct current (DC) shock catheter ablation (fulguration) was used for a short time in small numbers of patients with atrial tachycardia; this technique has been completely supplanted by radiofrequency (RF) catheter ablation.",
"   </p>",
"   <p>",
"    Radiofrequency catheter ablation (RFCA) techniques and outcomes in patients with atrial tachycardia will be reviewed here. Ablative techniques for the management of atrial fibrillation, and atrial flutter, both typical and atypical flutter, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/62/40938?source=see_link\">",
"     \"Radiofrequency catheter ablation to prevent recurrent atrial fibrillation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/19/24888?source=see_link\">",
"     \"Maintenance of sinus rhythm after cardioversion in atrial flutter\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ATRIAL TACHYCARDIAS AMENABLE TO CATHETER ABLATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial tachycardia may be unifocal or multifocal; some unifocal tachycardias originate in or around the sinus node.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unifocal (or ectopic) atrial tachycardia may have an automatic or reentrant mechanism, and a paroxysmal or incessant pattern (",
"      <a class=\"graphic graphic_waveform graphicRef74611 \" href=\"mobipreview.htm?42/4/43079\">",
"       waveform 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef50523 \" href=\"mobipreview.htm?20/2/20519\">",
"       waveform 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef57390 \" href=\"mobipreview.htm?29/42/30374\">",
"       waveform 3",
"      </a>",
"      ). Most varieties of unifocal atrial tachycardia are amenable to catheter ablation. Like atrial fibrillation, focal atrial tachycardia may arise from the pulmonary venous ostia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/3,4\">",
"       3,4",
"      </a>",
"      ]. The pathophysiology appears to be related, but not identical, to that of focal AF [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/9/9368?source=see_link\">",
"       \"Intraatrial reentrant tachycardia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/22/21864?source=see_link\">",
"       \"Focal atrial tachycardia\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H3\">",
"       'Indications for catheter ablation'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/62/40938?source=see_link\">",
"       \"Radiofrequency catheter ablation to prevent recurrent atrial fibrillation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sinoatrial node reentrant tachycardia (SNRT) is a specific type of unifocal atrial tachycardia in which sinoatrial (SA) nodal or peri-SA nodal tissue is part of the reentry circuit; this results in P waves during tachycardia which may be indistinguishable from normal sinus P waves&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34166?source=see_link\">",
"       \"Sinoatrial nodal reentrant tachycardia (SANRT)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inappropriate sinus tachycardia (IST), also known as chronic nonparoxysmal sinus tachycardia, is a distinct syndrome in which the resting sinus rate is elevated and there is an exaggerated chronotropic response to exercise [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/7\">",
"       7",
"      </a>",
"      ]. Although IST is most often treated with beta blockers, ablation may be considered in refractory patients. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/25/14742?source=see_link\">",
"       \"Sinus tachycardia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Occasionally, patients with more than one discrete ectopic atrial focus are candidates for curative ablation. Multifocal atrial tachycardia (MAT), however, is due to abnormal automaticity or triggered activity throughout the atria, and is therefore",
"      <strong>",
"       not",
"      </strong>",
"      curable with standard catheter techniques (",
"      <a class=\"graphic graphic_waveform graphicRef70173 \" href=\"mobipreview.htm?13/22/13671\">",
"       waveform 4",
"      </a>",
"      ). Refractory patients with MAT may benefit from complete atrioventricular junctional ablation and permanent pacemaker implantation or AV nodal modification [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/20/38216?source=see_link\">",
"       \"Multifocal atrial tachycardia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR CATHETER ABLATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with other forms of SVT, atrial tachycardia is usually benign and associated with only mild to moderate symptoms. Thus, most patients with atrial tachycardia are treated initially with medical therapy. Patient preference and refractoriness to pharmacologic therapy are reasonable indications for catheter ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some patients, atrial tachycardia is incessant and can cause a dilated cardiomyopathy, known as a tachycardia-mediated cardiomyopathy, due to the chronically rapid heart rate. Incessant atrial tachycardia frequently does not respond well to pharmacologic therapy; as a result, patients with possible tachycardia-induced cardiomyopathy should have their tachyarrhythmia treated aggressively with catheter ablation. In case reports and small series, patients with atrial tachycardia-induced cardiomyopathy frequently have complete resolution of left ventricular dysfunction with successful RF catheter ablation of the atrial focus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27097?source=see_link&amp;anchor=H11#H11\">",
"     \"Tachycardia-mediated cardiomyopathy\", section on 'Atrial tachycardia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2003",
"    <span class=\"nowrap\">",
"     ACC/AHA/ESC",
"    </span>",
"    guidelines for the management of supraventricular arrhythmias recommended catheter ablation in the following settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/12\">",
"     12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Recurrent symptomatic atrial tachycardia",
"     </li>",
"     <li>",
"      Incessant atrial tachycardia, regardless of symptoms",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     TECHNIQUES FOR CATHETER ABLATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Atrial tachycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mapping and ablating atrial tachycardia is technically more challenging than other forms of paroxysmal supraventricular tachycardia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/13\">",
"     13",
"    </a>",
"    ]. Atrial tachycardia can originate from any site in the right or left atrium, and even from the proximal pulmonary veins or superior vena cava. Thus, mapping becomes a much more complex three dimensional effort. Although atrial tachycardias tend to originate along the crista terminalis, atrial appendages, and pulmonary venous ostia, other sites are possible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/23/39289?source=see_link\">",
"     \"Electrophysiologic cardiac mapping: Techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/42/27305?source=see_link\">",
"     \"Electrophysiologic cardiac mapping: Use in specific arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Catheter ablation of atrial tachycardia depends largely upon activation mapping to identify an endocardial atrial site that is activated earlier than any other site (",
"    <a class=\"graphic graphic_waveform graphicRef58120 graphicRef50219 graphicRef82052 \" href=\"mobipreview.htm?39/40/40586\">",
"     waveform 5A-C",
"    </a>",
"    ). Timing is commonly referenced to the surface P wave; successful ablation sites are typically activated 30 msec or more prior to the onset of the surface P wave. If P waves are difficult to discern, however, timing can be referenced to a stable intracardiac site. Other mapping techniques, including pace mapping during sinus rhythm and entrainment mapping during tachycardia, are occasionally employed. Simultaneous mapping of multiple myocardial sites using a multielectrode basket catheter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/16\">",
"     16",
"    </a>",
"    ] or a catheter with multiple radiating spines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/17\">",
"     17",
"    </a>",
"    ] has been safely used in patients with atrial tachycardias, aiding in the rapid identification of sites of origin of the tachycardia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/25/19866?source=see_link\">",
"     \"Catheter ablation of cardiac arrhythmias: Overview and technical aspects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Identification of a tachycardia's origin as left versus right atrial may be difficult (",
"    <a class=\"graphic graphic_figure graphicRef62431 \" href=\"mobipreview.htm?24/46/25317\">",
"     figure 1",
"    </a>",
"    ). Early activation of the posterior or septal right atrium may actually be due to a left atrial focus, since the left atrium lies posterior to the right atrium. The following findings may be helpful:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Positive or biphasic P waves in lead aVL usually suggest a right atrial origin, while upright P waves in V1 suggest a left atrial origin [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      P wave morphology in lead V1 can help identify atrial tachycardias originating from the right pulmonary venous ostia from similar arrhythmias originating from the adjacent posterior right atrium. This was illustrated in a report of 24 patients with atrial tachycardias originating from these sites [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/4\">",
"       4",
"      </a>",
"      ]. The tachycardias originating from the right pulmonary venous ostia typically had a positive P wave in V1 (16 of 18, with the remaining two patients having a biphasic P wave) while those originating from the posterior right atrium usually had a biphasic P wave in lead V1 (six of eight, with the remaining two patients having a positive P wave).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several multielectrode catheters inserted at the beginning of a diagnostic electrophysiology study frequently give an initial indication of the origin of the tachycardia. A coronary sinus catheter reflects left atrial activity near the mitral annulus. A multipolar catheter may also be positioned along the crista terminalis to aid in mapping right atrial tachycardias. Detailed activation mapping of the right atrium with a deflectable catheter is performed during atrial tachycardia. A \"leap-frog\" technique may be used with two deflectable catheters in the right atrium. If no right atrial sites appear early or ablation is unsuccessful, mapping of the left atrium is then undertaken.",
"   </p>",
"   <p>",
"    Left atrial mapping is usually conducted via a transseptal approach; catheter manipulation is typically much more difficult when the catheter is positioned in the left atrium via a retrograde aortic-mitral approach. If the foramen ovale is not patent, then a transseptal puncture may be performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/19\">",
"     19",
"    </a>",
"    ]. Transthoracic, transesophageal, and recently intracardiac echocardiography have been used to facilitate transseptal puncture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/20\">",
"     20",
"    </a>",
"    ]. Once left atrial access is established, activation mapping in that chamber commences.",
"   </p>",
"   <p>",
"    Various newer imaging and mapping techniques are being used to help facilitate catheter ablation of atrial tachycardia. Intracardiac echocardiography has been used to identify the crista terminalis and other anatomic sites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/15\">",
"     15",
"    </a>",
"    ]. A non-contact mapping system, which creates endocardial maps of the surrounding chamber by recording from &gt;3300 sites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/21-23\">",
"     21-23",
"    </a>",
"    ], and an electroanatomic mapping system, which allows construction of three dimensional activation maps, appear to be quite helpful in mapping atrial tachycardia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. The success of ablation in patients with repaired congenital heart disease, in whom multiple complex reentrant circuits are present, can be improved by the combination of entrainment and electroanatomical mapping [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/23/39289?source=see_link\">",
"     \"Electrophysiologic cardiac mapping: Techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    New energy sources, most notably cryoenergy, have been applied to the ablation of atrial tachycardias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/28\">",
"     28",
"    </a>",
"    ]. Catheter cryoablation may be particularly effective when atrial tachycardia arises close to the AV node [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Inappropriate sinus tachycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of catheter ablation in patients with IST is less well defined. Total sinus node ablation and sinus node modification have been attempted in small numbers of patients with IST; both are technically difficult because the sinus node is a sizable complex of cells lying along the lateral right atrial wall, not a tiny discrete focus. Visualization of right atrial endocardial structures with intracardiac echocardiography facilitates catheter ablation for IST. The use of three dimensional nonfluoroscopic electroanatomic mapping system also improves the results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Total sinus node ablation leaves the patient with a junctional rhythm, which usually necessitates permanent pacemaker implantation.",
"     </li>",
"     <li>",
"      Sinus node modification involves an initial ablation at the superior aspect of the sinoatrial nodal complex. Ablation then proceeds inferiorly until the resting heart rate and the heart rate in response to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?22/31/23029?source=see_link\">",
"       isoproterenol",
"      </a>",
"      infusion decrease markedly. In patients who do not respond adequately to medical therapy or endocardial ablation, an alternative approach utilizing epicardial (via the pericardial space) ablation has been described [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/31,32\">",
"       31,32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With sinus node modification, there is a risk of recurrent IST during follow-up as well as incomplete resolution of symptoms despite successful reduction of the resting",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    exercise heart rate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/25/14742?source=see_link&amp;anchor=H6#H6\">",
"     \"Sinus tachycardia\", section on 'Inappropriate sinus tachycardia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ANTICOAGULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial tachycardia carries a low risk of systemic embolization in the absence of co-existing atrial",
"    <span class=\"nowrap\">",
"     fibrillation/flutter",
"    </span>",
"    and chronic oral anticoagulation is not recommended. Some experts recommend six to twelve weeks of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    therapy, if tolerated, after catheter ablation of atrial tachycardia for those patients not on oral anticoagulation for some other reason.",
"   </p>",
"   <p>",
"    We do suggest anticoagulation with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    during left atrial mapping and ablation to prevent the development of catheter related thrombi. Heparin may be discontinued after the procedure, or if extensive left-atrial ablation is performed, the following morning.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     RESULTS OF ABLATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported efficacy of ablation varies, due in part to the heterogeneity of these arrhythmias and the definitions of procedural success.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Atrial tachycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most series of atrial tachycardia ablation have included fairly small numbers of patients because of the relative infrequency of this arrhythmia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/14,24,25,33-36\">",
"     14,24,25,33-36",
"    </a>",
"    ]. In these studies, success rates are high (98 percent), but 5 to 33 percent of patients have recurrent arrhythmia. Larger studies have shown a somewhat lower success rate that varies with the type and focus of the arrhythmia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one series of 105 patients, ablation was initially effective in 77 percent, regardless of the site of origin; the success rate was higher with paroxysmal or permanent forms of atrial tachycardia than with repetitive forms (88, 71, and 41 percent, respectively) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/37\">",
"       37",
"      </a>",
"      ]. After a mean follow-up of 33 months, 10 percent of patients had recurrent arrhythmia, which originated from the original site in all patients.",
"     </li>",
"     <li>",
"      In a NASPE registry of 216 patients, ablation was initially successful in 80 percent with a right atrial focus, 72 percent with a left atrial focus, 52 percent with a septal focus, and 52 percent for intraatrial reentrant tachycardia; on follow-up, 15.2 percent of patients had recurrent tachycardia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ablation is also highly successful when intracardiac echocardiography is performed to facilitate catheter positioning, particularly when the origin is the crista terminalis of the right atrium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/15\">",
"     15",
"    </a>",
"    ], and when an electroanatomic mapping system is used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A pooled analysis of published reports found that the only multivariate predictor of acute success for catheter ablation of atrial tachycardia was a right atrial origin, while multiple ectopic atrial foci and the presence of structural cardiac disease were predictors of recurrence after an initially successful ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Sinoatrial nodal reentry",
"    </span>",
"    &nbsp;&mdash;&nbsp;In SNRT, successful ablation has been described in case reports and small series. The mapping and ablation strategy for SNRT is similar to that of other atrial tachycardias. In one series, ablation was successful in all 10 patients with SNRT and there were no recurrences during a mean follow-up of nine months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/39\">",
"     39",
"    </a>",
"    ]. A second study observed similar success in 14 patients who were followed 8 to 60 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Inappropriate sinus tachycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although studies are limited, ablation for IST seems to be modestly effective. In one report of 16 patients with drug resistant IST, four underwent total sinus node ablation; there were no recurrences during a 20-month follow-up but two patients required permanent pacemakers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/41\">",
"     41",
"    </a>",
"    ]. Modification of the sinus node was initially successful in 12 patients, but two had recurrent IST during a seven-month follow-up.",
"   </p>",
"   <p>",
"    In a second series of 29 patients, ablation at the site of earliest endocardial activation resulted in a reduction in sinus rate to &lt;90 bpm in 76 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/42\">",
"     42",
"    </a>",
"    ]. The slowing of sinus rate was abrupt in 41 percent of these patients, while it occurred in a gradual fashion during successive applications of radiofrequency energy in 59 percent. Symptoms recurred in 6 patients (27 percent) after 4.4 months; a repeat procedure was successful in three of these patients. Overall, symptoms from IST were eliminated in 66 percent of patients. In the NASPE registry, 40 patients underwent ablation for IST; acute success was achieved in 71.4 percent, but 10 percent had recurrent symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Epicardial mapping and ablation for IST may also be performed via a percutaneous pericardial approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/31\">",
"     31",
"    </a>",
"    ]. This approach appeared less useful for IST than for ventricular tachycardia, although the small number of patients treated in this manner (four with IST in this series) precludes accurate assessment of safety or efficacy (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/25/19866?source=see_link&amp;anchor=H21#H21\">",
"     \"Catheter ablation of cardiac arrhythmias: Overview and technical aspects\", section on 'Epicardial ablation'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Sinus node ablation, however, is not effective in patients with IST who have features of postural orthostatic tachycardia syndrome; although the sinus rate is effectively slowed, there is no significant improvement in clinical symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/43\">",
"     43",
"    </a>",
"    ]. Ablation is therefore not recommended for these patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/41/12951?source=see_link&amp;anchor=H13#H13\">",
"     \"Mechanisms, causes, and evaluation of orthostatic and postprandial hypotension\", section on 'Postural tachycardia syndrome and chronic orthostatic intolerance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    At present, catheter ablation in IST should probably be reserved for patients who remain significantly symptomatic despite aggressive attempts at pharmacologic therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     COMPLICATIONS OF ABLATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The complications associated with atrial tachycardia ablation are similar to those of catheter ablation in general. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/25/19866?source=see_link\">",
"     \"Catheter ablation of cardiac arrhythmias: Overview and technical aspects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Catheter ablation in the left atrium entails a small risk of thromboembolic complications.",
"     </li>",
"     <li>",
"      Extensive ablation in the lateral right atrium, as for IST, can cause right phrenic nerve damage [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/41\">",
"       41",
"      </a>",
"      ]. The risk is typically small and depends upon the site origin of tachycardia.",
"     </li>",
"     <li>",
"      Even when atrial tachycardias arise near the atrioventricular junction region, ablation is highly effective without a high risk of inducing complete heart block [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Sinoatrial nodal damage is possible in patients with SNRT or other tachycardias arising in the region of the sinus node region, but this complication appears to be quite rare.",
"     </li>",
"     <li>",
"      Total sinus node ablation for IST frequently necessitates permanent pacemaker implantation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33431/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H464851710\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atrial tachycardia is a relatively unusual form of SVT but is frequently poorly responsive to pharmacologic therapy. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/22/21864?source=see_link\">",
"       \"Focal atrial tachycardia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Unifocal atrial tachycardia is generally amenable to catheter ablation, though mapping and ablation are typically more difficult than for other forms of PSVT. Paroxysmal atrial tachycardias may be hard to induce in the EP laboratory, which obviously limits ablation success. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Atrial tachycardias amenable to catheter ablation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Incessant atrial tachycardia poses a risk of tachycardia induced cardiomyopathy;&nbsp;ablation should therefore be considered early in the treatment strategy. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Indications for catheter ablation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/22/21864?source=see_link&amp;anchor=H9439996#H9439996\">",
"       \"Focal atrial tachycardia\", section on 'Treatment of incessant AT'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sinus node reentrant tachycardia is amenable to catheter ablation.&nbsp;This arrhythmia is sometimes an artifact of programmed stimulation;&nbsp;care should be taken to make sure that this is a clinically significant tachycardia prior to mapping and ablation. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Sinoatrial nodal reentry'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Inappropriate sinus tachycardia is technically challenging to ablate successfully;&nbsp;medical therapy with a meta-blocker is generally recommended prior to attempting ablation. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Inappropriate sinus tachycardia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multifocal atrial tachycardia cannot be cured with catheter ablation.&nbsp;In selected patients who have a high burden of MAT unresponsive to medical therapy, AV junction ablation with permanent pacemaker implantation may be considered. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Atrial tachycardias amenable to catheter ablation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/1\">",
"      Coumel P, Aigueperse J, Perrault MA, et al. [Detection and attempted surgical exeresis of a left auricular ectopic focus with refractory tachycardia. Favorable outcome]. Ann Cardiol Angeiol (Paris) 1973; 22:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/2\">",
"      Prager NA, Cox JL, Lindsay BD, et al. Long-term effectiveness of surgical treatment of ectopic atrial tachycardia. J Am Coll Cardiol 1993; 22:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/3\">",
"      Kistler PM, Sanders P, Fynn SP, et al. Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins: acute and long-term outcomes of radiofrequency ablation. Circulation 2003; 108:1968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/4\">",
"      Yamada T, Murakami Y, Muto M, et al. Electrophysiologic characteristics of atrial tachycardia originating from the right pulmonary veins or posterior right atrium: double potentials obtained from the posterior wall of the right atrium can be useful to predict foci of atrial tachycardia in right pulmonary veins or posterior right atrium. J Cardiovasc Electrophysiol 2004; 15:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/5\">",
"      Narula OS. Sinus node re-entry: a mechanism for supraventricular tachycardia. Circulation 1974; 50:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/6\">",
"      Gomes JA, Mehta D, Langan MN. Sinus node reentrant tachycardia. Pacing Clin Electrophysiol 1995; 18:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/7\">",
"      Krahn AD, Yee R, Klein GJ, Morillo C. Inappropriate sinus tachycardia: evaluation and therapy. J Cardiovasc Electrophysiol 1995; 6:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/8\">",
"      Ueng KC, Lee SH, Wu DJ, et al. Radiofrequency catheter modification of atrioventricular junction in patients with COPD and medically refractory multifocal atrial tachycardia. Chest 2000; 117:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/9\">",
"      Morady F. Radio-frequency ablation as treatment for cardiac arrhythmias. N Engl J Med 1999; 340:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/10\">",
"      Chiladakis JA, Vassilikos VP, Maounis TN, et al. Successful radiofrequency catheter ablation of automatic atrial tachycardia with regression of the cardiomyopathy picture. Pacing Clin Electrophysiol 1997; 20:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/11\">",
"      Gillette PC, Wampler DG, Garson A Jr, et al. Treatment of atrial automatic tachycardia by ablation procedures. J Am Coll Cardiol 1985; 6:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/12\">",
"      Guidelines for Clinical Intracardiac Electrophysiological and Catheter Ablation Procedures. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures). Developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 1995; 92:673.",
"     </a>",
"    </li>",
"    <li>",
"     Lesh MD. Radiofrequency catheter ablation of atrial tachycardia and flutter. In: Cardiac Electrophysiology: From Cell to Bedside, 2nd ed, Zipes DP, Jalife J (Eds), WB Saunders, Philadelphia 1995. p.1461.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/14\">",
"      Lesh MD, Van Hare GF, Epstein LM, et al. Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation 1994; 89:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/15\">",
"      Kalman JM, Olgin JE, Karch MR, et al. \"Cristal tachycardias\": origin of right atrial tachycardias from the crista terminalis identified by intracardiac echocardiography. J Am Coll Cardiol 1998; 31:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/16\">",
"      Schmitt C, Zrenner B, Schneider M, et al. Clinical experience with a novel multielectrode basket catheter in right atrial tachycardias. Circulation 1999; 99:2414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/17\">",
"      Sanders P, Hocini M, Ja&iuml;s P, et al. Characterization of focal atrial tachycardia using high-density mapping. J Am Coll Cardiol 2005; 46:2088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/18\">",
"      Tang CW, Scheinman MM, Van Hare GF, et al. Use of P wave configuration during atrial tachycardia to predict site of origin. J Am Coll Cardiol 1995; 26:1315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/19\">",
"      De Ponti R, Zardini M, Storti C, et al. Trans-septal catheterization for radiofrequency catheter ablation of cardiac arrhythmias. Results and safety of a simplified method. Eur Heart J 1998; 19:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/20\">",
"      Daoud EG, Kalbfleisch SJ, Hummel JD. Intracardiac echocardiography to guide transseptal left heart catheterization for radiofrequency catheter ablation. J Cardiovasc Electrophysiol 1999; 10:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/21\">",
"      Schmitt H, Weber S, Schwab JO, et al. Diagnosis and ablation of focal right atrial tachycardia using a new high-resolution, non-contact mapping system. Am J Cardiol 2001; 87:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/22\">",
"      Paul T, Windhagen-Mahnert B, Kriebel T, et al. Atrial reentrant tachycardia after surgery for congenital heart disease: endocardial mapping and radiofrequency catheter ablation using a novel, noncontact mapping system. Circulation 2001; 103:2266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/23\">",
"      Higa S, Tai CT, Lin YJ, et al. Focal atrial tachycardia: new insight from noncontact mapping and catheter ablation. Circulation 2004; 109:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/24\">",
"      Marchlinski F, Callans D, Gottlieb C, et al. Magnetic electroanatomical mapping for ablation of focal atrial tachycardias. Pacing Clin Electrophysiol 1998; 21:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/25\">",
"      Natale A, Breeding L, Tomassoni G, et al. Ablation of right and left ectopic atrial tachycardias using a three-dimensional nonfluoroscopic mapping system. Am J Cardiol 1998; 82:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/26\">",
"      Hoffmann E, Reithmann C, Nimmermann P, et al. Clinical experience with electroanatomic mapping of ectopic atrial tachycardia. Pacing Clin Electrophysiol 2002; 25:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/27\">",
"      Delacretaz E, Ganz LI, Soejima K, et al. Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol 2001; 37:1665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/28\">",
"      Friedman PL. Catheter cryoablation of cardiac arrhythmias. Curr Opin Cardiol 2005; 20:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/29\">",
"      Wong T, Segal OR, Markides V, et al. Cryoablation of focal atrial tachycardia originating close to the atrioventricular node. J Cardiovasc Electrophysiol 2004; 15:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/30\">",
"      Marrouche NF, Beheiry S, Tomassoni G, et al. Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia. Procedural strategies and long-term outcome. J Am Coll Cardiol 2002; 39:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/31\">",
"      Schweikert RA, Saliba WI, Tomassoni G, et al. Percutaneous pericardial instrumentation for endo-epicardial mapping of previously failed ablations. Circulation 2003; 108:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/32\">",
"      Koplan BA, Parkash R, Couper G, Stevenson WG. Combined epicardial-endocardial approach to ablation of inappropriate sinus tachycardia. J Cardiovasc Electrophysiol 2004; 15:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/33\">",
"      Kay GN, Chong F, Epstein AE, et al. Radiofrequency ablation for treatment of primary atrial tachycardias. J Am Coll Cardiol 1993; 21:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/34\">",
"      Chen SA, Chiang CE, Yang CJ, et al. Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation 1994; 90:1262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/35\">",
"      Poty H, Saoudi N, Haissaguerre M, et al. Radiofrequency catheter ablation of atrial tachycardias. Am Heart J 1996; 131:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/36\">",
"      Chen SA, Tai CT, Chiang CE, et al. Focal atrial tachycardia: reanalysis of the clinical and electrophysiologic characteristics and prediction of successful radiofrequency ablation. J Cardiovasc Electrophysiol 1998; 9:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/37\">",
"      Anguera I, Brugada J, Roba M, et al. Outcomes after radiofrequency catheter ablation of atrial tachycardia. Am J Cardiol 2001; 87:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/38\">",
"      Scheinman MM, Huang S. The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol 2000; 23:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/39\">",
"      Sanders WE Jr, Sorrentino RA, Greenfield RA, et al. Catheter ablation of sinoatrial node reentrant tachycardia. J Am Coll Cardiol 1994; 23:926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/40\">",
"      Ivanov MY, Evdokimov VP, Vlasenco VV. Predictors of successful radiofrequency catheter ablation of sinoatrial tachycardia. Pacing Clin Electrophysiol 1998; 21:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/41\">",
"      Lee RJ, Kalman JM, Fitzpatrick AP, et al. Radiofrequency catheter modification of the sinus node for \"inappropriate\" sinus tachycardia. Circulation 1995; 92:2919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/42\">",
"      Man KC, Knight B, Tse HF, et al. Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping. J Am Coll Cardiol 2000; 35:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/43\">",
"      Shen WK, Low PA, Jahangir A, et al. Is sinus node modification appropriate for inappropriate sinus tachycardia with features of postural orthostatic tachycardia syndrome? Pacing Clin Electrophysiol 2001; 24:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33431/abstract/44\">",
"      Lai LP, Lin JL, Chen TF, et al. Clinical, electrophysiological characteristics, and radiofrequency catheter ablation of atrial tachycardia near the apex of Koch's triangle. Pacing Clin Electrophysiol 1998; 21:367.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1010 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-543E46505B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33431=[""].join("\n");
var outline_f32_41_33431=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H464851710\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ATRIAL TACHYCARDIAS AMENABLE TO CATHETER ABLATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INDICATIONS FOR CATHETER ABLATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      TECHNIQUES FOR CATHETER ABLATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Atrial tachycardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Inappropriate sinus tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ANTICOAGULATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      RESULTS OF ABLATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Atrial tachycardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Sinoatrial nodal reentry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Inappropriate sinus tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      COMPLICATIONS OF ABLATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H464851710\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1010\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1010|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/46/25317\" title=\"figure 1\">",
"      Atrial tachycardia foci",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1010|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?42/4/43079\" title=\"waveform 1\">",
"      Atrial tachycardia ECG 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?20/2/20519\" title=\"waveform 2\">",
"      Atrial tachycardia ECG 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?29/42/30374\" title=\"waveform 3\">",
"      Atrial tachycardia ECG 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?13/22/13671\" title=\"waveform 4\">",
"      Multifocal atrial tachycardia ECG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?16/49/17176\" title=\"waveform 5A\">",
"      EP study tracings during atrial tachycardia mapping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?8/9/8341\" title=\"waveform 5B\">",
"      EP study tracing showing VPB during atrial tachycardia mapping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?8/15/8438\" title=\"waveform 5C\">",
"      EP study tracing RF ablation atrial tachycardia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/25/19866?source=related_link\">",
"      Catheter ablation of cardiac arrhythmias: Overview and technical aspects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/23/39289?source=related_link\">",
"      Electrophysiologic cardiac mapping: Techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/42/27305?source=related_link\">",
"      Electrophysiologic cardiac mapping: Use in specific arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/22/21864?source=related_link\">",
"      Focal atrial tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/9/9368?source=related_link\">",
"      Intraatrial reentrant tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/19/24888?source=related_link\">",
"      Maintenance of sinus rhythm after cardioversion in atrial flutter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/41/12951?source=related_link\">",
"      Mechanisms, causes, and evaluation of orthostatic and postprandial hypotension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/20/38216?source=related_link\">",
"      Multifocal atrial tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/62/40938?source=related_link\">",
"      Radiofrequency catheter ablation to prevent recurrent atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34166?source=related_link\">",
"      Sinoatrial nodal reentrant tachycardia (SANRT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/25/14742?source=related_link\">",
"      Sinus tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27097?source=related_link\">",
"      Tachycardia-mediated cardiomyopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_41_33432="Clinical manifestations, pathologic features, and diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma";
var content_f32_41_33432=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations, pathologic features, and diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/41/33432/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33432/contributors\">",
"     Peter M Mauch, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33432/contributors\">",
"     Jon C Aster, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/41/33432/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33432/contributors\">",
"     Arnold S Freedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33432/contributors\">",
"     George P Canellos, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/41/33432/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33432/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/41/33432/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an uncommon subtype of Hodgkin lymphoma (HL). This disorder is differentiated from all other forms of HL, which are commonly referred to as classical Hodgkin lymphomas (CHL), by characteristic pathologic and clinical features.",
"   </p>",
"   <p>",
"    NLPHL represents a more indolent disease than CHL, and is therefore managed uniquely. Since this disease is so uncommon, most information concerning treatment and outcome has come from reports of single institutions or pooled, multi-institutional retrospective analyses.",
"   </p>",
"   <p>",
"    The epidemiology, pathogenesis, clinical presentation, pathology, diagnosis, and differential diagnosis of NLPHL are reviewed here. Treatment and prognosis of NLPHL are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/45/34520?source=see_link\">",
"     \"Treatment of nodular lymphocyte-predominant Hodgkin lymphoma\"",
"    </a>",
"    .) Treatment of the other Hodgkin lymphoma subtypes is discussed separately. (See related topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 5 percent of patients initially diagnosed with HL have the uncommon variant NLPHL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/1\">",
"     1",
"    </a>",
"    ]. The incidence of NLPHL in the United States and Europe has been stable at approximately 8 to 9 cases per 10,000,000 people per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. For unknown reasons, an increase in incidence among children has been noted.",
"   </p>",
"   <p>",
"    Approximately 75 percent of patients with NLPHL are male [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/2\">",
"     2",
"    </a>",
"    ]. The age distribution has two peaks: one in children and one in adults, the latter with a median age of 30 to 40 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/4\">",
"     4",
"    </a>",
"    ]. Unlike CHL, NLPHL is more common in the United States among African-Americans compared with Caucasians [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of NLPHL is unclear. There is little known about the genetic changes that underlie this tumor. The neoplastic cell, usually referred to as a lymphohistiocytic or L&amp;H Reed-Sternberg cell variant, is a germinal center B cell [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. These cells have productive immunoglobulin gene rearrangements, and show evidence of ongoing somatic hypermutation of their immunoglobulin genes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/8\">",
"     8",
"    </a>",
"    ]. Consistent with these observations, neoplastic L&amp;H variants are typically found within expanded B cell follicles that are rich in follicular dendritic cells and an unusual population of",
"    <span class=\"nowrap\">",
"     CD4+/CD57+",
"    </span>",
"    T cells.",
"   </p>",
"   <p>",
"    Although both NLPHL and CHL are malignant lymphomas of germinal center B cell origin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/5-7\">",
"     5-7",
"    </a>",
"    ], these disorders behave very differently due in part to variations in cross-talk with surrounding reactive cells, which make up the bulk of the tumor in all forms of Hodgkin lymphoma. The growth and survival of NLPHL cells, like normal germinal center B cells, appears to depend on signals produced by the immunoglobulin receptor within the milieu of the expanded B cell follicles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/9\">",
"     9",
"    </a>",
"    ]. It is likely that dendritic cells and a special subset of follicular T cells (described under morphology) contribute to L&amp;H cell growth and survival.",
"   </p>",
"   <p>",
"    Because L&amp;H cells do not appear to be a rich source of cytokines and chemokines, systemic symptoms, such as fever, night sweats, and weight loss, which are common in CHL, are typically absent in NLPHL. In contrast to NLPHL, the growth and survival of the Reed-Sternberg cells of CHL is independent of immunoglobulin receptor signaling, and instead depends on alternative receptors, such as CD30 and CD40, that activate the transcription factor NF-kB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/10\">",
"     10",
"    </a>",
"    ]. Moreover, the Reed-Sternberg cells of CHL produce a broad array of inflammatory cytokines and chemokines that have both local and systemic effects. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/23/2426?source=see_link\">",
"     \"The Reed-Sternberg cell and the pathogenesis of Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Certain non-malignant architectural changes have been described in patients who eventually develop NLPHL. These lymph node abnormalities include reactive follicular hyperplasia or progressive transformation of germinal centers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/11\">",
"     11",
"    </a>",
"    ]. Whether this association has any pathogenic significance is unclear. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39080?source=see_link&amp;anchor=H23#H23\">",
"     \"Evaluation of peripheral lymphadenopathy in adults\", section on 'Progressive transformation of germinal centers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    T",
"    <span class=\"nowrap\">",
"     cell/histiocyte-rich",
"    </span>",
"    B cell lymphoma",
"    <span class=\"nowrap\">",
"     (T/HRBCL)",
"    </span>",
"    is a variant of diffuse large B cell lymphoma that has a similar morphology and an identical immunophenotype to NLPHL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/12\">",
"     12",
"    </a>",
"    ]. Some advocate that these tumors may be a biologic continuum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/13\">",
"     13",
"    </a>",
"    ], in which",
"    <span class=\"nowrap\">",
"     T/HRBCLs",
"    </span>",
"    represents tumors that have lost their dependence on trophic factors produced within B cell follicles.",
"   </p>",
"   <p>",
"    EBV is involved in the pathogenesis of CHL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/1,14,15\">",
"     1,14,15",
"    </a>",
"    ], but has no role in NLPHL. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3703?source=see_link\">",
"     \"The role of Epstein-Barr virus in Hodgkin lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/23/2426?source=see_link\">",
"     \"The Reed-Sternberg cell and the pathogenesis of Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the two largest series of patients with NLPHL, the following symptoms and signs were noted at presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lymphadenopathy (100 percent). NLPHL tends to present as a chronic, asymptomatic lymphadenopathy involving peripheral lymph nodes above or below the diaphragm rather than central lymph node sites. Affected lymph nodes are often easily detected by physical examination [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/16-18\">",
"       16-18",
"      </a>",
"      ]. A mediastinal mass is only present in 2 to 7 percent.",
"     </li>",
"     <li>",
"      B symptoms (6 to 15 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/4\">",
"       4",
"      </a>",
"      ]. Patients with NLPHL rarely complain of B-type symptoms (fever, drenching night sweats, weight loss) at the time of initial presentation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/37/14935?source=see_link&amp;anchor=H13#H13\">",
"       \"Staging and prognosis of Hodgkin lymphoma\", section on 'Criteria for B symptoms'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Spleen (8 percent) and liver (2 to 3 percent) involvement [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/4,19\">",
"       4,19",
"      </a>",
"      ]. Routine laparotomy is no longer considered standard in patients with Hodgkin lymphoma. When performed, upstaging occurs in a small percentage of patients with NLPHL [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/20,21\">",
"       20,21",
"      </a>",
"      ]. In a study that included 51 patients with NLPHL, 4 and 13 percent of stage IA and IIA patients were upstaged following staging laparotomy, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/20\">",
"       20",
"      </a>",
"      ]; this compares with over 20 percent for patients with CHL [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/17,22\">",
"       17,22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bone marrow involvement (1 to 2 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/4,19,23\">",
"       4,19,23",
"      </a>",
"      ]. One study of 275 patients diagnosed with nodular lymphocyte predominant Hodgkin lymphoma found seven patients with purely nodular NLPHL and bone marrow involvement [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/23\">",
"       23",
"      </a>",
"      ]. All patients with bone marrow involvement also had clinical, laboratory, radiologic, or morphologic evidence of aggressive disease prior to bone marrow biopsy. Some (and perhaps most) patients with marrow involvement have tumors that are difficult to distinguish with certainty from",
"      <span class=\"nowrap\">",
"       T/HRBCL,",
"      </span>",
"      which commonly involves the bone marrow and the spleen. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'T cell/HRBCL'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Lung involvement (1 to 4 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/4,19\">",
"       4,19",
"      </a>",
"      ], which can consist of a pulmonary lymphoid infiltrate [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Skeletal involvement (1 to 3 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/4,19\">",
"       4,19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Approximately 75 percent of patients with NLPHL present with stage I-II disease. This compares with approximately 50 to 60 percent of patients with CHL who present with similar stage disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;NLPHL can be distinguished from CHL by characteristics found on lymph node biopsy (",
"    <a class=\"graphic graphic_table graphicRef57079 \" href=\"mobipreview.htm?17/23/17788\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Classification schemes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Previously, a number of classification schemes based entirely upon histology were used to describe this HL variant (ie, Jackson and Parker, Lukes and Butler, Rye symposium) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/25-29\">",
"     25-29",
"    </a>",
"    ]. Subsequent classification systems, principally the REAL and WHO schemes, have been developed that rely upon both morphology and immunophenotype. A proposed but not yet widely accepted classification system, named the InterLymph classification scheme, differs from REAL and WHO classifications and was developed to facilitate analysis of retrospective studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among all existing systems, the WHO classification is the schema most commonly used. This is principally because this system provides a classification of lymphoma subtypes that best guides therapy and prognosis in all lymphomas.",
"   </p>",
"   <p>",
"    All classification schemes for Hodgkin and non-Hodgkin lymphoma are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/53/21337?source=see_link&amp;anchor=H11#H11\">",
"     \"Classification of the hematopoietic neoplasms\", section on 'Hodgkin lymphoma (HL)'",
"    </a>",
"    .) and (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/13/15578?source=see_link\">",
"     \"Epidemiology, pathologic features, and diagnosis of classical Hodgkin lymphoma\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     REAL classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The revised European-American lymphoma (REAL) classification first identified NLPHL as a distinct clinicopathologic entity separate from the other subtypes of HL and non-Hodgkin lymphoma (NHL) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     WHO classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The updated 2008 World Health Organization classification system is the current gold standard for categorizing hematologic malignancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/32\">",
"     32",
"    </a>",
"    ]. NLPHL remains under the general category of Hodgkin lymphoma but is separated from the Classic Hodgkin lymphomas based upon certain morphologic and immunophenotypic features (",
"    <a class=\"graphic graphic_table graphicRef57079 \" href=\"mobipreview.htm?17/23/17788\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Morphology",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     L&amp;H variant",
"    </span>",
"    &nbsp;&mdash;&nbsp;A key morphologic feature of NLPHL is the presence of an atypical variant of the Reed-Sternberg (RS) cell known as the lymphocytic and histiocytic (L&amp;H) cell or L&amp;H variant (",
"    <a class=\"graphic graphic_picture graphicRef82911 \" href=\"mobipreview.htm?0/39/633\">",
"     picture 1",
"    </a>",
"    ). These L&amp;H cells have vesicular, polylobulated nuclei and distinct but small, usually peripheral nucleoli, without perinucleolar halos [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/33\">",
"     33",
"    </a>",
"    ]. The term \"popcorn cell\" is sometimes used for these cells because its nucleus resembles an exploded popcorn kernel. While the diagnosis of NLPHL is contingent upon finding L&amp;H variants, cells with similar morphology can be seen in other disorders. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Background cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;CHL is characterized by the presence of scattered Reed-Sternberg cells in a polymorphous background of acute and chronic inflammatory cells. By comparison, NLPHL is characterized by L&amp;H cells in a background of small B-lymphocytes, follicular dendritic cells, and follicular CD57+ T-lymphocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/34\">",
"     34",
"    </a>",
"    ], which often form rosettes around the L&amp;H cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Growth pattern",
"    </span>",
"    &nbsp;&mdash;&nbsp;Distinctly nodular architecture is evident in the majority of cases. This pattern is enhanced by stains for follicular dendritic cell markers, such as CD21 and CD23, which bring out expanded, nodular follicles that are also usually rich in B cells and L&amp;H cells (",
"    <a class=\"graphic graphic_picture graphicRef67339 \" href=\"mobipreview.htm?19/26/19874\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Nodular and diffuse architectures may co-exist in the same lymph node specimen, and the diffuse areas may demonstrate increased proportions of T cells that appear to \"break up\" the B cell-rich nodules. In some cases, a predominantly diffuse architecture is seen; with special stains, however, focal areas of nodularity can almost always be identified.",
"   </p>",
"   <p>",
"    A minority of cases of NLPHL may contain a significant number of diffuse areas. It is controversial whether purely diffuse cases exist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Immunophenotype",
"    </span>",
"    &nbsp;&mdash;&nbsp;The immunophenotype of the malignant L&amp;H cells in NLPHL is different from that of the classical Reed-Sternberg cells seen in CHL. This plays an important role in differentiating among the various HL variants. The neoplastic cells of CHL are typically CD15+, CD30+, CD45- (leukocyte common antigen), CD20-.",
"   </p>",
"   <p>",
"    In contrast, the L&amp;H cells of NLPHL are CD45+, BCL6+, CD19+, CD20+, CD22+, CD79a+, BCL6+, and CD15-; they only rarely express CD30. These cells therefore express the B cell surface antigens (CD19, CD20, CD22, CD79a) and the germinal center B cell-specific transcription factor BCL6. (",
"    <a class=\"graphic graphic_picture graphicRef78028 \" href=\"mobipreview.htm?9/50/10020\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef57079 \" href=\"mobipreview.htm?17/23/17788\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/13/15578?source=see_link&amp;anchor=H25#H25\">",
"     \"Epidemiology, pathologic features, and diagnosis of classical Hodgkin lymphoma\", section on 'Nodular lymphocyte predominant HL'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of NLPHL requires the identification of characteristic morphologic and immunophenotypic features within lymph node biopsies. Because this is an uncommon disease, it is most reliably diagnosed by experienced hematopathologists.",
"   </p>",
"   <p>",
"    We rely upon the following to diagnose NLPHL:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of L&amp;H cells within the background of a fully or partially nodular growth pattern",
"     </li>",
"     <li>",
"      Background cells consisting of small B cells, CD3+CD4+CD57+ T cells, and CD21+ CD23+ follicular dendritic cells",
"     </li>",
"     <li>",
"      Characteristic L&amp;H cell immunophenotype. These cells are usually CD20+, BLC6+, CD15-, and CD30-. An expanded set of markers, including epithelial membrane antigen (EMA) and other B cell markers, such as CD79a and the transcription factors BOB-1 and OCT-2, can be helpful in difficult cases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Prior to the routine use of immunohistochemical and molecular diagnostic tools, a number of lymphomas, including NLPHL, CHL, and certain non-Hodgkin lymphomas, were easily confused with one another. This was best illustrated in a study from the European Task Force on Lymphomas (ETFL), in which clinical data and biopsy material was collected from 426 patients with presumed NLPHL based upon the Rye classification system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/4\">",
"     4",
"    </a>",
"    ]. After the biopsy specimens were meticulously reviewed using the stringent morphologic and immunophenotypic criteria of the REAL classification system, 51 percent were confirmed to be NLPHL, while the remainder was reclassified (",
"    <a class=\"graphic graphic_figure graphicRef51531 \" href=\"mobipreview.htm?38/56/39822\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    This finding emphasizes the importance of careful pathologic study of all new diagnoses of NLPHL and also supports the reevaluation of the initial pathology of NLPHL patients who later develop NHL thought to be transformed NLPHL. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/45/24282?source=see_link\">",
"     \"Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/45/34520?source=see_link&amp;anchor=H21#H21\">",
"     \"Treatment of nodular lymphocyte-predominant Hodgkin lymphoma\", section on 'Transformation to NHL'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of NLPHL includes both non-malignant and malignant causes of lymphadenopathy. In particular, it is important to distinguish NLPHL from other lymphomas that require a different treatment approach (",
"    <a class=\"graphic graphic_table graphicRef57098 \" href=\"mobipreview.htm?6/28/6605\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Benign and malignant causes of lymphadenopathy that can be confused with NLPHL follow below. Particular attention is given to those malignancies that most closely resemble NLPHL.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Lymphadenopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with NLPHL present with peripheral lymphadenopathy. Causes of lymphadenopathy are varied and include those that are infectious, autoimmune, benign, and malignant. A general approach to lymphadenopathy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39080?source=see_link\">",
"     \"Evaluation of peripheral lymphadenopathy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Reactive hyperplasia or PTGC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Progressive transformation of germinal centers (PTGC) is an uncommon condition, often presenting as unexplained, asymptomatic, persistent or recurrent lymphadenopathy. PTGC is characterized by the presence in a lymph node of one or more nodules three to five times the size of a typical reactive follicle, with a predominance of small mantle zone B cells, as well as disruption and eventual replacement of the germinal center [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. While PTGC and nodular lymphocyte predominant Hodgkin lymphoma are often associated, and some patients with PTGC may develop lymphoma at a later date, PTGC is not considered to be a premalignant condition. It may be associated with chronic inflammatory or autoimmune conditions.",
"   </p>",
"   <p>",
"    The distinction between NLPHL and PTGC lies in the L&amp;H cells, which are only present in NLPHL. L&amp;H cells may be only seen focally and thus missed on initial review. Biopsies showing reactive hyperplasia or PTGC should be re-evaluated to make certain that a diagnosis of NLPHL is not inadvertently missed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     T cell/HRBCL",
"    </span>",
"    &nbsp;&mdash;&nbsp;T",
"    <span class=\"nowrap\">",
"     cell/histiocyte-rich",
"    </span>",
"    B cell lymphoma",
"    <span class=\"nowrap\">",
"     (T/HRBCL)",
"    </span>",
"    is a variant of diffuse large B cell lymphoma. It can be very difficult to distinguish from NLPHL because the two have a very similar morphology and an identical immunophenotype [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/12\">",
"     12",
"    </a>",
"    ]. Some advocate that these tumors may be a biologic continuum since some cases are impossible to accurately characterize as one or the other [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, it is important to try to distinguish between these two diagnoses since they behave and are treated very differently. While NLPHL usually presents as low-stage disease and follows an indolent course, most cases of",
"    <span class=\"nowrap\">",
"     T/HRBCL",
"    </span>",
"    present as high-stage disease and have a much poorer outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with NLPHL,",
"    <span class=\"nowrap\">",
"     T/HRBCL",
"    </span>",
"    tumors contain scattered neoplastic CD20 positive B cells within a reactive background. In addition, the neoplastic cells in",
"    <span class=\"nowrap\">",
"     T/HRBCL",
"    </span>",
"    can closely resemble L&amp;H cells, as well as centroblasts, immunoblasts, or classic Reed-Sternberg cells.",
"   </p>",
"   <p>",
"    The key differentiating features are the composition of the background cells and the growth pattern (",
"    <a class=\"graphic graphic_table graphicRef57098 \" href=\"mobipreview.htm?6/28/6605\">",
"     table 2",
"    </a>",
"    ). In NLPHL, small B cells, CD3+CD4+CD57+ T cells, and follicular dendritic cells are commonly found in the background. In",
"    <span class=\"nowrap\">",
"     T/HRBCL",
"    </span>",
"    the background is mostly CD8+ cytotoxic T cells and macrophages. Follicular dendritic cells are absent. While the growth pattern in NLPHL is at least partially nodular, the growth pattern in",
"    <span class=\"nowrap\">",
"     T/HRBCL",
"    </span>",
"    is predominantly diffuse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Lymphocyte-rich CHL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphocyte-rich classical Hodgkin lymphoma (LRCHL), a variant of CHL, can be difficult to distinguish from NLPHL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/38\">",
"     38",
"    </a>",
"    ]. LRCHL often has a similar clinical presentation to NLPHL; in both entities, early stage disease, non-bulky disease and an absence of B symptoms predominate. LRCHL has a slightly better prognosis than other subtypes of CHL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/1\">",
"     1",
"    </a>",
"    ]. Morphologically, LRCHL contains classical neoplastic Reed-Sternberg cells among a background of small lymphocytes. Growth is usually in a nodular pattern but can be diffuse.",
"   </p>",
"   <p>",
"    The key distinguishing feature of LRCHL is the immunophenotype of the malignant cells (",
"    <a class=\"graphic graphic_table graphicRef57098 \" href=\"mobipreview.htm?6/28/6605\">",
"     table 2",
"    </a>",
"    ). Unlike NLPHL, LRCHL malignant cells have the immunophenotypic pattern of CHL. In addition, about 40 percent of LRCHLs are EBV+ (",
"    <a class=\"graphic graphic_table graphicRef57079 \" href=\"mobipreview.htm?17/23/17788\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;After the diagnosis of NLPHL is confirmed, the patient should undergo a work-up and staging evaluation similar to that performed for patients with CHL. Staging is performed using the Ann Arbor staging system with Cotswolds modifications (",
"    <a class=\"graphic graphic_table graphicRef66651 \" href=\"mobipreview.htm?19/23/19836\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. This system is described at length separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/37/14935?source=see_link\">",
"     \"Staging and prognosis of Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     History and physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A detailed history should include documentation of the presence or absence of B-type symptoms and a complete physical examination should include careful evaluation of all lymph node stations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Blood studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood work is necessary as part of the initial evaluation. This provides prognostic data such as the calculation of the International Prognostic Score (IPS), and also helps detect involvement of bone and possible liver and kidney dysfunction to aid in treatment decisions. However, in practice these studies are not usually helpful as most patients present with early stage disease.",
"   </p>",
"   <p>",
"    Recommended studies include: complete blood cell count with differential, chemistries including calcium, blood urea nitrogen (BUN), creatinine, serum alkaline phosphatase, aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase, albumin, and erythrocyte sedimentation rate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/12/13512?source=see_link&amp;anchor=H112049651#H112049651\">",
"     \"Overview of the treatment of classical Hodgkin lymphoma in adults\", section on 'International prognostic score'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accurate staging guides therapy and should include an intravenous contrast-enhanced computed tomography (CT) of the neck, chest, abdomen, and pelvis to evaluate the extent of disease. PET imaging may not provide useful additional information over CT scans in the staging of patients with NLPHL. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'PET scan'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Bone marrow exam",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone marrow involvement is rare in NLPHL, being present in only 1 to 2 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/4,23,41\">",
"     4,23,41",
"    </a>",
"    ]. Accordingly, bone marrow biopsy and aspirate should be considered only for patients with stage IIB-IV disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Staging laparotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;As is true for patients with CHL, staging laparotomy with splenectomy is no longer considered standard in the evaluation of a patient with NLPHL for several reasons. Since the spleen is rarely involved in NLPHL, the adverse risks associated with splenectomy outweigh possible benefits. Moreover, the staging information obtained by CT scanning is usually adequate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     PET scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since positron emission tomography (PET) imaging does not add useful information over CT scans in the staging of NLPHL patients, we tend to avoid 18-fluorodeoxyglucose (FDG)-PET at our institution in the initial staging or follow-up of these patients. PET has been shown to be sensitive for disease detection in patients with CHL and is used for baseline studies and to assess response to therapy in this population. However, the FDG-avidity of NLPHL is lower than that of CHL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33432/abstract/42\">",
"     42",
"    </a>",
"    ] and so it may therefore be difficult to distinguish malignant activity from the background FDG-avidity of benign, reactive lymphadenopathy or PTGC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an uncommon subtype of Hodgkin lymphoma (HL). Approximately 5 percent of patients initially diagnosed with HL have the uncommon variant NLPHL. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathogenesis of NLPHL is unclear. Increasing evidence suggests that the neoplastic cell, usually referred to as a lymphohistiocytic or L&amp;H Reed-Sternberg cell variant, is a germinal B cell. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      NLPHL tends to present as a chronic, asymptomatic lymphadenopathy involving peripheral lymph nodes above or below the diaphragm, which are often easily detected by physical examination. A mediastinal mass is only present in 2 to 7 percent. Mediastinal, splenic, liver, and bone marrow involvement is uncommon. Likewise, B symptoms are present in less than 15 percent of patients. The majority of patients with NLPHL present with stage I-II disease. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of NLPHL uses the World Health Organization classification and relies upon a combination of characteristic morphologic features on lymph node biopsy plus immunophenotyping (",
"      <a class=\"graphic graphic_table graphicRef57079 \" href=\"mobipreview.htm?17/23/17788\">",
"       table 1",
"      </a>",
"      ). Evaluation of the lymph node biopsy reveals a fully or partially nodular growth pattern with morphologic evidence of L&amp;H cells with the characteristic L&amp;H cell immunophenotype (CD20+, BCL6+, CD15-, and CD30-) within a background consisting of small B cells, CD3+CD4+CD57+ T cells, and CD21+ CD23+ follicular dendritic cells. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of NLPHL includes both non-malignant and malignant causes of lymphadenopathy. Distinction between these diagnoses relies upon evaluation of both morphology and immunophenotype. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Staging is performed using the Ann Arbor staging system with Cotswolds modifications (",
"      <a class=\"graphic graphic_table graphicRef66651 \" href=\"mobipreview.htm?19/23/19836\">",
"       table 3",
"      </a>",
"      ). The staging evaluation includes the following studies (see",
"      <a class=\"local\" href=\"#H20\">",
"       'Staging'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Historic evaluation for B symptoms",
"     </li>",
"     <li>",
"      Physical evaluation of all lymph node stations",
"     </li>",
"     <li>",
"      Baseline blood work: complete blood cell count with differential, chemistries including calcium, blood urea nitrogen (BUN), creatinine, serum alkaline phosphatase, aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase, albumin, and erythrocyte sedimentation rate.",
"     </li>",
"     <li>",
"      An intravenous contrast enhanced computed tomography of the neck, chest, abdomen, and pelvis. Positron emission tomography imaging is not routinely recommended since FDG-avidity of NLPHL is poor.",
"     </li>",
"     <li>",
"      Bone marrow biopsy should be reserved for patients with stage IIB-IV disease.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds), IARC Press, Lyon 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/2\">",
"      Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/3\">",
"      Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010; 116:3724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/4\">",
"      Diehl V, Sextro M, Franklin J, et al. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol 1999; 17:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/5\">",
"      Braeuninger A, K&uuml;ppers R, Strickler JG, et al. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A 1997; 94:9337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/6\">",
"      Marafioti T, Hummel M, Anagnostopoulos I, et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med 1997; 337:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/7\">",
"      Ohno T, Stribley JA, Wu G, et al. Clonality in nodular lymphocyte-predominant Hodgkin's disease. N Engl J Med 1997; 337:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/8\">",
"      Liso A, Capello D, Marafioti T, et al. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. Blood 2006; 108:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/9\">",
"      Schmitz R, Stanelle J, Hansmann ML, K&uuml;ppers R. Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. Annu Rev Pathol 2009; 4:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/10\">",
"      Brune V, Tiacci E, Pfeil I, et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 2008; 205:2251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/11\">",
"      Miettinen M, Franssila KO, Sax&eacute;n E. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas. Cancer 1983; 51:2293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/12\">",
"      Boudov&aacute; L, Torlakovic E, Delabie J, et al. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood 2003; 102:3753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/13\">",
"      R&uuml;diger T, Gascoyne RD, Jaffe ES, et al. Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol 2002; 13 Suppl 1:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/14\">",
"      Weiss LM, Chen YY, Liu XF, Shibata D. Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 1991; 139:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/15\">",
"      Uccini S, Monardo F, Stoppacciaro A, et al. High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients. Int J Cancer 1990; 46:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/16\">",
"      Regula DP Jr, Hoppe RT, Weiss LM. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N Engl J Med 1988; 318:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/17\">",
"      Mauch PM, Kalish LA, Kadin M, et al. Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis. Cancer 1993; 71:2062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/18\">",
"      Borg-Grech A, Radford JA, Crowther D, et al. A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease. J Clin Oncol 1989; 7:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/19\">",
"      Shimabukuro-Vornhagen A, Haverkamp H, Engert A, et al. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials. J Clin Oncol 2005; 23:5739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/20\">",
"      Bodis S, Kraus MD, Pinkus G, et al. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease. J Clin Oncol 1997; 15:3060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/21\">",
"      Ha CS, Kavadi V, Dimopoulos MA, et al. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria. Int J Radiat Oncol Biol Phys 1999; 43:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/22\">",
"      Leibenhaut MH, Hoppe RT, Efron B, et al. Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease. J Clin Oncol 1989; 7:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/23\">",
"      Khoury JD, Jones D, Yared MA, et al. Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol 2004; 28:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/24\">",
"      Li G, Hansmann ML. Lymphocyte predominant Hodgkin's disease of nodular subtype combined with pulmonary lymphoid infiltration and hypogammaglobulinaemia. Virchows Arch A Pathol Anat Histopathol 1989; 415:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/25\">",
"      Jackson HJ, Parker FJ. Hodgkin's disease. II. Pathology N Engl J Med 1944; 231:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/26\">",
"      WRIGHT CJ. The \"benign\" form of Hodgkin's disease (Hodgkin's paragranuloma). J Pathol Bacteriol 1960; 80:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/27\">",
"      SMETANA HF, COHEN BM. Mortality in relation to histologic type in Hodgkin's disease. Blood 1956; 11:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/28\">",
"      HANSON TA. HISTOLOGICAL CLASSIFICATION AND SURVIVAL IN HODGKIN'S DISEASE; A STUDY OF 251 CASES WITH SPECIAL REFERENCE TO NODULAR SCLEROSING HODGKIN'S DISEASE. Cancer 1964; 17:1595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/29\">",
"      Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res 1966; 26:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/30\">",
"      Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007; 110:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/31\">",
"      Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361.",
"     </a>",
"    </li>",
"    <li>",
"     Swerdlow SH, Campo E, Harris NL, et al. WHO classification of Tumors of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/33\">",
"      Falini B, Bigerna B, Pasqualucci L, et al. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. Blood 1996; 87:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/34\">",
"      Nogov&aacute; L, Rudiger T, Engert A. Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2006; :266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/35\">",
"      Hicks J, Flaitz C. Progressive transformation of germinal centers: review of histopathologic and clinical features. Int J Pediatr Otorhinolaryngol 2002; 65:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/36\">",
"      Verma A, Stock W, Norohna S, et al. Progressive transformation of germinal centers. Report of 2 cases and review of the literature. Acta Haematol 2002; 108:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/37\">",
"      Maes B, Anastasopoulou A, Kluin-Nelemans JC, et al. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features. Ann Oncol 2001; 12:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/38\">",
"      de Jong D, Bosq J, MacLennan KA, et al. Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome of a rare entity. Ann Oncol 2006; 17:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/39\">",
"      Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31:1860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/40\">",
"      Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989; 7:1630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/41\">",
"      Pappa VI, Norton AJ, Gupta RK, et al. Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases. Ann Oncol 1995; 6:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33432/abstract/42\">",
"      Hutchings M, Loft A, Hansen M, et al. Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake. Hematol Oncol 2006; 24:146.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4730 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.167.4.114-B39C775BF0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33432=[""].join("\n");
var outline_f32_41_33432=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Classification schemes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - REAL classification",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - WHO classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Morphology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - L&amp;H variant",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Background cells",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Growth pattern",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Immunophenotype",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Lymphadenopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Reactive hyperplasia or PTGC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      T cell/HRBCL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Lymphocyte-rich CHL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      STAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      History and physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Blood studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Bone marrow exam",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Staging laparotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      PET scan",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/4730\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4730|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?38/56/39822\" title=\"figure 1\">",
"      Reclassification of presumed NLPHL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4730|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/39/633\" title=\"picture 1\">",
"      Nodular lymphocyte-predominant HL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/26/19874\" title=\"picture 2\">",
"      Nodular lymphocyte predominant HL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/50/10020\" title=\"picture 3\">",
"      Nod lymph predom HL CD20",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4730|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/23/17788\" title=\"table 1\">",
"      Hodgkin immunophenotype",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/28/6605\" title=\"table 2\">",
"      Differential dx NLPHL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/23/19836\" title=\"table 3\">",
"      Cotswolds system in HL",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/53/21337?source=related_link\">",
"      Classification of the hematopoietic neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/45/24282?source=related_link\">",
"      Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/13/15578?source=related_link\">",
"      Epidemiology, pathologic features, and diagnosis of classical Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39080?source=related_link\">",
"      Evaluation of peripheral lymphadenopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/12/13512?source=related_link\">",
"      Overview of the treatment of classical Hodgkin lymphoma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/37/14935?source=related_link\">",
"      Staging and prognosis of Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/23/2426?source=related_link\">",
"      The Reed-Sternberg cell and the pathogenesis of Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3703?source=related_link\">",
"      The role of Epstein-Barr virus in Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/45/34520?source=related_link\">",
"      Treatment of nodular lymphocyte-predominant Hodgkin lymphoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_41_33433="Chronic kidney disease associated with atherosclerotic renovascular disease";
var content_f32_41_33433=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chronic kidney disease associated with atherosclerotic renovascular disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/41/33433/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33433/contributors\">",
"     Lionel U Mailloux, MD, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33433/contributors\">",
"     Norman M Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/41/33433/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33433/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/41/33433/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/41/33433/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/41/33433/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 27, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic kidney disease associated with atherosclerotic ischemic renovascular disease is a potentially reversible disorder. Progressive renal artery stenosis that threatens the entire renal mass, possibly resulting in renal insufficiency or end-stage renal disease (ESRD), is usually defined as significant high grade stenosis of both renal arteries or of stenosis to a single solitary kidney.",
"   </p>",
"   <p>",
"    This should be suspected in patients with acute, severe, or refractory hypertension who also have an otherwise unexplained elevation in serum creatinine concentration above 1.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (132",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    or who have developed an acute decline in renal function following therapy with an angiotensin converting enzyme (ACE) inhibitor or angiotensin II receptor blocker [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The diagnosis of bilateral renovascular disease is usually established by imaging studies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/17/31001?source=see_link\">",
"     \"Establishing the diagnosis of renovascular hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment may be indicated both for blood pressure control",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    preservation of renal function. On the other hand, bilateral renovascular disease can be an incidental finding, occurring in patients with little or no hypertension or renal insufficiency. Such patients do not require therapy directed at the renal vasculature.",
"   </p>",
"   <p>",
"    Many renal artery lesions are detected at the time of coronary angiography by cardiologists performing \"drive by\" renal angiography. In three studies, between 9 and 11 percent of patients had renal artery stenosis greater than 50 percent detected during renal angiography performed at the time of cardiac catheterization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/3-5\">",
"     3-5",
"    </a>",
"    ], though it is not known whether such lesions are functionally significant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/6\">",
"     6",
"    </a>",
"    ]. The optimal treatment of such lesions is not known. This issue is being addressed by the CORAL trial, which is an ongoing randomized trial that is comparing renal artery stenting combined with optimal medical therapy to optimal medical therapy alone on cardiovascular and renal end points [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The approach to patients with renal insufficiency associated with bilateral renovascular disease will be reviewed. The issue of blood pressure control with clinically important bilateral renal artery stenosis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8040?source=see_link\">",
"     \"Treatment of bilateral atherosclerotic renal artery stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic ischemic renovascular disease is an increasingly recognized disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/1,2,8-11\">",
"     1,2,8-11",
"    </a>",
"    ]. In the United States, the prevalence and incidence of atherosclerotic renovascular disease based upon administrative data in the general population greater than 65 years of age were estimated to be 0.5 percent and 3.7 per 1000 patient-years, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It has been estimated that ischemic renovascular disease may be responsible for 5 to 22 percent of patients with advanced renal failure who are over the age of 50 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/2,13-16\">",
"     2,13-16",
"    </a>",
"    ]. In one study, the primary diagnosis leading to end-stage renal disease (ESRD) in patients greater than 65 years of age was ischemic nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Association with systemic atherosclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to reviewing the clinical features associated with atherosclerotic renovascular disease, it is important to appreciate that many of these patients have angiographic evidence of coronary, cerebral,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    peripheral atherosclerotic arterial disease and a smaller number have clinical evidence of extrarenal atherosclerotic disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/12,17\">",
"     12,17",
"    </a>",
"    ]. In addition, patients with extrarenal atherosclerosis often have concurrent renal artery stenosis as detected during angiography for coronary or peripheral artery disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/1-3,9,15,18-21\">",
"     1-3,9,15,18-21",
"    </a>",
"    ]. However, 25 to 50 percent of these patients are not hypertensive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/2,3,18\">",
"     2,3,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These relationships can be illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a general population study of over one million individuals derived from Medicare data, almost 6000 had atherosclerotic renovascular disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/12\">",
"       12",
"      </a>",
"      ]. Among these patients, concurrent atherosclerotic heart, cerebrovascular, and peripheral artery disease was present in 67, 37 and 56 percent, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/12\">",
"       12",
"      </a>",
"      ]. These prevalence estimates were two- to four-fold higher than in those without atherosclerotic renovascular disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with newly diagnosed renovascular disease had, at two-year follow-up, four- to five-fold higher rates of coronary, cerebrovascular, peripheral arterial, and heart failure events compared to those without renovascular disease.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a review of almost 4000 patients who underwent abdominal aortography immediately after coronary angiography, incidental &ge;50 and &ge;75 percent renal artery stenosis was present in 9.1 and 4.8 percent, respectively, and was bilateral in 0.8 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/3\">",
"       3",
"      </a>",
"      ]. The presence of &ge;75 percent renal artery stenosis was associated with a significant reduction in survival (57 versus 89 percent in the remaining patients, adjusted hazard ratio 2.0 for mortality). Among patients with renovascular disease, four-year adjusted survival was lower with more severe disease (48 versus 68 percent with &gt;95 versus 75 to 95 percent stenosis, and 47 versus 59 percent for bilateral versus unilateral disease).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A similar increase in renovascular disease in patients with coronary disease has been noted in other studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/2,9,18,19\">",
"     2,9,18,19",
"    </a>",
"    ]. In a series of over 14,000 patients who underwent abdominal aortography immediately after coronary angiography, &ge;50 percent stenosis was present in 6.3 percent and was bilateral in 1.3 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A high prevalence of renal artery stenosis has been noted in patients with peripheral artery disease with or without hypertension [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/20,21\">",
"       20,21",
"      </a>",
"      ]. This was illustrated in a prospective study of 100 patients presenting with signs of peripheral artery disease: bilateral renal artery stenosis was present in 24, seven of whom had complete occlusion on one side [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/20\">",
"       20",
"      </a>",
"      ]. Other reports have noted an 11 to 42 percent prevalence of &ge;50 percent stenosis in one renal artery in such patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/1,2,15,21\">",
"       1,2,15,21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL CLUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of clinical findings that suggest an increased likelihood of secondary hypertension, some of which specifically suggest the presence of renovascular disease. These findings are used clinically to determine which patients should be evaluated for renovascular disease (",
"    <a class=\"graphic graphic_table graphicRef56130 \" href=\"mobipreview.htm?41/38/42604\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27991?source=see_link\">",
"     \"Who should be evaluated for renovascular or other causes of secondary hypertension?\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/17/31001?source=see_link\">",
"     \"Establishing the diagnosis of renovascular hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These clinical clues are important for a second reason in patients with renovascular disease that is diagnosed on an imaging study performed for some other reason. In such patients, the absence of any of these clues makes it much less likely that the renovascular disease is responsible for hypertension, if present, and therefore makes benefit from percutaneous or surgical intervention less likely.",
"   </p>",
"   <p>",
"    This is an important issue since bilateral (or unilateral) atherosclerotic renovascular disease can be an incidental finding on angiography for peripheral artery disease, occurring in patients with little or no hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Such patients do not require therapy directed at the renal vasculature, since there is no evidence that revascularization will improve renal or other outcomes in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/22\">",
"     22",
"    </a>",
"    ]. However, some develop progressive disease. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Progression of renal artery lesions'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/17/31001?source=see_link\">",
"     \"Establishing the diagnosis of renovascular hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A few patients with chronic ischemic renovascular disease are normotensive, which may be due in part to a reduced cardiac output [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of renal artery stenosis is made by imaging studies in patients thought to be at risk. No single noninvasive screening test is sufficiently sensitive to definitively diagnose or exclude bilateral renovascular disease that results in ischemic chronic kidney disease. Issues related to screening and diagnostic tests are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/17/31001?source=see_link\">",
"     \"Establishing the diagnosis of renovascular hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients at risk for bilateral renal artery stenosis can also develop two other disorders that can present with similar clinical findings but cannot be corrected by surgery or angioplasty: benign hypertensive nephrosclerosis and atheroembolic renal disease.",
"   </p>",
"   <p>",
"    Benign nephrosclerosis has a similar clinical presentation to chronic ischemic renal disease: hypertension, slowly progressive renal insufficiency, a bland urine sediment, and possible evidence of atherosclerotic vascular disease. It is only the presence of the clinical clues described above that suggests the presence of renovascular disease. However, this distinction is not absolute because some patients with chronic ischemic renal disease also have intrarenal nephrosclerosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/42/6824?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of hypertensive nephrosclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Atheroembolic renal disease can be precipitated by aortic manipulation or occur spontaneously. It can generally be distinguished from bilateral renal artery stenosis or nephrosclerosis by an abrupt decline in renal function, evidence of extrarenal emboli (manifested by digital gangrene, livedo reticularis, or abdominal pain), and the frequent but transient presence of hypocomplementemia, eosinophilia,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    eosinophiluria. Arteriography is contraindicated in this setting, since there is a high risk of inducing further embolization. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/13/13528?source=see_link\">",
"     \"Clinical presentation, evaluation, and treatment of renal atheroemboli\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/15/31994?source=see_link\">",
"     \"Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PROGRESSION OF RENAL ARTERY LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The loss of renal function in renovascular disease can result from a usually reversible consequence of antihypertensive therapy or an irreversible reflection of progressive narrowing of the renal arteries",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    progressive intrinsic renal disease. It is unclear what percentage of renal vascular lesions initially found to be stenosed are physiologically important, leading to hypertension",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    renal insufficiency. Few patients with renal artery stenosis that is incidentally discovered on angiography performed for some other reason (eg, peripheral artery disease) progress to end-stage renal disease at prolonged follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/17/31001?source=see_link\">",
"     \"Establishing the diagnosis of renovascular hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Atherosclerotic renal arterial lesions progress over time at widely varying rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/23\">",
"     23",
"    </a>",
"    ]. Studies in which serial arteriography or Doppler ultrasonography was performed suggested that progressive stenosis occurs in 11 percent of arteries with atherosclerotic lesions at 2.6 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/18\">",
"     18",
"    </a>",
"    ] and in 30 to 60 percent within four to seven years, despite adequate control of the blood pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/1,2,23,24\">",
"     1,2,23,24",
"    </a>",
"    ]. In the largest of these series, patients who had &ge;75 percent stenosis in one or more renal arteries at follow-up had a significantly higher serum creatinine compared to other patients (1.6 versus 1.1",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    [141 versus 97",
"    <span class=\"nowrap\">",
"     micromol/L])",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/18\">",
"     18",
"    </a>",
"    ]. However, this observation does not mean that percutaneous or surgical intervention would improve outcomes. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Revascularization'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Initial reports also suggested that progression to total occlusion occurred in 10 to 15 percent of stenotic renal arteries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/1,2,24\">",
"     1,2,24",
"    </a>",
"    ]. This was more likely in lesions with more than a 75 percent initial narrowing of the vascular lumen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, a later prospective study noted a lower incidence of progression to total occlusion. In this report, serial duplex Doppler ultrasonography was performed on 295 kidneys in 170 patients with atherosclerotic renal artery stenosis, almost all of whom were on antihypertensive therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/23\">",
"     23",
"    </a>",
"    ]. The cumulative incidence of any progression at three years was 28 percent among arteries with an initial stenosis that was less than 60 percent and 49 percent among arteries with more than 60 percent stenosis at entry. However, complete occlusion occurred in only nine renal arteries (3 percent), seven of which were initially classified as having &gt;60 percent stenosis.",
"   </p>",
"   <p>",
"    Thus, significant stenosis carries a risk of long-term loss of renal mass and function, with occasional acute deterioration or even anuria if a single functional kidney progresses to total occlusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     RISK FACTOR REDUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with atherosclerotic renovascular disease have a high rate of systemic atherosclerosis and are at increased risk for adverse cardiovascular outcomes. As a result, they are considered to have a coronary artery disease equivalent and should be treated according to current guidelines for secondary prevention of cardiovascular disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/60/40906?source=see_link\">",
"     \"Secondary prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MEDICAL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principal specific management options in patients with chronic ischemic renovascular disease are medical therapy, angioplasty (usually with stent placement), and surgery. A 2006 systematic review of management strategies for renal artery stenosis in general, including bilateral renal artery stenosis associated with renal insufficiency, concluded that the published evidence was inadequate to draw any robust conclusions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with atherosclerosis should be aggressively treated for secondary prevention of cardiovascular disease. These modalities include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , statins, blood pressure control, cessation of smoking, and, in patients with diabetes, glycemic control. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/60/40906?source=see_link\">",
"     \"Secondary prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Medical therapy with antihypertensive drugs, particularly ACE inhibitors or angiotensin II receptor blockers (ARBs), can effectively control the blood pressure in most patients with bilateral renal artery stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/28\">",
"     28",
"    </a>",
"    ]. Although now uncommon, hypertension can be resistant to antihypertensive therapy; such patients may be candidates for revascularization. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Possible indications for intervention'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8040?source=see_link\">",
"     \"Treatment of bilateral atherosclerotic renal artery stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite adequate control of blood pressure, the chronic administration of an ACE inhibitor (and perhaps other antihypertensive drugs) may also lead to atrophy behind the stenosis and will not prevent progression of the stenotic lesions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/43/29369?source=see_link&amp;anchor=H9#H9\">",
"     \"Treatment of unilateral atherosclerotic renal artery stenosis\", section on 'Loss of functional renal mass in the stenotic kidney'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As previously mentioned, the cumulative incidence of any progression at three years in a large series was 28 percent among arteries with an initial stenosis that was less than 60 percent and 49 percent among arteries with more than 60 percent stenosis at entry [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/23\">",
"     23",
"    </a>",
"    ]. Complete occlusion occurred in only nine renal arteries (3 percent), seven of which were initially classified as having &gt;60 percent stenosis. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Progression of renal artery lesions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In addition to issues related to blood pressure control and progressive renal artery atherosclerosis, these patients are also at risk for extrarenal cardiovascular events. General renal and cardiovascular outcomes with medical therapy alone were perhaps best studied in a retrospective report of 68 patients with high grade (&gt;70 percent) atherosclerotic renal artery stenosis who did not undergo revascularization, 21 of whom had bilateral stenosis or stenosis in a single kidney [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/29\">",
"     29",
"    </a>",
"    ]. Among these 21 patients (average age 75 years), the average serum creatinine concentration was 1.6",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    compared to 1.3",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (141 versus 115",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    for those with unilateral disease.",
"   </p>",
"   <p>",
"    At three year follow-up, the mean blood pressure was",
"    <span class=\"nowrap\">",
"     160/81",
"    </span>",
"    mmHg. An increase of at least 50 percent in the serum creatinine concentration was observed in 4 of 21 patients (19 percent), two of whom progressed to end-stage disease. The remaining 17 patients had stable renal function. However, the mortality rate was 43 percent, due most commonly to myocardial infarction or heart failure. The outcomes were better in patients with unilateral disease: 13 percent had renal progression and 21 percent died.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     REVASCULARIZATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Possible indications for intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal revascularization with surgery or percutaneous techniques may be considered in the following settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/1,2,30-33\">",
"     1,2,30-33",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severe or refractory hypertension",
"     </li>",
"     <li>",
"      Recurrent episodes of flash pulmonary edema",
"     </li>",
"     <li>",
"      Possibly, otherwise unexplained progressive renal insufficiency",
"     </li>",
"     <li>",
"      An inability to maintain renal function as the systemic blood pressure is lowered, even with medical therapies other than angiotensin inhibition",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8040?source=see_link\">",
"     \"Treatment of bilateral atherosclerotic renal artery stenosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/23/7544?source=see_link\">",
"     \"Evaluation of acute decompensated heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It has been suggested that stable renal insufficiency in the presence of marked bilateral stenoses is an indication for intervention. However, intervention in the absence of the above indications, such as bilateral significant renovascular disease (or unilateral disease in a single viable kidney) as an incidental finding during coronary angiography, is not recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By comparison, variable results relating to renal function outcomes are observed after either surgery or percutaneous interventions. This is an important issue. The observations cited above that progressive renal artery stenosis is common on repeat angiography or Doppler ultrasonography and may be associated with an elevation in serum creatinine does not necessarily mean that intervention for reasons other than the above indications will improve outcomes. Many such patients remain stable with medical therapy alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Progression of renal artery lesions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    An overall review of the medical literature suggests that approximately 50 percent of patients with renovascular disease have no change in renal function, while 20 to 25 percent improve and 15 to 25 percent lose renal function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/30,34\">",
"     30,34",
"    </a>",
"    ]. As an example, one study followed 190 patients with angiographically demonstrated renovascular disease (50 with bilateral stenosis), of whom 54 were treated medically, the rest with angioplasty with or without stenting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/35\">",
"     35",
"    </a>",
"    ]. There was no difference between the groups in terms of renal survival or total mortality after a mean follow-up of 4.5 years after adjustment for baseline characteristics, although there was a trend for lower serum creatinine in the revascularized patients.",
"   </p>",
"   <p>",
"    When considering revascularization in chronic ischemic renovascular disease, the ability to identify patients likely to benefit in terms of renal outcomes remains difficult. Prolonged renal ischemia can lead to renal atrophy that is characterized histologically by tubular loss and a chronic interstitial nephritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Although nonspecific, an elevated serum creatinine concentration suggests the presence of these irreversible processes.",
"   </p>",
"   <p>",
"    Older studies suggested that clinically significant functional recovery can be achieved with revascularization if filling of the distal renal arterial tree is seen (thereby allowing bypass to be performed) and if one or more of the following criteria is present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/38\">",
"     38",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Visualization of the collecting system either on an intravenous pyelogram or during the pyelogram phase after renal arteriography.",
"     </li>",
"     <li>",
"      Kidney length &ge;9 cm.",
"     </li>",
"     <li>",
"      The presence of intact glomeruli on frozen section biopsy obtained at the time of surgery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It has also been suggested that a noninvasive test, calculation of the resistance index by duplex Doppler ultrasonography, can identify patients who are likely or unlikely to respond to revascularization with a high degree of accuracy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/39\">",
"     39",
"    </a>",
"    ]. A high resistance index was associated with a poor outcome and may indicate irreversible intrarenal vascular disease. However, the reliability of Doppler ultrasonography is extremely operator dependent and more experience with the predictive value of this technique is required. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/17/31001?source=see_link\">",
"     \"Establishing the diagnosis of renovascular hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with relatively severe renal dysfunction, such as those with serum creatinine concentrations of greater than 3.0 to 4.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (265 to 354",
"    <span class=\"nowrap\">",
"     micromol/L),",
"    </span>",
"    are more likely to have intrarenal disease. Revascularization is unlikely to be beneficial in these individuals, particularly if the kidney(s) are less than &le;8 cm in length [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/30\">",
"     30",
"    </a>",
"    ]. However, an infrequent patient with total main renal artery occlusion in whom viability of the parenchyma is being maintained with collateral vessels may benefit from intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reversibility after revascularization is also likely in patients with a relatively rapid decline in renal function that is either unexplained or that occurs shortly after the institution of therapy with an angiotensin converting enzyme (ACE) inhibitor or following severe volume depletion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/17/31001?source=see_link\">",
"     \"Establishing the diagnosis of renovascular hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Percutaneous transluminal angioplasty",
"    </span>",
"    &nbsp;&mdash;&nbsp;Percutaneous transluminal angioplasty (PTA) alone (ie, without stenting) has been primarily used for nonostial lesions that are most amenable to this procedure. Initial observational studies suggested a 65 to 70 percent initial success rate: 35 to 50 percent improvement; and 12 to 50 percent stable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/1,2,42,43\">",
"     1,2,42,43",
"    </a>",
"    ]. Most PTA procedures are now performed with stent placement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Stent placement and outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In an attempt to improve the efficacy of angioplasty in ostial lesions and to diminish the incidence of restenosis, balloon-expandable intravascular stents have been placed at the time of PTA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/7,11,22,34,44-50\">",
"     7,11,22,34,44-50",
"    </a>",
"    ]. The magnitude of benefit was evaluated in a review of 14 studies of renal artery stent placement in 678 patients and 10 studies of renal PTA alone in 644 patients with both; the studies included unilateral and bilateral disease due to both atherosclerosis and fibromuscular dysplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/34\">",
"     34",
"    </a>",
"    ]. Stenting was associated with a significantly lower restenosis rate than PTA alone (17 versus 26 percent at follow-up of 6 to 29 months).",
"   </p>",
"   <p>",
"    Initial uncontrolled studies suggested that angioplasty plus stenting may be beneficial with respect to preserving or improving renal function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/11,34,44,46-54\">",
"     11,34,44,46-54",
"    </a>",
"    ]. However, in the review cited above, improvement in renal function was usually modest, being defined as more than a 15 to 20 percent reduction in serum creatinine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/34\">",
"     34",
"    </a>",
"    ]. In addition, three randomized trials published after this review showed",
"    <strong>",
"     no benefit",
"    </strong>",
"    from PTA with stenting compared to medical therapy with respect to both renal function and blood pressure control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/55-57\">",
"     55-57",
"    </a>",
"    ] and no difference in cardiovascular events or mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. Issues related to blood pressure control after intervention are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8040?source=see_link&amp;anchor=H9#H9\">",
"     \"Treatment of bilateral atherosclerotic renal artery stenosis\", section on 'Stent placement and outcomes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, these trials had several important limitations; thus, one cannot preclude benefit in selected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/58\">",
"     58",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The number of patients with true (more than 70 percent) bilateral stenosis was limited as many lesions had 50 to 70 percent stenosis, which is probably not hemodynamically significant. In addition, in one trial, many patients were falsely identified as having renal artery stenosis greater than 50 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The patients were",
"      <strong>",
"       not",
"      </strong>",
"      selected because they had clinical clues suggesting that the stenosis was likely to contribute to the hypertension (",
"      <a class=\"graphic graphic_table graphicRef56130 \" href=\"mobipreview.htm?41/38/42604\">",
"       table 1",
"      </a>",
"      ). This is a potentially important issue since bilateral (or unilateral) atherosclerotic renovascular disease can be an incidental finding on angiography for peripheral artery disease with little or no hypertension &nbsp;and no progressive renal disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/20,21\">",
"       20,21",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Possible indications for intervention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The largest trial, ASTRAL, included 806 patients with either unilateral or bilateral atherosclerotic renal artery stenosis who were randomly assigned to either medical therapy alone or medical therapy plus revascularization (95 percent with angioplasty with stent placement, 5 percent was angioplasty alone) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/55\">",
"     55",
"    </a>",
"    ]. Fifty nine percent of patients had stenosis of greater than 70 percent and 60 percent had baseline creatinine greater than 1.7",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (150",
"    <span class=\"nowrap\">",
"     micromol/L).",
"    </span>",
"   </p>",
"   <p>",
"    At a median follow-up of almost three years, there was no significant difference in the rate of progression of renal impairment between the revascularization and medical therapy groups. There were also similar rates of all renal events (including new onset kidney injury, initiation of dialysis, renal transplantation, nephrectomy or death from renal failure), major cardiovascular events (hazard ratio 0.94), and death (hazard ratio 0.90).",
"   </p>",
"   <p>",
"    The 2005",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines on the management of peripheral artery disease, published before the two largest randomized trials, including ASTRAL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/55,56\">",
"     55,56",
"    </a>",
"    ], concluded that percutaneous revascularization was reasonable in patients who have progressive chronic kidney disease associated with bilateral renal artery stenosis or renal artery stenosis in a solitary functioning kidney [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Procedural complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of procedural complications can occur with angioplasty with or without stenting. Most are relatively minor and include puncture site hematoma and renal artery dissection. However, serious problems can arise, including renal artery thrombosis or perforation (often requiring surgery) and acute renal failure due to atheroembolic disease (which may be irreversible) or to a reaction to the radiocontrast agent (which is reversible). These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8040?source=see_link&amp;anchor=H10#H10\">",
"     \"Treatment of bilateral atherosclerotic renal artery stenosis\", section on 'Procedural complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the ASTRAL trial described above, there were 38 complications that occurred within 24 hours of procedure in 31 of the 359 patients (9 percent) who underwent revascularization with stenting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/43\">",
"     43",
"    </a>",
"    ]. Nineteen of these events were serious, including pulmonary edema and myocardial infarction; there were five renal embolizations, four renal arterial occlusions, four renal artery perforations, one femoral-artery aneurysm, and three patients with clinically significant cholesterol embolization. Among 280 patients who underwent revascularization and for whom data were available, 20 percent had an adverse event between 24 hours and one month. These included two deaths, four cases of groin hematoma or hemorrhage, five cases of acute kidney injury, and one renal artery occlusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery has been evaluated for both preservation of renal function, which will be discussed here, and for control of blood pressure, where it is generally performed in specific anatomic settings. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8040?source=see_link&amp;anchor=H11#H11\">",
"     \"Treatment of bilateral atherosclerotic renal artery stenosis\", section on 'Surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted above, initial observational studies suggested that PTA with stenting may preserve or improve renal function. However, randomized trials, although flawed, showed no improvement in outcomes compared to medical therapy with respect to renal function, blood pressure control, cardiovascular events, or mortality. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Stent placement and outcomes'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    There are no randomized trials that have compared surgery to medical therapy or PTA for preservation of renal function in patients with chronic kidney disease associated with atherosclerotic renovascular disease. In observational studies, the success rate with surgical revascularization was as high as 85 to 90 percent: approximately 55 to 65 percent of patients showed improvement as evidenced by a postoperative fall in the serum creatinine concentration, while another 30 percent had stable function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/1,2,32,59-62\">",
"     1,2,32,59-62",
"    </a>",
"    ]. Even patients on dialysis may improve, recovering sufficient function for dialysis to be discontinued [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/60-63\">",
"     60-63",
"    </a>",
"    ]. In three reports, for example, 49 of 67 patients (73 percent) with bilateral renal artery stenosis no longer required dialysis after surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. A similar response has been seen in occasional patients who have been dialyzed for as long as one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast to these findings, we and others feel that clinically important and durable improvements in renal function after surgical revascularization are unlikely &nbsp;in patients with a serum creatinine concentration greater than 3.0 to 4.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (265 to 354",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    who typically have significant intrarenal disease. A successful outcome is also unlikely in patients with small kidneys (length less than &le;8 cm) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/30\">",
"     30",
"    </a>",
"    ]. In addition, any benefits must be weighed against an average in-hospital mortality rate of approximately 10 percent after vascular surgery. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'In-hospital mortality'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A number of different operative procedures can be used. An aortorenal bypass has been most common, but ileorenal, splenorenal, or hepatorenal bypass is being performed more frequently to avoid manipulation of the atherosclerotic aorta [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/38\">",
"     38",
"    </a>",
"    ]. Most operations involve either bilateral repair or unilateral repair with contralateral nephrectomy of a nonfunctioning, atrophic kidney [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/59\">",
"     59",
"    </a>",
"    ]. The latter approach is usually taken when one renal artery is totally occluded and the size of the ischemic kidney is substantially reduced.",
"   </p>",
"   <p>",
"    The 2005",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines on peripheral artery disease recommended surgery in patients with atherosclerotic renal artery stenosis who have clinical indications for revascularization, particularly if they have multiple small renal arteries, early primary branching of the main renal artery, or require aortic reconstruction near the renal arteries for other indications (eg, aneurysm repair or severe aortoiliac occlusive disease) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     In-hospital mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential benefits of surgery in these settings must be weighed against the operative mortality rate. In-hospital mortality following renovascular surgery in most reports has been between 3 and 7 percent, with the risk being increased in patients with diffuse atherosclerosis and heart failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/2,31,64,65\">",
"     2,31,64,65",
"    </a>",
"    ]. However, most of these studies came for high-volume referral centers.",
"   </p>",
"   <p>",
"    A higher in-hospital mortality rate of 10.1 percent for atherosclerotic disease was noted in an analysis of over 6600 renal artery bypass graft procedures performed for hypertension or ischemic nephropathy from 2000 to 2004 in the United States; almost 70 percent were performed in teaching hospitals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/64\">",
"     64",
"    </a>",
"    ]. Independent risk factors for in-hospital mortality (relative risk 1.6 to 2.2) were advanced age and a history of chronic kidney disease, heart failure, or chronic lung disease. The mortality rate was similar with renal bypass graft alone or combined with abdominal aortic aneurysm repair or aortobifemoral bypass. There were no deaths in 105 procedures fibromuscular dysplasia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/0/26631?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of fibromuscular dysplasia of the renal arteries\", section on 'Surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These observations provide support for percutaneous transluminal angioplasty with stenting as the preferred approach in most patients with bilateral atherosclerotic renal artery stenosis who have an indications for intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/58,64\">",
"     58,64",
"    </a>",
"    ], since hypertension and renal outcomes appear to be similar to those attained with surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/65\">",
"     65",
"    </a>",
"    ]. This would not apply to patients who require aortic reconstruction near the renal arteries for other indications (eg, aneurysm repair or severe aortoiliac occlusive disease) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Symptomatic coronary or cerebrovascular disease may need to be repaired prior to renovascular surgery, a regimen that can reduce overall mortality. In addition, the mortality risk of surgery must be compared to the poor survival in patients with chronic ischemic nephropathy who progress to maintenance dialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with atherosclerotic renovascular disease should be treated with risk factor reduction according to current guidelines for secondary prevention of cardiovascular disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/60/40906?source=see_link\">",
"     \"Secondary prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atherosclerotic renal artery lesions may remain stable or progress over time to greater degrees of stenosis at widely varying rates. There is no consensus about the exact approach and the optimal time to intervene since clinical trial data are limited. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Progression of renal artery lesions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The randomized trials cited above, although flawed, provide no support for routine use of revascularization to improve renal function, hypertension, cardiovascular outcomes, or mortality. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Stent placement and outcomes'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8040?source=see_link&amp;anchor=H9#H9\">",
"     \"Treatment of bilateral atherosclerotic renal artery stenosis\", section on 'Stent placement and outcomes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, some patients have clinical clues that suggest that revascularization will lead to improvement; such clues were not a requirement for entry in the randomized trials (",
"    <a class=\"graphic graphic_table graphicRef56130 \" href=\"mobipreview.htm?41/38/42604\">",
"     table 1",
"    </a>",
"    ). These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severe or refractory hypertension",
"     </li>",
"     <li>",
"      Recurrent episodes of flash pulmonary edema",
"     </li>",
"     <li>",
"      Otherwise unexplained relatively rapid decline in renal function",
"     </li>",
"     <li>",
"      Inability to maintain renal function as the systemic blood pressure is lowered with medical therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A clinically significant and durable improvement in renal function after percutaneous or surgical revascularization is unusual in our experience in patients with a serum creatinine concentration greater than 3.0 to 4.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (265 to 354",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    who are likely to have significant intrarenal disease. A successful outcome is also unlikely in patients with small kidneys (length &le;8 cm) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relative efficacy of surgery and angioplasty with stent placement have not been compared in a randomized trial. However, surgery is associated with an appreciable rate of in-hospital mortality (about 10 percent in a national review in the United States) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'In-hospital mortality'",
"    </a>",
"    above.) As a result, the revascularization procedure of choice in most centers is percutaneous angioplasty with stent implantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/8,31,44-48\">",
"     8,31,44-48",
"    </a>",
"    ]. This recommendation is based upon clinical experience and the success of stenting in coronary lesions.",
"   </p>",
"   <p>",
"    When intervention is performed, surgery was particularly recommended in the 2005",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines in patients with multiple small renal arteries, early primary branching of the main renal artery, or require aortic reconstruction near the renal arteries for other indications (eg, aneurysm repair or severe aortoiliac occlusive disease) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/41/33433/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/1\">",
"      Greco BA, Breyer JA. Atherosclerotic ischemic renal disease. Am J Kidney Dis 1997; 29:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/2\">",
"      Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 1993; 118:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/3\">",
"      Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 2001; 60:1490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/4\">",
"      Rihal CS, Textor SC, Breen JF, et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc 2002; 77:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/5\">",
"      Weber-Mzell D, Kotanko P, Schumacher M, et al. Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J 2002; 23:1684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/6\">",
"      Schachter ME, Zalunardo N, Rose C, et al. Incidental atherosclerotic renal artery stenosis in patients undergoing elective coronary angiography: are these lesions significant? Am J Nephrol 2009; 29:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/7\">",
"      Cooper CJ, Murphy TP. Is renal artery stenting the correct treatment of renal artery stenosis? The case for renal artery stenting for treatment of renal artery stenosis. Circulation 2007; 115:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/8\">",
"      Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001; 344:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/9\">",
"      Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis 2001; 37:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/10\">",
"      Valderr&aacute;bano F, Berthoux FC, Jones EH, Mehls O. Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The EDTA-ERA Registry. European Dialysis and Transplant Association-European Renal Association. Nephrol Dial Transplant 1996; 11 Suppl 1:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/11\">",
"      Korsakas S, Mohaupt MG, Dinkel HP, et al. Delay of dialysis in end-stage renal failure: prospective study on percutaneous renal artery interventions. Kidney Int 2004; 65:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/12\">",
"      Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 2005; 68:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/13\">",
"      Scoble JE, Hamilton G. Atherosclerotic renovascular disease. BMJ 1990; 300:1670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/14\">",
"      Appel RG, Bleyer AJ, Reavis S, Hansen KJ. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int 1995; 48:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/15\">",
"      Mailloux LU, Napolitano B, Bellucci AG, et al. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994; 24:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/16\">",
"      van Ampting JM, Penne EL, Beek FJ, et al. Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant 2003; 18:1147.",
"     </a>",
"    </li>",
"    <li>",
"     Textor, SC, McKusick, M. Renovascular hypertension and ischemic nephropathy: angioplasty and stenting. In: Therapy in Nephrology and Hypertension, Second Edition, Brady HR, Wilcox, CS (Eds). London, WB Saunders, 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/18\">",
"      Crowley JJ, Santos RM, Peter RH, et al. Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J 1998; 136:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/19\">",
"      Edwards MS, Craven TE, Burke GL, et al. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Med 2005; 165:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/20\">",
"      Choudhri AH, Cleland JG, Rowlands PC, et al. Unsuspected renal artery stenosis in peripheral vascular disease. BMJ 1990; 301:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/21\">",
"      Leertouwer TC, Pattynama PM, van den Berg-Huysmans A. Incidental renal artery stenosis in peripheral vascular disease: a case for treatment? Kidney Int 2001; 59:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/22\">",
"      Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113:e463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/23\">",
"      Caps MT, Perissinotto C, Zierler RE, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998; 98:2866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/24\">",
"      Pohl MA, Novick AC. Natural history of atherosclerotic and fibrous renal artery disease: clinical implications. Am J Kidney Dis 1985; 5:A120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/25\">",
"      Roche Z, Rutecki G, Cox J, Whittier FC. Reversible acute renal failure as an atypical presentation of ischemic nephropathy. Am J Kidney Dis 1993; 22:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/26\">",
"      Dwyer KM, Vrazas JI, Lodge RS, et al. Treatment of acute renal failure caused by renal artery occlusion with renal artery angioplasty. Am J Kidney Dis 2002; 40:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/27\">",
"      Balk E, Raman G, Chung M, et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med 2006; 145:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/28\">",
"      Dworkin LD, Jamerson KA. Is renal artery stenting the correct treatment of renal artery stenosis? Case against angioplasty and stenting of atherosclerotic renal artery stenosis. Circulation 2007; 115:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/29\">",
"      Ch&aacute;bov&aacute; V, Schirger A, Stanson AW, et al. Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc 2000; 75:437.",
"     </a>",
"    </li>",
"    <li>",
"     Textor, SC, McKusick, M. Renovascular hypertension and ischemic nephropathy: angioplasty and stenting. In: Therapy in Nephrology and Hypertension, 2d ed, Brady HR, Wilcox, CS (Eds). London, WB Saunders, 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/31\">",
"      Alcazar JM, Rodicio JL. Ischemic nephropathy: clinical characteristics and treatment. Am J Kidney Dis 2000; 36:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/32\">",
"      Textor SC, Novick AC, Tarazi RC, et al. Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease. Ann Intern Med 1985; 102:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/33\">",
"      Textor SC. Ischemic nephropathy: where are we now? J Am Soc Nephrol 2004; 15:1974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/34\">",
"      Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology 2000; 216:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/35\">",
"      Losito A, Errico R, Santirosi P, et al. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant 2005; 20:1604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/36\">",
"      Marcussen N. Atubular glomeruli in renal artery stenosis. Lab Invest 1991; 65:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/37\">",
"      Truong LD, Farhood A, Tasby J, Gillum D. Experimental chronic renal ischemia: morphologic and immunologic studies. Kidney Int 1992; 41:1676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/38\">",
"      Novick AC, Ziegelbaum M, Vidt DG, et al. Trends in surgical revascularization for renal artery disease. Ten years' experience. JAMA 1987; 257:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/39\">",
"      Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001; 344:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/40\">",
"      Muray S, Mart&iacute;n M, Amoedo ML, et al. Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis 2002; 39:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/41\">",
"      Cheung CM, Wright JR, Shurrab AE, et al. Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol 2002; 13:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/42\">",
"      Pattison JM, Reidy JF, Rafferty MJ, et al. Percutaneous transluminal renal angioplasty in patients with renal failure. Q J Med 1992; 85:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/43\">",
"      Connolly JO, Higgins RM, Walters HL, et al. Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. QJM 1994; 87:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/44\">",
"      van de Ven PJ, Beutler JJ, Kaatee R, et al. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet 1995; 346:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/45\">",
"      Burket MW, Cooper CJ, Kennedy DJ, et al. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J 2000; 139:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/46\">",
"      Harden PN, MacLeod MJ, Rodger RS, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997; 349:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/47\">",
"      Rees CR, Palmaz JC, Becker GJ, et al. Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: preliminary report of a multicenter study. Radiology 1991; 181:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/48\">",
"      Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. QJM 1999; 92:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/49\">",
"      Watson PS, Hadjipetrou P, Cox SV, et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000; 102:1671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/50\">",
"      Rocha-Singh K, Jaff MR, Rosenfield K, ASPIRE-2 Trial Investigators. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol 2005; 46:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/51\">",
"      Tan J, Filobbos R, Raghunathan G, et al. Efficacy of renal artery angioplasty and stenting in a solitary functioning kidney. Nephrol Dial Transplant 2007; 22:1916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/52\">",
"      Chatziioannou A, Mourikis D, Agroyannis B, et al. Renal artery stenting for renal insufficiency in solitary kidney in 26 patients. Eur J Vasc Endovasc Surg 2002; 23:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/53\">",
"      Bush RL, Martin LG, Lin PH, et al. Endovascular revascularization of renal artery stenosis in the solitary functioning kidney. Ann Vasc Surg 2001; 15:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/54\">",
"      Shannon HM, Gillespie IN, Moss JG. Salvage of the solitary kidney by insertion of a renal artery stent. AJR Am J Roentgenol 1998; 171:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/55\">",
"      ASTRAL Investigators, Wheatley K, Ives N, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009; 361:1953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/56\">",
"      Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 2009; 150:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/57\">",
"      van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000; 342:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/58\">",
"      Dworkin LD, Cooper CJ. Clinical practice. Renal-artery stenosis. N Engl J Med 2009; 361:1972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/59\">",
"      Hansen KJ, Starr SM, Sands RE, et al. Contemporary surgical management of renovascular disease. J Vasc Surg 1992; 16:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/60\">",
"      Libertino JA, Bosco PJ, Ying CY, et al. Renal revascularization to preserve and restore renal function. J Urol 1992; 147:1485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/61\">",
"      Hansen KJ. Prevalence of ischemic nephropathy in the atherosclerotic population. Am J Kidney Dis 1994; 24:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/62\">",
"      Hansen KJ, Cherr GS, Craven TE, et al. Management of ischemic nephropathy: dialysis-free survival after surgical repair. J Vasc Surg 2000; 32:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/63\">",
"      Kaylor WM, Novick AC, Ziegelbaum M, Vidt DG. Reversal of end stage renal failure with surgical revascularization in patients with atherosclerotic renal artery occlusion. J Urol 1989; 141:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/64\">",
"      Modrall JG, Rosero EB, Smith ST, et al. Operative mortality for renal artery bypass in the United States: Results from the National Inpatient Sample. J Vasc Surg 2008; 48:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/41/33433/abstract/65\">",
"      Weibull H, Bergqvist D, Bergentz SE, et al. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg 1993; 18:841.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3841 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-201.211.0.116-E259C7487F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33433=[""].join("\n");
var outline_f32_41_33433=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Association with systemic atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL CLUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PROGRESSION OF RENAL ARTERY LESIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      RISK FACTOR REDUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MEDICAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      REVASCULARIZATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Possible indications for intervention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Percutaneous transluminal angioplasty",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Stent placement and outcomes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Procedural complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - In-hospital mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3841\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3841|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/38/42604\" title=\"table 1\">",
"      Features of secondary HTN",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/42/6824?source=related_link\">",
"      Clinical features, diagnosis, and treatment of hypertensive nephrosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/13/13528?source=related_link\">",
"      Clinical presentation, evaluation, and treatment of renal atheroemboli",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/15/31994?source=related_link\">",
"      Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/17/31001?source=related_link\">",
"      Establishing the diagnosis of renovascular hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/23/7544?source=related_link\">",
"      Evaluation of acute decompensated heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/60/40906?source=related_link\">",
"      Secondary prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8040?source=related_link\">",
"      Treatment of bilateral atherosclerotic renal artery stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/0/26631?source=related_link\">",
"      Treatment of fibromuscular dysplasia of the renal arteries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/43/29369?source=related_link\">",
"      Treatment of unilateral atherosclerotic renal artery stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27991?source=related_link\">",
"      Who should be evaluated for renovascular or other causes of secondary hypertension?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_41_33434="Tinea versicolor arm";
var content_f32_41_33434=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F59533%7EPC%2F72396%7EDERM%2F52438%7EPC%2F73839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F59533%7EPC%2F72396%7EDERM%2F52438%7EPC%2F73839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tinea versicolor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 267px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple small salmon-colored macules are evident on the arm that coalesce in some areas.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Beth G Goldstein, MD, and Adam O Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tinea versicolor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 397px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tinea versicolor. Hypopigmented macules and patches are present on the back.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Berg D, Worzala K. Atlas of Adult Physical Diagnosis, Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tinea versicolor chest",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hyperpigmented macules and patches are present on the chest in this patient with tinea versicolor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo courtesy of Paul S Matz, MD. Reproduced from: Chung EK, Boom JA, Datto GA, Matz PS (Eds). Visual Diagnosis in Pediatrics. Philadelphia: Lippincott Williams &amp; Wilkins, 2006. Copyright &copy; 2006.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tinea versicolor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 281px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tinea versicolor. Hypopigmented macules and patches are scattered on the shoulder and arm of this patient.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33434=[""].join("\n");
var outline_f32_41_33434=null;
var title_f32_41_33435="Genetics myotonic dystrophy";
var content_f32_41_33435=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F65850&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F65850&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Genetic characteristics, prevalence and onset of myotonic dystrophy (DM), types I and II",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Type of DM",
"      </td>",
"      <td class=\"subtitle1\">",
"       Inheritance and chromosome location",
"      </td>",
"      <td class=\"subtitle1\">",
"       Mutation",
"      </td>",
"      <td class=\"subtitle1\">",
"       Anticipation",
"      </td>",
"      <td class=\"subtitle1\">",
"       Congenital form",
"      </td>",
"      <td class=\"subtitle1\">",
"       Prevalence* and age of onset&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       DM I (Steinert's disease)",
"      </td>",
"      <td>",
"       AD, 19q13.3",
"      </td>",
"      <td>",
"       Unstable expansion of CTG repeat in DMPK gene",
"      </td>",
"      <td>",
"       Yes",
"      </td>",
"      <td>",
"       Yes, severe developmental delay associated with CTG expansion &gt;750 repeats; affected parent is almost always the mother",
"      </td>",
"      <td>",
"       <p>",
"        1:8000*",
"       </p>",
"       <p>",
"        Congenital&bull;",
"       </p>",
"       <p>",
"        Most common: 20 to 40 years&bull;",
"       </p>",
"       <p>",
"        Occasional: Juvenile onset&bull;",
"       </p>",
"       <p>",
"        Occasional: &gt;40 years&bull;",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       DM II (Proximal myotonic myopathy)",
"      </td>",
"      <td>",
"       AD, 3q13.3-q24",
"      </td>",
"      <td>",
"       Expansion of CCTG repeat in intron 1 of ZNF9 gene",
"      </td>",
"      <td>",
"       No strong evidence",
"      </td>",
"      <td>",
"       No",
"      </td>",
"      <td>",
"       <p>",
"        1:8000*",
"       </p>",
"       <p>",
"        Most common: 30 to 60 years&bull;",
"       </p>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AD: autosomal dominant.",
"     <br>",
"      * Proportions of DM caused by types I and II is not yet known.",
"      <br>",
"       &bull; Age of onset.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33435=[""].join("\n");
var outline_f32_41_33435=null;
var title_f32_41_33436="Tests for diagnosing HIV I";
var content_f32_41_33436=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F74816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F74816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Spectrum of available tests for the diagnosis of HIV-1 (I)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Assay",
"       </td>",
"       <td class=\"subtitle1\">",
"        CD4 counts",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent positive, sensitivity",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Routine serology",
"       </td>",
"       <td>",
"        &gt;3 mos post viral transmission",
"       </td>",
"       <td>",
"        &gt;99.3-99.7",
"       </td>",
"       <td>",
"        Readily available and inexpensive. Specificity is 99.7 (MMWR 1990; 39:380) or higher (NEJM 1988; 319:961).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rapid test SUDS (Murex Diagnostics, Norcross, GA)",
"       </td>",
"       <td>",
"        &gt;3 mos post viral transmission",
"       </td>",
"       <td>",
"        &gt;99",
"       </td>",
"       <td>",
"        Advantage is test results are available in &le;10 min. Specificity is 99.6, so positive tests should be confirmed. Highly sensitive so negative tests do not usually require confirmation. Other rapid tests are available but are not FDA approved (Int J STD AIDS 1997; 8:192; Vox Sang 1997; 72:11).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        p24 antigen",
"       </td>",
"       <td>",
"        200-500/mm",
"        <sup>",
"         3",
"        </sup>",
"       </td>",
"       <td>",
"        10-20",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Measures free viral antigen by EIA and indicates high viral load. Acid treatment increases detection of p24 antigen due to its release from immune complexes. These tests are infrequently used in clinical practice due to relative insensitivity and because their use is largely supplanted by quantitative plasma HIV RNA assays",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &lt;200/mm",
"        <sup>",
"         3",
"        </sup>",
"       </td>",
"       <td>",
"        37-95",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Immune complex-disassociated p24 (ICD p24)",
"       </td>",
"       <td>",
"        200-500/mm",
"        <sup>",
"         3",
"        </sup>",
"       </td>",
"       <td>",
"        30-70",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &lt;200/mm",
"        <sup>",
"         3",
"        </sup>",
"       </td>",
"       <td>",
"        75-85",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Peripheral blood mononuclear cell culture (PMBC culture)",
"       </td>",
"       <td>",
"        &lt;500/mm",
"        <sup>",
"         3",
"        </sup>",
"       </td>",
"       <td>",
"        95-100",
"       </td>",
"       <td>",
"        Technique is viral isolation by co-cultivation of patients PBMC with PHA-stimulated donor PBMC with IL-2 over 28 days. Expensive and labor-intensive. May be qualitative or quantitative. Main use of qualitative technique is viral isolation for further analysis and for HIV detection in infants. Quantitative results correlate with stage: Mean titer is 2000/10",
"        <sup>",
"         4",
"        </sup>",
"        cells in asymptomatic patients and 2260/10",
"        <sup>",
"         4",
"        </sup>",
"        cells in patients with AIDS (NEJM 1989; 321:1621; Lancet 1998). The greatest potential use is for therapeutic monitoring in patients in clinical trials who have no detectable virus by quantitative HIV RNA.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Barlett, JG. Medical Management of HIV Infection. Port City Press, Baltimore, MD 1998.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33436=[""].join("\n");
var outline_f32_41_33436=null;
var title_f32_41_33437="PEEP ventilation in COPD";
var content_f32_41_33437=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F52671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F52671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Impact of auto-PEEP on trigger sensitivity and inspiratory effort",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 194px; background-image: url(data:image/gif;base64,R0lGODlhjAHCANUAAP///wkJCQAAAICAgMDAwEBAQFBQUD8/P39/f9/f3xsbG7+/v5iYmPHx8S0tLc3NzYaGhru7u3R0dPDw8CAgIDAwMKqqqqCgoODg4J+fn2JiYpCQkNDQ0BAQEGBgYLCwsHBwcC8vL+/v709PT19fX29vbw8PDx8fH8/Pz6+vr4+Pj3h4eC4uLgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAACMAcIAAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsUwEBBMAEwQYS7i0HEO0wELAtLfAvk8cBRdEyctKIAV7wwRWxAAYuUkcAwPHRMNDHMO24sC24LJ9AgIGAAQCA0vv6wIVtvTrQvgC7vj2Tu/i/YK3pAA/Pfus5AMwgOCRDwIoUBDwoQi+Dr4M0qOmcR21i97S4dkYUMiGAgYqfhMQzYCADQA8WpNJ7V3Ll98MFCgA85YH/5QEJ/x0GW/CAJQqP6CcuIemkQs6QeAa8MGAAaPK9B1sKNBIBQEcONSzyG8DOwAGN9CylXZtzLJnReap14ECxHggBIBwqVIYS4YE13FzJnjAMpuAuzL0cFTAsq8gPBCELDlehQ4DvnKAWGEAU4QsDVAj0tCAZwINO3xV3UGArsIGi17gpuutVrL9ohlkLHA3t9uI5Y5UxpKg6ltx/VIY0Po1vWhv10V7t7w5kQkbDHztJsBDP+7eA4otMKCyS10G95iW3KG2kLpCJhgV8DFaw4/74jVc1962/yGCfbVMRwcRqFVmjgk3HFqCxQTdXwN1gNJoCwF4kF8SilbEZRuYNf9ASQGBCI9N3HyYHoN+GDSaPtAJcZ+DgOHnIkHZEAVAa/IJ0AFZOzmjIhE/WtijggvOEw9fDfXkV4sH/vZWibkhEREBeQ0wQV1UwnMlBVnG00EHFxCwwWzwfPAZHgR0xp4tQ7iklmgv/hXnVg4JIdkylTXkHREVCuHbAOh1R9t/RN4BYWW3uNQBCEUEZyE9WkHqaBEXSEfQBa3FBgCmxcXDgUsRfTCBQRJdeAcGX9UTkk+tUYBBnPbR5x9X4YyV6DpX4QYkPhzxSigoGGwwwAZsTjDbBWwWWiim/yjbREcVCPGVQdE6q6BZixpm7RKiTjARARC1w9e2chHIJLlITPT/KkG0ouvuu2YxSmu7SOz3nGLv5ntKXnvGC0BeSjphqr4Ei+LSch9iMKW6UQxc8MOd5LfpRBQ4A4XDEGcsHMYadxwLxx6HzArIIpd8CskmpywKyio3koAFBjiggAIB1GxzABq0rI/OkkRgwAE3By10AAm0zDLPglgwdM0KOGCABAxIAAEDEDhgs9FIK9IA0EE7AEEEDSwhQc1YZ23I1l1HEEXNRad8dCANGMB02A8nYPXNENC9dgAWqPy2HwlwffPDY9usgNpV0NyO24vIPTQD+j5wswFtW1HzAX4nkkDQDDwAQc0O5Ot4AA5ULsXmAWB+d98m/53H5zYjLgTNCvSx/8DtIiCBeR0N3Cz7E2i3HUEERRceAOQlu37H6MgTwQDZfAiAAAInoHCE8mTATjoVMuvtfM0SCCH5AaY/jD0doyMheQDqCJEC5iUccEAKO6vQdgbWszE6BFFosPgS4BtCAiTwO/MVQgNXS0LNkOe9OhwkAyMAAP1EcIKi8YMEKhCCCcp3BpqxDQq9I1oTaHeE3oUvFQTwhrEMk6wnnC8OhatdEiIgNLUpLQD/g4P0SlA9ACwgfiZYQEwAgIITACADJGCD4aDwAAA0gINJ8GASLNBAUWwDQgCYlq0uNoj1sS8JXuSb9yIANQA8b3dtEMDt3BcC6x1AiAd54wiEqAYPhv/OCc/jXxRuWMUiSE4BzfuERqATLgCMi4uCSKASYCfDJARugDUrYBkulAAElAAAIggBHIWQgQMYUQ02u2MTGlA6KtQsZ0yAgB5DEZx51UlggvAgFIUAgSYCQJFMeMABwscABaxyDKbK5AFGoMkhajADdWRaEyCQQ+5B7wnPo1wnWsmuVzbhhW0o3AmPQMM21ayPS4jb9j5xt0YqAWi2tMLzAgBOMBqAdZsIjr8ApgR7WQoQqPui+vQGu3Y+wQGlzIT2RglPLIDOCkr75SQ4YJYK1EJhXGIYIv3gwXQyIYSBpILSzFmJfC7Bc16A3TanQLVLEIgaF6CYxVz4h3U2kwj/ByioEA66hec5wKJqwCkYbObP50kyC6vLwgMUoFNVXAgXesClEdi51ABwFAufQ+MamsY/BszyCo5TqBGIFwabFVUKEnCAP0txIbOsyAgFOGsaYPdVJawzDJtTwFXDKUIp6PJuXqDhM4tgAamKwWZavQIDfkqKCy1nT9aIBwYowJhr/GSlY6jZS4cANvVFMgykbAdXnxABolrBeF1Q6hCe11Yv3C0ApY1CAgBpVCFwwB47YohA+DGBCqgFAFyagAEgCwaugVGfRzhlGRw3VwCo7XNYeMADElDc/l22hGq4Yc1SS9KMhuIgIIBJSmS7M7RQIxnCmGwX9DrSImhApkWQ/6IZHkA3wuLQr1kg4fNQGQW9ilJ8qHXDaeXKhdXC9xMHoUAFCsBY7hozre6ADgHOJYS7taO5ANyrXT+YhgUWoXBjnUIDlisECchQARrI8Ewl3LvApsFuhkOvFgibCX68Nj472gCjFOYnlXTAFsMqYQI0ADnaiXirNTPxYEeYujUMjwghrKUZBDczxeluunoQp80OAAEIQ9PEmOBHdtskKgoUIC9C+MCAASDmCnighVMMABnLywTRCqF3Ii6cGyQnBCtPwQISkIAGBLe0mslUr6jcHIvfoMugKWCX1IUCA6ybhlxwwD1mwOadJexWCx8BAiouYZDd4GExaK/Pp9wvEf8SuDn65qHQfaZdk4F2AA04DQL+o5kD8mwVBN5sZgb4cRY40JoBgKBaZ5B0FJAnVie4eQq+jcSnnQa1IRtBcAbQgAd31wBdx4GMrga1treNQwMkWgsekNCHhC0Fcj+hyNB87oWxrECnviEA7L6CcqEwuqDFG3AM0IAE+OxUpql6ZgAF+AGsAlA2l4E83IBIGsy9TOgxQLxEIKERnkdS4baB0nMWGsQ95gEzdxzYkQZAOWpTDmJgwxzucAsRELAPerDAAAwIG52VgDpGS8DO5vVzGyRnbTKs09Q6w0Br1tGXkBeAMRUYEG/0g3BAxYQbFFhVEkZq8Ihj3KCWXkPPyxD/AUa3LFjdUAM/EDyBsZ/VSQAKM4ORIIEf39C6XsM6Dk1BApwX7AJrb8IKkUUFs19jR0eH0lFK9BohQKUJzztcE0TbzSzcDOifKEEEeVYpKmgR5FwMfMXQohZilAfl8ABB1Jug19GKV6/W3boSbC1Zu0NCBEHkGQGyhXYmFPKQDeN8Lfx0dnzRR60A/N/MjaDeIajSC2EEX+fAwFw+IOC/IrPn31yJL1gieAjXd5Hvp+gASVZ2CG03AupMTUPVNyFwSxO4VZq9aKoxwAJUOwBAZebBPn+bDSdA5ten8QTqT8Hv2DdgO8EQXrYTvsAxejVlGnB/d+M9+TUGDMBv3DaB/0szaG+QAZ+kMicXDE4wTzixBNI3gFyQgENDVAmwXBx0Q5m2XvCnZ/VHgUETbRowg1AjOHpwAAjQMtL3BBBFABIVBwkwNfW2NEWAS/emBtVGN+a3aXiwACaQOymDGlC3cU+hUnqQAEMYSkIgXQwEb5AgN09FByNwSTzjGZNgAadFhB0GeYuwPl4HhJNnMhv4FZYgXUKDZ5UgcWYzB/aUd5AQAdk2d0w4CQxQbHs4B1I4LGh2iJdwO45IRwLkerKADWRGLJxggYnwiEmAAgegf3IwPfIzPUWQAZ74Lr82D4ziCSRQioyADyaQP0VQSZA4B6LISSigAo4IAAlAAjgoRP8i8HwloH/vMwLWczuk2AoIBw+x1QkZIACsqAj5oAICEEGdNEz0I4tHhAAJgIsIQD8LoI0AoAI5WI0jQD/iKAQIkEFZUIsA4EkI8I05WEwkkIMlMI6YkwIjIAIJcAK/aALBiIzQ4FAMZwjN+IyIkA8LIACYM4bUIwAJkJA5eAACYAJqZAIhAAAkIAAqIALTCAAMeQIOmZEogAICkETrmINC8EboiAAocJEAIIpP6EMLOY/UA4+vYBbdsQHL6AkF2QjrgAAh4Iy6+HwgeTvS044CAIUZCXshMD9CWUmepEYJWQIlIACweAXsqJIv+Y67I4oHsQCYcwC4iDvs2AoecBX/jRUKPbkI6yA/yJQAFolEUnmUEjkEzViVzbiUcBkCcilEJ2ACJ+CSJzkEWjk9sJc79QgAxfQ+Lzl5+liWq4Aa/2IAkPYJa5kIfZKQcySRRhmRF8KRHbkOF6mZYKlGL7kO6jiYKUlHopgBITACOEhErwmbQlACTRkClYSSZrlbuEIKl3kIfYKRExmUnYmURDACGumRySmcFmmaCbAOUFgGSolMUIhEREIeeaFwvimYrpACJYkGJBACIUCGGCg/0SkXVjFg7yAKj7hGRNB8qICcs8iITQARoUcBogCKOKibnGSQ9CkcFwATG1B0oMCO+DOWQrSLvYhJwCiMw1SMC3CM//9JCttAABdAoJ+QlSfwjqIoj/RojxKUj/vYj/84oaJgn8OCn6OQlazJki4Jk7kDlh5JkydgkyY6CtrBGOs5Ciugm4XJlStpTDIqlo74i/x5o4JUIpW3oj7aoocJAIm5mJiDAI6Zm0gqCsyxEx1AhZnAokHqmrCZgy05ArQJpbdppVcKCrXFH1KnCtOJSZxkkmmaCuIgC+E5npx0AuY5p6jQEHz6p4Gwo4A6qHvALDvhh4SaqGywg4raqI76qFakE7wFqZRaBkOXIJWaqWTwDmoxZgChQseyiJo6qn7hIogaDg3RIpdHqqy6Ei1XENIRZmeBe606qvOQEPIAIf4HC//M9QAWEAEcVquQQE36YU1FEILVVwloqG2vJomxkABkJH8yYzhNdmhW8U7OWgnypBf/8oEsdQkNwHowiEPLpyyeI4HjSjrv9H2fwFD18FAL4xq5ZwlDqABSYwH42n6BmH5vyAoNYDxdIzWYBn9UAwF5Jn/bZq/ZiggnNTERMalLMJB6sE6g069I9gBhNTQOYLGlYAEvSDpWpWHRirBDw2PmtzKUcFpcqgQN0EtCcwD3xwl2iEOYKAVdl4U2w7EnIwlhtLBFAAESKE2lEEYKsIJdgLHSZmjv9AoSWwdetLJT0FmGVrOWwGQnC1UlqLMA9oc5SwYeG4M+ewifZrRo0AD/FiCupEO2ntC0cqA9YQsFAEs6VNsIp8WG18ZvQltYjkCxV1sFEZCGdVUJn9YHD1BvnjUKbPsG+RSzXhCuk0MJIaRzgFCIN1N1mpC4bRC5b5sFANsG+Nq3S6A99wU3fGa5l4C5a5BPm7sFgjO3WxBGXgO6SFZ/assHO/Z4a7sIsXMHFMu4WECC9oYFpzW6iECxOMMJqDsEDRABZ0t/AWC6U9C1eXBsYwB/zCQ0zmq8vusHxmuIp5tX/oOuj6sFdwO9cLA+5jsG6MdTqlV/0McIxnOErdgFkctt6ZtKNLUH6+S6YEBK7OsE4rq9hPA5q+sHbDs5eqZK7FVtA3UFDdwH/9RrBLI7dRH8ZuJ6v4OauM21Pu/bBF4ECHrluhN8BKCFBFgYNAXMiMkbulBmSt8UCBWMBl5UQA8AuPKrqCscYcTrBHfDv3FwQwL8BV60sWQkNBjMM3snqhHrBuvkeoVjt3xwOUWgiVPVZ1prNqs6rxfnhVBwQx28B7ZGFuvwimvwaTQLqLdHEVrMBsnmBKgThn+AOhYVjR3JBk+kqLv6rdmkbm12dYBgcbeRkF8srFaQx0cQgjncx1BchC1sCAhkTj8ZlP5JyFjggQFzTXBgNTtsBLZ2w3oAO3yikJ1IyWDQgz8IS2/AR0tgX1qjbsGZm0UjAuJIP6RMBSn1sOUGB/8hBL0x/MdzdxsCZAIkMAJPqKdAWctrkMhMUHzBRWGKADRwfJoHQJxBGZvIvHAw5MfSuwigjATNKEQokAAp8EOmec3BFge7fASOs8iEsDX9WgIUWT1B+Z3mfM5xoIfgJ1n1HDLKzAQ39DuwM8j77C793Mf6VMID3TEFzcLTdVo+nNCFstARFjQPDdFEItFKkHy1a9HkgtEs62Qc7TEeHdJ7ONIknTUmfdI8k9IqXTYtfaO44B5gh6F6/NL/SQA28neqwa3/Z9MmSg8CQU840tM+PaHt8iNBssZF3TIdMQRHLStJPVFL3TIl59QOMS6awQQheKpTbTIEIBkegFLsABH/KtrVjoqrINAaFdCmZt3Wbv3WcB3Xcj3XRoABSsyIdk3XSxBuHkDT2jANHIB3bE0ufO3Xej0R60ABIDDYu4IPaeV0BYPYEbHYei3G/rABlVkE4gDWKYQaujAbSiEVP3EMOP1ldz0yLWdbmQ3XCtNy9LBbd90uL0IqEyEhEUFm7JAXUGsKre3a7MB3pyB9vj3cxF3cxn3cyJ3cyl3cu1VPDjHb/FAS6UEUnjEwwr3c2J3d2r3d2t3cdO3aqq3Vzw3V0U0Q6REbUCIS4I3ZlY1b9KDYjH2s490r34EiZiEaH7An6SDZ8N3eQ1DYUiDb5F3fJ1LdySELAO7fRJDXV8rgKQr+4BAe4RI+4RRe4RZ+4Rie4Rq+4Rze4R7+4SAe4iI+4iRe4iauCEEAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    To trigger a breath, alveolar pressure (Palv) must decrease by the amount of auto-PEEP, plus the set trigger sensitivity. The large dip in esophageal pressure (Pes) reflects this effort. The addition of external PEEP reduces the Palv-Pes gradient and decreases the breathing workload, without a significant increase in end-inspiratory Palv.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from Smith, TC, Marini, JJ, J Appl Physiol 1988; 65:1488.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33437=[""].join("\n");
var outline_f32_41_33437=null;
var title_f32_41_33438="Approach to paraneoplastic and autoimmune encephalitis";
var content_f32_41_33438=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F72802&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F72802&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 517px\">",
"   <div class=\"ttl\">",
"    Diagnosis and treatment of paraneoplastic and autoimmune encephalitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 497px; height: 283px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     GlyR: glycine receptor; IVIg: IV immunoglobulin; LGI1: leucine-rich glioma-inactivated 1.",
"     <br>",
"      * Differential diagnosis and exclusion of other disorders has been examined in several reviews.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Unknown antigens refer to antigens whose identity has not been established but are visible using patients' antibodies with brain immunohistochemistry and cultures of neurons.",
"       <br>",
"        &Delta; T-cell suppression refers to strategies focused on decreasing T-cell activation (rituximab) and cytotoxic T-cell mechanisms (cyclophosphamide, tacrolimus, or cyclosporine).",
"        <br>",
"         <span class=\"lozenge\">",
"          &loz;",
"         </span>",
"         Tumor surveillance and chronic immunosuppression should be considered in some disorders (&alpha;-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor [AMPAR], &gamma;-aminobutyric acid-B receptor [GABA",
"         <sub>",
"          B",
"         </sub>",
"         -R], and contactin-associated protein-like 2 [Caspr2]) and subgroups of patients with anti-NMDA receptor (NMDAR) encephalitis with higher risk for relapse (eg, patients without tumor) or to have an underlying tumor (older than 18 years).",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011; 77:179. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33438=[""].join("\n");
var outline_f32_41_33438=null;
var title_f32_41_33439="Parapneumonic effusion CT";
var content_f32_41_33439=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F80445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F80445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Parapneumonic effusion chest CT scan",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 251px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD7AWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UooooAKKKKACiiigAooooAKKKKACiiigAooooAKKcqszBVBZj0AGc1t6d4R1/UebXSbsqf4nTy1/NsCgDCor0Cw+FurymM313Y2at1UyGRx9AoIP512Wk/BvTSEN1fXtw2edqrEp/D5j+tAHhtFfQ918H9FjtXdbW8O3PK3HPT3FRaV8D9Jvr2C3uby/svPXcjSzxkAe/wAlAHz7RXuHif4CXNlLOui6zBdmM8LKhCt9HGefwH1rybxB4d1Xw9ciDWLKW1c/dLDKuP8AZYcH8DQBkUU7FPhglnbbDE8jeiKT/KgCKirElldRj95bTr9YyKi8t/7jflQAyinFWHUEfUU2gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACpba3muplitonllboiKWJ/AV6J8MfhNrvja4DxWsiWajcxJCFh9TwP8APFe52Pw3tfB7Jb3yW0J2bjFAdxcf7TdT070AeBeFPhZr/iC8jt1h8h3z8m0u+B3wOB+Jr3Lwv+zVpljF9s8X3pS3TBZTJj88cD866q01SXSpxLoZS2YLtL7FJx+IxWZrniCee3dNS1G5kUnO15CQT9KAI7rQPCGhXH2bwpAPu7WmZQvPscZP41m3OkSSlpFZ3RRksSePzrlbzxzpVqZP3irJE2CJGHJrB1H4i211C0balsQ/wxo2D7cDmgDso7q1hu1hkkLZ7A5x+Nd7o00bWkZ4yThW7V4Ra+L4ZkMMV7Y4xgM6hD+tdl4Y8XQwx+RcXUEgbkbZFIzQB62WJ8yOTcQwzjHSuetHgTWCGDZbhSST37Vl3HiZ0WQvLEsWzKHO45PYYqhpfijwzetbWd9HeafqDMWN7M3BPYY7fjQB6dC2woCAQ35VT8ZeHN3hmTVLtYJLdm2vayxB1IzjODnJ49K6jRfBczRW8s+rQ3Nvwy+XEMOvUfNmu6it4oQfKQLxjjsPagDwf4ZfDTwJq8l3e6joumzXIYNHb8gBcfe2ZwQfyrvLPQ7DSrZorOyitLYt/qoECAe2Frq9T8P2OoTW87I0FxAcpLBhGx6HjkVQltxFera3lxGzFTJGXYKXAOMfXmgDmfGdnHNZLNYq9o8S8hJDhq4Swiv55/nnkJzjBbOf84r0fxdbT2miTSu0aRAcJu3M+fpWB4ftGcW8s0TxpMM/MNuR7UAMi0Ka6tyt19nmiPDI6hh+RyK4vxP8LvDt2rvcaHbK5/5aWwMB/wDHeP0r1qSGaMZG7gHOOg/SmXUG6FhgEYzjuM0AfLetfBjTnDNpGq3Fu/UR3SB1+m5cH9K891z4deJNJDMbE3kK9ZLM+aPyHzfpX1zLoGoXbtJbW7yxZ5MY3Vl3Whzxz/vonikBGAcgj9KAPitgVYqwIIOCD2pK+sfFPg7T9aTGq2EVy+OJguyRfT5xg/hzXjHiz4Yz2MclzosjzxJ96CUjeo9mwAfyH40Aea0U+WN4ZGjlRkdTgqwwRTKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiprW3lurhILeNpJXOFVaAI0VnYKilmY4AAySa+hvgf8EW1BE8ReL9trpcX7xFk4zj1B6/y+proPgP8EYlEWu+Jo1+zoN4LnAb/AHfRfVu/b1r0fxzNqfjC7g0Lwf5f9nQY3spwgA4ycdAOwoA6vwlrGn3Vnqum+FUghktj/o6twZOBlzn3/pmvNPG8eo6SbjUNZguYokJaa5n+5/310/Crmv8AiDwj8HNNjOt3P9peKf8AWJaWjYkOem4/wL7tyewNfNfxU+L3iX4iuIdSlS00tGDJYW2RHnsWJ5Y/Xj0FAG74i+LqgSQaNarMpGPNmyq/gvU/jivO9Y8Xa3qwK3d9II/7kXyD9Ov41g0UAKSSSSSSe5oFFLQAU4LQKntbeW6njgtonlmkOFRBkk/SgBiFlxtdh9GNbOj3us311BpdhJPdzXUixRw43szE4AXuK7rw18Lz9mF1r7Mz9fskJ6D/AGmHX6Cvc/hp4N0+0v8AT7qOxt4BbsHTykAOR0JPU/jQBp+CJfEvgPw7DY3X74RLxaSAvs9cMD69ulal54y8VXhDaeLe3Qdltyfz3E12WpWy3TzShFRjyVxyfeqSWyLFiKPGRkkAZoAxNO8V+K4z/pENtcqWxloSpA+qnFV/EttqviswvcbIfs4bakKkDnucn2FdN9lKsoAzzkjHpUu4o20IBwOcYoA4aLw5fQhTHI244GGya1JbvW305LS8PmRpjZ+7G4Y7ZFdeqKw3zBCOoYcYFV5Y1EQYKOv3sCgDjk1jUrRmVsOo4yIj8o96qX/iWR0CvP5eB3jIP6110zKjFnIKseSRzSRpFMjGRI3HYMgNAHEaD4xvrHUfMt5VuEbhoimAw9evWtrWPGCX9xFJcWwhVBgg9R+NM1/wnply4u4oFt5hyTGAM1zmr+F1mCsLvLgcAjFAHoOkeI9NW18q8hikt2Hy7IwxH1qPWdM8Oaro7S2ukwTxN8rFX2Ohryu+0/U7K1hWxnTcnJJHWue1Dxprfh/VBPNavNp6n5xCPmUHq2O9AFzxp8FLTxHBNceFryOa7iGWtZfllTjoD/FxXz/418B+I/Bjw/8ACQaXc2sE+fJmdPkfHbPY+3WvpfwX4msPEPiKCHRNVhjvZZBJBK77PqGXv6V7D8VtMstU+HGo2+vWsd5EkSu6Y/jBAyp6g8nBHNAH5v0V6t4x+El1b2Mur+EZX1TS0yZYCMXEHqCP4x7jn2ryojBweDQAlFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRT4o3mkWOJS8jHCqBkk0APtLaa8uY7e2jaSaQhVVepNfWXwV+EWn+GLKDXfGAU3M2DDbHlpO4G309vzry74Y6dYeE3Gq6okc9+OQrYKxfge9ej6p8c9P0GCS/Fi2pau4Ig+0MQqH2HYUAe9+N9T0Gy8LPceJ7z+zNKAG7e/lE8cIAOSf9kV8x/EL9olo7N9F+GVodLsRlG1GZQZ5BnqinO3I/ibLc9FIrxXxx4017xtqx1DxFfyXMgyI484ihX+6idFH6nvmucoAmurma7uZbi6mknuJWLySysWZ2PUknkn3qKikoAdS0lLQAU4CkFOFAGv4W0OfxDrUGn2zLGXyzysMhFA5Jr2/wp4OstBj/AHcbvM3352OGb/AewrN+Fnhl9G04Xl5H/pd0A/b5U7CvU4rFpAsjAlNuNp+vWgCGwsxJfRR5bHHAzXpugWq2sClI9rABiDnI/wDrVzfhi0WOUsyli3HOOa6+EBnCYOFHcCgC/kZymSpHI5/nS4jRlcAknPPX8P8A69JGxeNTk545yOaZv2SbX+5nIwBge1ACShX5G4P2Jp0SFQSwILdeeaaVDEbFyccdMn2zU3BLKy4kPU5HFADZSYshVOD3Hb2qKZ2EQDxnp3Oc+9WVYqoU4Cr1DdCfrVa92qgkAz0wCRj2yfSgDOmBfyy4z8nC881WmuRCOd24YAxyM06e6wxIxk8HBGFqjlt7nDHB7ckUAFzNI7HABA4IGcLVCWEzqC/mAZyN1XRErsFOTkdO341a8oRxqpXnGenWgDm9X0veqbSWb8cD681xuqWohWdZgGQ8N1Oc9q9CvVDKc/z5rl9VgSQsCo5OBxkfyoA+VfF2mXHh7xEZrPzbeMyebbSoxUoQc8MOQQa9U8HftH67a2Y0zxrYw+ItMYBGkJ8m5Ucc7gNrYGeoBJ6tWn430CHV9JubQIvnEF4GJHysOh+lfO0iNHIyOMOpKkehFAH2R4Ql0HxB/wATD4daqbkAbp9Kmby7qEHr8hPzD1IyPSuE+Ovwut0t4NeskS0kuSRJgYUP6SDtn1/OvnWzuriyuormznlt7iJt0csTlHQ+oI5Br0ey+MniOW0ex8Rzf2xZyLsZpsCXH+9jn8efegDzq9tJ7K4aG6iaKUfwt6eo9RVevRnl0zxBa+QjeYnVN3EkP4/5FcXrOj3OlS4mXdExwkqj5W/wPtQBm0UUUAFFFFABRRRQAUUUUAFFFFABRRSgZOB1oAVVLsFQFmJwABkk16J4b8ODS7UXV5gX7j5VP/LIfy3fyqbwd4a/s6IXd7Fm+dcorD/Uj/4r+VdXa2Lyt5hfESjLk8UAcxrU8dvYmWc4jAyF7mvNr25ku7hppTyeg7AdgK7j4h7ZbXzbckxLKEJx7HH8q4CgAooooAWiiigBaUUgpRQA4VteEdMbVtftLYIXTcHcD+6KxRXpvwFsjdeKLp+NsUIPPGcmgD3XR7VGhWGRQBGoC5xx7VvwW4VDwdirgioYYBHgqNpAyD7VtQxb7J8E9Mn/AOvQBZ0NE8hgOpOR6/St2At5oJJHPUHvWR4fw1tleeefatmBiJfnHQckjqaALLY4ZQcdfpTG+YADIbpwcUnIITcNvcDnNLD9wru+ue1AEgHyLkHcoBNPHK7cc44HXk0xiojygKcevYd6RCQw4Ct32g5FAEm7CkHrnBwev6YrL1W6G1olyueCByKff3RjDRkkEdj3rI83DYJJORjHUUAR7cgbQSTkfWiEmQ8qAOAGA60m5MHqHB3ZHT8qt26q67gxVD+dAD7eIgnrlupzTpwJXKKW2KuWyMZPYf59KnUqgLK20ADgnkn1psj9MA4HI5GaAMnUgCjJty+OD6Vzt5H5aspOT3weB/8AXror3lj83zNyenT3rFvY1ePYG+Uck5/nQBw+sxFQSScMc8HoPSvmrxjbi28TahGowplLAemea+nPEMAjjZmOQfevnH4ioq+JZCpyWQE89+aAOXooooAlt55beVZYJGjkXoynFdroutw6tCbPUEjMrDGxvuyfT0NcLSglSCpII5BHagDovEHhx7INcWJae16sMZaMe/qPeucruPCutPfyCzuT/pOP3ZGB5mOx9/510es/DR9StmutHTyLwLueBvuMe+P7p/T+dAHklFWL60uLG6ktryF4Z4zhkcYIqvQAUUUUAFFFFABRRRQAV2HgDR0mmbVLsKYbdgIlb+OT1x6D+eK5W0t5Lu6it4RmSVgij3NfRPw58Gyazd2+mWWfsdlF5krDkcckn3JzQBh3xMMSZ+ZpjknGc+2RWfruomK0S1gfDP8AewecV6H418OMNOi1CKEpDbXHlb9m0HjpkV5Jr10ZL2ZmY7BwBnIoAydfcDw7NGG6yo+PoSK4quo8QTFNLVWJzO3HBGQO9cvQAUUUUAFLSUtAAKcKbThQA4V7b+zckIfW3c4kIjQH25NeIivRfgtrH9neIJoHk2LcKuPdhQB9NW0mWUEDd3YdRWzZ4UOApIPUdcmudgc+aHGWP3lx6V0FtKFA2sTng5NAFzRGBkkCsFw3Ax/9atghlyW+Y/3c85rmoZHstSWRP9Q/BC55HrXTSFXjjmjzsccAHr9aAGpMc5GMn2qRHRo8jr3/AP1VCwBQEsxI7entmm7iGPzM2OoxQBoSSbQp7kZ45zVaW4FuhbneMYH+elNmcrEoGTuO5ix4/nWdeyFN5aQs5b8aAIbmXzmJfBP8XbHtVfzCUCgkqfUYx7f/AF6YUbcY2GSO+cn61PHGWUtMOox8w4wPxoAbGoZiHBz1BHPHvWrChjj2DaMgA+g+lVrSMgl8E4wDg9fQf/Wq5GueV+bcfmyfu9aAEd9gAVd6/SoHfPIzg8g//XpZ2+YBSxK9z932+tVANq4iZ3UKFGSSeOOpOT9TmgCvfk5Yg9sYxWRdSKCwOSQBnOQDV28Zg2PmC55OfmrNu2TaRsYAHJOc4oA5XxHuks5du4DrkKTXzR46ffrr55dVAY+pya+ndUcXFpcQqxxsLD3wK+UNduPtOr3UmcjzCB9BQBn0UUUAFFFFAD4pHilSSJikiEMrA8gjoa+vvAVy+ueFNP8AFNiUMc2Ib2EHiGdeG49G4YfWvj6vev2TvEcEXiLUfCGqNmw1yL92p6CZQSMe5GfyFAHq/wAZ/hVp/iXwvHr2l2wF1HFumWM847sv07ivj7W9LuNHv3tbkZI5RwDh17MK++Ph/rJsNcvPCt6MCJmEZc9T6DtgjtXhf7Q/w/Wz1S4is4SFfddWR7AH70ftz/SgD5ropTxSUAFFFFABRRRQB1vw8sw+oTXki5EC7Uzj7x/+tn86+x/hDYLoHwzvNZuRsm1AF1JxnZ91Bke+TXzJ4J0eU6HYW8QAnvZFxk4+Z2AX9MV9p+IdDW40DTdGtSIoY3iQIM/cQev4UAeY/tD6hF4e+FumwZ2G5uFkc98hcn68nFfI9x4gtDK0kdtNIx6CRgB+OK99/bX1VRdeH9HiONkbTMM9uAK+XKALmpahPqMwkuGACjCIowqD0AqnRRQAUUUUAFLSUtABSikpRQA6remXb2N7Dcx/ejbNVKUUAfV3g7xBFqum2shYbiuCBXaxOrBWXJGOAT1r56+FWroNPKF9rxttIJwPavZdK1N5MF2LN/CuT+tAHUTMZYPvnI6cjpnn+tX9I1IKgjkLbc46j6YrIWcSPjkEj5sHI+lNLLDKzDAjcZwScGgDrzIjAKh3Y5HIBpSwYKQ5ywwFyK5201ERgYkC9+TnBq8NQXahzuVj0GaAL9xtCDLZUHJHt3qiwJkXccM3APT6Zp004kjVSHUE/Kc9Khlm3XCbSSmRgdAT+dADnPlsQv48joO5piTGWYcg8bQAcZP4029k2yNHEQ20/wAPXnrUdqqCULncQeR6UAbMR2DcoOcnoQcGka5YDYB+GMc06HHkDA/hyMZ/z+NNnIRI1Y/MOpA/Q0AU5ZD5TO2SF6DPU55qCW5xjBO7GBzjFT3LwgSNggL0X0NZFzPjOHBA53Y5oAZPJk/eY9eCec1iazc4ix8qx4yNx6//AF6svMJQTvY55Pr+PP8AniuT8WagLeBmdwiJ0B6igDF8Wa39k0G4uExGoV1Jz7f54r5uYliSep5ruPiL4mOp+VYWzYtozufHdvf1rhqACiiigAooooAKuaPqNzpGq2eo2Enl3dpKs0T9cMpyPqOOlU6KAPvUXVl4y0fw74z0o+W15EGlAbOyROqk+oIK/hWn8arOLVPh8mqqA0tk8c6kddrMFYD8wf8AgNfMH7Pnj2XSnuPCt7Kv2C9kFxbNJyIp1HIHs6jH1A9TX0zLq9lr/wAMNesF2+bDavuUcg55B/P+lAHxJ8QtNWw8QySRLthux56j0JPzD88/nXMV6t8S7AXXh2K7XLS2cgDfLzsbg/rivKaACiiigAqW1ha4uYoYxl5HCKPcnFRVu+Cbf7T4nsQRlY3Mp/4CMj9QKAPoP4caatx478O2KxFoIpg7IORtRc/hyBX09N5snia3XpDFbs/Pck4r54+CUwk+JemgsQwgn4J/2fpX0VK8dtfXt3K5CRW4Zs9ABknHftQB8P8A7VOptqPxavlyDHbRrCuDnpwf5V4/Xb/Fy5N94pe9ZstOXfjp941xFACUUUUAFFFFABRRRQAtLToIZLieOGCN5ZpGCIiKWZmJwAAOpPpXZ6pZaf4N0240+7jtNS8T3UZjnGRJFpikcoOzXHYnkR9BlvugHF0optOFAHbfDKWOS8vrGR4EaaMSRNI4U+Yp4Ck+oJ49q9h8LLeNF87o204LkZI9vavmkdRXqXwu8bi1uo9O1jc6McJc7jv9gw/ix+dAHuVpFtRfM24zkMvBz0rS+yR7SY1EmeSpHWs2GQ3EayQSeYhXgAYqxFc5ZCSxHbGfloAu/ZeUVY2Q47DIzU1nvhCq/wA2DjBUc06CdOgZlbgkc9fxo1No3sp38whwBt253fX60AacJWSQbH3IeSBz6CnaliFUkRQpJIClRyBXnGg+KpbbxA9tKZWCgjGCM10l/q5nt5Gw4VhwSSMGgDRS8QGWaR8YwqD+tP068HB8oDd3OPmrmLBo72yjnZyidQrZH4VqwSq+SDtCYwcHBHagDp0u285lUFVJyeOo7AU6VA4aTt07YNYymQQByWUKcZJ9atCVliwS0hA2g4OOtAEd1KoUqWwB1VR09MVjSzxrMeN3XlhVXXL02ZIkyitnaBkf/rrmLvxB9ngLyZywyu0EUAdDe6hFBCzSPhzn73r2ryH4ra00Ol7d4E9w2FXgnHc9K0vEGvxxwfaLtnCnlRjnPt7mvGfEWsT6zfmefKqo2on90UAZZJJJPU0lFFABRRRQAUUUUAFFFFAEtrM1vcxTRnDxuHB9CDmvoPw54xcRzW7KVM8QUnHDZ/SvnevWPC+mXF/o9vepFIUwqhhxkgc9TQB0+o2y6hY3doxBW5haPJ5AOPl7euDXgLAqxVhgg4INe+2zeWFKg/Ie4AI9ySa8b8ZWq2nijUokxsMpkXByMN839aAMWiiigArrvhtEH1a5kOcrAVGM9Sw/+vXI133wuhBGoyFQc+WgyfqT/SgD1LwVqcuk+KtKvl3YgmBbnqp4I+nNeo/FLxe7Wl8LKRkS4QQ7fw715DDCUkBRGHsRxmrGoxvcqPtRGQOATQB5P8Sbcw3mnsQfnhP6H/69cbXuni3wf/wkeigaeFF9aqZIgTgOP4l6fiK8/wBM+GviO/h837NFbJ2+0SbSfwGaAOLorqbnwB4kgnaP+zWkx/HG6lT+Oapp4T1tpHRtPmiKdTINo/AnigDBoq9eaVe2bET20gA6sBuH5iqR4NACVYsbS4v7yC0soJLi6ncRxRRqWZ2JwAAOprpfhV4Rm8cePNJ0KIMIZ5d1y4/ghXl2+uAQPcgV9Y/tF6L4Z0TwXealp9zpegeJUtBbWsqqFnngAAaFAOeVG0MBkD5chS1AHy/cXNv8PoZbLT3huPFzqUub+Ng6abngxQMODLjIaQfd6Lzlq4PJJyaSgUALSikrestNt5fA2r6o4b7XbajZW0ZzxsliumfI9cwp+vrQBhinKdpBBIIOQR2ptOFAHp/gj4hNbxm21eVIyAAs7A4I98dD/OvRdO8ZaXdRARX9v8vzZeRQc/nXzaKUAZ5AoA+oV8WaGqgz6raMfQTqDj86bZeIrPUpGitpoXjXkbZVYn9a+YQB6D8q9D+E2havcan9vtV8nT1GJGfgTeyjqfrQB6/qGkWTXMV9jyto3M2cdOuT2pun3una7bzRaZeFpIXxIxjKqoHoT1/Cp5oo50CXMW8hsiF+Sxx6VehhvJJRHBZ7JNgCec4VV+gFAHK2CalZ6tJbna1ryVbjaOf513Oi6bdTMJJGHloOFBHHbOKyvEmiaugt2doEtdyl0iyW47H616H4cCtpMSqgWQ/eHfP4UAZwsbqNTkIfTnBHtUEk72QVroJnABUAHP8AjWxcq4JV2IZiOV9K5/U4TcRmFi6IvG8Hlv8ACgDyT4+eJ47SWwtrCTc00fmcAfKM4/nXnF74ojvYNMX7T5ZiQiXeDw2fbrxV3416dbafrlstukodlYs7nhuRjH5mvOKAOv1vWdPNtOkEkl7eM4MUxTZHEO+AeSa5Ekk5JyTSUUAFFFFABRRRQAUUUUAFFFFABX3H8LfDcCfC7wHCsKg3cRknI5J3/Nn8q+HK/R7w5bw6baeC7WNmSNLDYkfb/VrQB4b8XNDh8OeNHtrSLFrNEssW7AxnIOD9RXgnxPhxrdtcDpNbrnnPKkj+WK+nf2kQR4r0hgOtkR/4+f8AGvnL4oIWtdMlIxtaROn+6aAPPqKKKACvSvhgNml3DnvMcD1wo/xrzWvUPAaKPDtuSAd0jsfzx/SgDvIF3AMQwYfMOM/1/pXoejeBptd8PWV4F2C4k2I+D2OOR1xwe3avN9OTewI3ccZ7Yr6a+EmyX4e6UpwxjMgOexEjH/CgDyCXSLnQNc/s28YJPHgqT0YdiPapNZ1CzgZlaN/MHUqOK9K+LemRmPTtZUbZLeTyZHHUo3T8j/OvnzW7lpNSncYyXOORk0Aak+uW+4mOIDnjcCCKQ6nb3JCTRlgw7jj8a5RWAbBXB5xwCKmC/KSj7WH0yaANm58J6LqyOqCW3Lgh/LYqPwOa8z8U/C6/0uUvZXC3Nu3QuDuH1IyK9As7mWFhwrLu65xk10VteiWAiUhx6nA//XQB4J4Q8Xa/4Du9Ui0F7ez1K7UWz3bIGliQHJVC3yqGOMkjPyjBFYOv3F/d6tcT6teyX1653SXEkxlLnHdiTmvZLnwFZ3vik6jebGsJEO6Fs5ZvUEGvKPGeiLoWu3FrA7SWucxMw5x6H3FAGFSij60ooAK6vTf+SW+If+wzpv8A6Iv65Sur03/klviH/sM6b/6Iv6AOWFLR39KUCgBRTh7UgFbvhDQJfEGqrAoIto8NO47L6D3NAG98O/B51l/7Rv0P9nxE7V4/ekeuf4RX1Z8N/AM1x5WoazCLaxVR9mtU+VpF/vNj7o9utW/hH4CisLOK+1C3i8hVUWdueQgH8RHr6fnXqxZg5Gz5QM7s/wBKAMe/8K6FfwLDdaXaui9CE2sP+BDB/WuW1H4aW9u3n+Gbt7KYciC4Jmhb2yfmX65P0rv8sSpKnJ6k8Yp25UChmxk4G49aAPnTxnceILG/trPVrAWMKvzOMOkv0fpjH0P0rptHuxHZI6OrEAhgpHzD1r1y+tLPV7GW1u4o7i3fKujDOD/Q147q2hXfhvUp0WXNlF+8RiDyn9aAL93ctLlhwc9hnFYOpONzAHGDnP8A9eq0Hi+wlUvuB3DK5PIx7dq81+IXxOtLC3ks9NK3N+y42g5jhz/ePc+w/GgDgvjhrFtqXiaCC0BJtItssh/icnP6DFecVJPLJcTSSzOXkdizMepJqOgAooooAKKKKACiiigAooooAKKKKALWlwfadTtICM+bMiY+rAV+l1zbiG90KJVYiIMgIPTCD/Cvzg8GFF8XaI0oJjW9hZgPQOK/R/w3qqa55t0FC+UfLVd2cZ5z/KgDxn9olkfxfpS7lylkSRjOMua+d/ieANHs+D/rz1H+zXtfxZ1JdW8c6lLCfMht8W4Kk4+Qc4x15zXivxW2ppemrgB2ldsADsB/jQB5pRRRQAor1PwSmPDVmTnBL8lTj75ryuvVfBX/ACLliQDjL9BnB3GgDsdOQk/L0B9D/KvoT4EXW/wxd2jY3wXJf8HAI/ka+fbHbIvXOePnQL/I5r1H4M6oNN8WC0mISPUIjGMkAb1+Zf03AfWgD2TX9PbUvDd9ZfMzyRsEz1JByv6gV8leJoTbalImNpDbsbiOvUgdK+yndYxl2VR6k4r5b+IdlE2rzXUA3wuzgBMZ4NAHDuDnDESd/TH1xyaswESfKwA79DUU0KoFG4rxyHwTSxrtJAQFRjABBoAkYSRtxKfpyR+dSQ3hgUFssenUgiqzsq5BySTx0AH41G0wJOwYB6lsEGgDt9IvIrq3dFIUt1OOF/P+decfFuKwtY0iunWWUoTCpyNpz1BHStzRLlUuQu8euFIqh8ZbFr3wxDf7VL20gBIAzg+460AeKpM0ayJHhVcYbnNRUUooAVAu8b87c84r7Fh+BvgWL4UXdymtaz/ZV1HDrMl35kWcRQylcDZjbtmfIznOOeufjsDPHb2r6A8R/FPTW/Z7i8J6PdO18ZY7N1YYZbcDeT7jICfQmgDwFtu47M7c8Z64oxRSigAr2X4I6aUlhS4QsLyVZWTp8g4X8+a8p0LTZNX1e1sYuszgE/3V7n8q+lvhVYQy+ILUGBwVnjRUGflVSAM0AfUSRJFAsUQEaKu1Qo4UdqqWQuoiVupEljH3ZQMMeehFXqDnjGKAEC4J5PPNMniEqYYKfTI6VJRQBDHCsb7lRQx6sByaxfG1qs2jSTkKWt/m+YZyD1H8q6Co7iMSwSIyLIGUja3Q0AfBfxR1htOvLu3trVILqdynmgglI+vA9Tnr2rydjycnJ9a9a+PiLLrQuRFscPsYgYHp6V5IaAG96KKSgAoopWGDjIP0oASiiigAooooAKKKKACiiigDQ0RW/tCKRDtaM7wfftX1f4O+IB8OeBLgqFk1S7QJEWfBDc/MfpnNcH8NvgxcHQrDVfECPBNffPa2hO1mX+8/oMEfnUOu6HPoPii4spyy+TggckDPbpQBYdAQDLtJY5diC3Pr715v8WJlF7ptqmNscLS8KBnc3t/u16LK+Qi7i2WxyTk/hxXkfxFu/tXi69AOVgKwD/gIAP65oA5miiigAr03wJKW8PwBdv7uRwwzyec/1rzKu1+Hd2v+l2TDLECZBznjg/0oA9O058ABlDZ55GR+WK27aaW3lhuLVzHdQMHicZBDA5B9hXI20u0qUwuOeAR+fWt+1uVZAw2HjoW5/DmgD6B1/wAUQ6x8PF1K0dFnYDfEc/K4HzD/AArytkF9pVxBhiw/eISc896qaA7Xs8dlAx3zsAEzwx9xmu9/4V5qOm273mnz+aBky2xXDD6ev0oA8fO9kCYbeOxPT9Kz5v3cjFQXOOMDGfat7xDaiG7baFMbHcvyg/h1rGlQFcfuzIoPAB6fnQBCHLHEzgcZxkkL+B/pTgodhsUA/UgH3qOOMEhwQBnuuR9MZqyIHZwqmJu5BJGB7UANs4F89BwW+6QrkYra8UWCXHgnUUlkxEIS5Lg8EDt61TtLYm5UuCDnsVYY/nWp4uSzi+H+sS3RCKLchMHBLY4HvQB8wL0rW0XQdS1pJDplo85j5bHAOfc1sfDbSLbVNZzewx3EUQXbE77d7k8DHceor6C03TP7LsyIUSMsdziMAgE9hQB5B4d+F4m8p9bvxA7cmCIZI+rdM10V98LdFt4EeGSWUkHJLEBT2zXV312sLFi0uFOWDKAT/Ssa51PzpRvJ2DkD1/CgDzrVfBken2VzcKkspjO0JzjJrjLy0mtHVZ42jLDIBr3AXAdXjVmAbufWuD1rw9cavre21+WIL+9mPIHqeKANP4QaNG9jqerzMN4/cxL39/zOBX0do2g3fgldH1kvHeWU0kYudqkNDv8AX6Z6/nXmPgDToW1HTdE047oUYPIpwdwHXn6+or6B1XXrForrT2Hl2jWzR7sEhSFPr396AO6orI8H3kt/4X0y6uDulkgUs3944xn8etUfHPi608I2EM91FJNLO5SKNeMkdcnsPzoA6ORtiFtrNjso5pVOVBwRnsa8QPxN8QXk5kt1tIIB0QJz+JOalg+Kup2EhOoRW91GTyo+RgPbHFAHtdFYXhDxRYeKtNN3pzMCh2yxuMFG9Pf60zx1qV7pPh2e601V88Mq72GRGCeWx3/+vQB8wfGPTP7UXUhMpWdZXXAHKsOxH14r5uYEEgggjgg19Rap9qmu70zTCdJ3LElcsc9STj1rxn4j+En06Q6laBmtpDmUFSCpP8X09aAOAPWkpaKAEooooAKKKKACiiigAooooAK9o/Zm+Gb+NvFqapqdvu8P6W4kl3j5Z5RysfuO7e2B3rx6xtJ7+9t7S0jaW5uJFijjXqzMcAD8TX6SfDzwlB4N8CadoFkEV4IMSyAf6yYjLufqxP4YoA0NHurTVWlvljhMdtI0MEm0fKoxkg9q+UvHmsjX/GOqaghzA8xEfOfkHA/QdK93+KesweDvBMGj2DhLy+BgQrwQv/LR/wBcfj7V84ToiMQMnPcHrQBIkyrOsjsQiDecZACgZP8AKvDLydrq8nuH+9LI0h+pOa9b8S3X2Pw5qNyGwzReSuM8lzj+Wa8doAKKKKACrOnXcljew3MX3o2zj1HcfiOKrUUAet2d2t5bxXFswMTrlQMcexHrWlFdC1IYI3XDENz+teV+HtafS5SkgMlo5y6DqD6j3r0GxuFngWe1fzIZBwyj9DzwaAOt8O+IX0zWbPUIlaT7NKshQc5A6ivsCx1O2v8ASYdSsm862miEqMvUr1/P29eK+HrZVVt0ZK4HI969m+BPjc6PdL4e1aQ/YLqT/RJWPEMh/gPordvQ/WgDrvih4Nhu7R9V0wk283zSop4Qn+MexPUV4ZcWsmnztDKJY5FP3sAhvp619g29oIvPgZUe0kyVQjIGc7lOeMe3ua8X+Ifhyy0zVBbTwbrOcb4JMZMfqvvj+VAHkUbAyZU4XvgH/CrsTg7YlV1Awcev5fyrVvfCstufMsXSWPqCQ24D/Gk0/S5FmG9AGxwGGcnr1/pQA3SYy1wqgyb+m5kPFSfFyC3ufAr2lxPJHEjK7yAYAIPQ1vpZfZLN5mAV2HAVQc+9eNfGzVXxYaRE7nd++l7bz0ANAFT4G6d9s8Yz3QQvaWkZI64LH7teveILsJCoUssgPGMisD4baX/wjnhGIERG6uB5srLg8noM9+Kiv2N1dMwBA7bjjFAFSaQuGJFxuz6nafoKpyoVZWAlznAUdzWgtnt2ld2cfeB4+n86ZIAjK5CO3UMxx+VADYzKyFBMQxH8cfIp9pEbZDEGJ81uXTI3nHSug8M+GtZ8RXfk2lvuAwW+bIQf7RPA/nXX+KdB03wRYxh5FvdfmGVVV+SEeoz/AF5oA5Lwe8fha4u7ieFpL+b7z7c+Wv8Ad+vvUWp6te61eILd52POyMoRgnvirHhjSbrxX4ns7a8lW3W6JLbcEhRyTz3OK9w8JeGdF02+kgsLBJFhJJnnGZCaANzwQt3H4YsY79CkyIF57jscdqg8e+FLbxfoT2Nw5hmU+ZBOoyY3/wAPUV0bMFUliAB1JqvBf2dxIY7e7t5ZByVSQMR+ANAHyj4g0u/8Hagun6sk0MhPyTBy0cy+qk/y6jvS+G4tY8Waumm6Xbefz+8kcEJEvdmboP5npX1ZqOnWWp2/kajaW93BnPlzxh1/I0un2Npp1stvp9rBa268iOCMIo/AcUAZHgjwxbeFNEWxt2MkjHfNKRje/wBOw9BTvHGkXGt+G7qzs3CXBwyZOMkds1tTzRW8ZknkSKMclnYKB+JrBl8b+GY5xD/blhJKf4IphIfyXNAHzPetJpc7x6kJoL1SVaJlK47VSt7hL83NtdmNY2Uq6vnDA9uete1fEO90vVpTJHYWstxGu9JZEyWHufpXi3xBis5o7CW1jCJMjbyg2gMD2/woA8X8a+GLjw9qEmEZ7F2/dSjkDP8ACff+dc1XtEupxi2NvfmO4ixsIlQNkDsQetcoPBH/AAkGpGLwvJEJn+7aTSbefRWP8j+dAHA0VveKfCHiDwpcCHxDpF5YMfutLGQrfRuh/A1hUAJRRRQAUUUUAFFb3g/wjrvjHU1sPDunT3k5PzFRhIx6sx4UfWveNL/ZyvtDtEvNZ1bTxegZEKZfH+6COfrQB5r8JdLfS/Emn6xdIplicNBGTyrdmPvX3XBrsVr4a/tfW5EtYgm5iWGPbHufSvlWfS4fD2o27yFpY1fd8yj5iBxg0/xf42v9fe3guZVjtLbiK2R/lHuQByaAJvGXiS58VeJ7rVbhtkJHl20JcExRjOAP5n3NYF5OyDG5/bJYY/lVG4vGefd/CevJ5/Ss7UL+O0tJbq8wIkPCg8u3YCgDE+It+UtbXTQzb2bz5ASenRev4muCqxf3Ul9eS3Exy8jZ+noPwFV6AJIYmmfahQH/AG3Cj8yQKKjooAKKKKACtDSNWutKmL2rja3343GVce4rPooA9Y0HWLXW9v2WQQ3SjLW7Abv+Anow/WtsRup/fJg/7XBrw5GZHVkJVlOQQcEGu20Tx1OqrBrIaZMYFwgHmAe/97+dAH1b8K/irhbfRvFUgXACQX7t970WT0P+1+frWt8ZrS6dbS52NLYrgidSP3Z9DjsfWvnOyu1u7cXFjKbq2bjeOg9j6H2Nd34T+IuqaNpzaZfYvNJYFfKlBYoD2BPb2oASDUbq2k2MH8vtkHaa3E1aIwYlEbqeflPeum+D5sNaub7yolR4f3iJIgYYJ9DXqeoaFotzbkX2nWRjA5JiUY/HtQB4Ut6sqh3YbQMZ2nK1w+v+HtJ1jXVvbycSYx8seecduv6CvbPE/wAJjIryeF9SNqW5NtdZkjb2DfeA/OvG/EMGq+F9SWz1vS5Ip2G5WiIZX91PcUAaE80KhY0aMIoCqiofwFVPJV3Pkpubudh4rLfWJIyCYZfNPGwqDjPtXp3w+8Fal4lt47vVJjYWH/PNAPNk+n9360AcVb6ZPcTrbgyM0nC28aNLIfYKK9P8IfCpiY7rxAwgi4xaxtl2/wB5v4c8cL+Yr03QfD2l6DB5el2ccJIw8mMyP/vMeTU2s6tY6NZtdalcxwRDgFjyx9AO59hQBn6qIvDnh1l0iO2s4ohgblO1Rj73HU/Xr7186+IbptSv5ZzPNO+c+ZlgWOev0re8a+MbrxJfOskjW+mr/qoFcDI9W9TXODyUVdkf3uMgHn8aAN74VWb3fjCO6ZWUWi+cVB5PYdule5QzLp9vcTbWkuCSzbzgAdetfOWj6tJoesx6lp+2O4XKuGUbZF7qRnoa6PxL8RJdXtngt7JLLzcrJKZ9xY+g9BQBD478U3viW6NqkTSWkTkNlsI30GelYGm2/wBhl32ySWuDkCMFfyNSWe4K++a3UAfdHf1pTdgHZuKt17nHpmgD2n4beMhqv/Eq1GRjfxg+U79ZlA7/AO0OvuK6Xxhr0XhvQLnUZQGZMLEhz87noP6/hXzppsV/e+INNj0yaRLsTqwKdV2nOa7n463GoXEukQzL5FgMyNHv5Z843YHYf1oA4TXL+7168e71OX7TIxOVB3qvsBngVzrWKxySSInkoxwSqkY/GtRZ0bCIwZ2zn1xTb6eDyoPKjaRuVkO7jNAF/wALatFJaPHLNI8ifIqsPvY9z1rnNXkfU98bKkMcUhOMdzUNxcTG5RbaQxhezD+WKPMcKCmxevJYkk+4oAyJbExAqSjSem3qKpadssNUiuWV1CMGJjUgj6GumSWRgCWiKE4BU4Ofxpr7JEUtHuT3agD6d8GarZeKPDFukkSanYuoR/OQOM+jqf51ynjD9nnwH4gjka0099Gu2Hyy2DbVB94zlfyA+teR+D9ZvvB+oG80KSGJWOJbdnzFKM/xDPX3HrXvHhr4q6JqQWLVXXS7vjPmtmI/R+344oA+a/Gn7MvifRmabQ501q0HaJQkwH+4zAH6AmvG9T8PXum3ctteL5E0ZwyTKUcfUGv0zF9atZG7S5ha1C7vOVwUx65FfKXxs1ew8U+INtlaQmZWCrOijL9sE96APn3TvDd1fyxJDuPmEAFUJr6j+GP7M+iw2ltqPjGebUJpFEi2aHy41HUbiDk/TIrqPhZ8IbLTtPgutdfzr9lWWONcARD1xXtXyxRckKijkngACgDj5Ps3hg2Xh7wdpNrbvLyRFDiOFf7zY6n6mrOuzaF4T0641vX51JUfNNN8zO3ZUX1PYCuH8d/GbQvDJmsvDccWq6oSQzq/7hG/2n6tj0H5ivnPxf4i1zxTqQvfEN4LqUcRxkBY4h6Ko4H160AbPjzxtP4r1mfUfIFtCvy21uFb5U/2iO5rkWvZ921o13Hk8MCP/Huap3YigiMt0yW8PZmPXHZR1J+lc5feIgCy2EK9MebKoLfgOg/WgDp9Q1OKyh829xFkfLGpbdJ9Mn9a4bWtWn1W4DygJEnEcS9FH9T6mqU0rzSF5XLuepJzUdABRRRQBJA6xyBniSVR/C5IB/Ig0U1VLMFUZYnAFFADaKKKACiiigApaKKAL2k6reaTdefYTtE/Rh1Vx6MDwR9a73SPGVpfqI72NLW7IwGziJj/AOy15pxS4oA968L+J9T8K6zFqenjMi8EdY5F/unnoa+kvBPxb8NeKgtpcTLpupMMNa3ZAVj0wr/db6cH2r4G0vXdQ0xdkExaHvFINyfl2/Ct+LxbZXHGo6cykDrAwIz/ALp/xoA/RO3jls8xgtNbf8s+ctGPTnqPTv25rnfiN4Zi8UaSkAu4bS4Q70lkQHj056V8j+FfirdaCqDRvFF/axL/AMut2hlj6dgQwH4V6RaftA6pLaCKV/Dl05HLlip+u0t1/CgCPxL4PvfCtwJJ7uK5jcDEkL5H8s1q+Evic/hdHhntZtQjbACqdpX6HFee634r1HXbxrq7njkD/wDLOM7UHpgDisxZc87lHPXdz/OgD2XUfjbq99EyaXpUGm548yd/Oce4AAA/HNcZd6tc6lcyXOq3M17df35WJIz2A6KPYACuWhDuFAmxjn5cHP45q4om8tgXY84zkDJ+uaANc3MPDs2CegKjgflUbXiDLeYhB7gdPesiRZgWEhdjwTwSMfnVeRZyPlVwW5yBx+dAGv8AbIJXG513LznkD2zgVNBeoQqKy4X0UY/PFcuYrsKQH3hjnBNPWC9U4HTBzhuf5UAdYLpfmKs2Mc4GM/pUF1cxMsMKtskb5Mk4yfrj9KwYotSUqhRGXsxU1Nc6TfXsIN0VSBSGLEgAfU0AewfAiw+0eIr+e4lbfZxLsjJHzFs5bOO2P1rW/aJs400nTdTN3JFJHL9nES4+cMM5/DH618+nxWvh24SXTfEdvZ3KDaXtZjIxGeQdgOeneq/iD4sw6o0T6nd6jqzIPlRlCovuMnjP0oA1xd21rLGS6uhIAOCxyfftzStKo3GIKMtuGFPJ/CuIk+JVnlvL0EkH+9ddPySqj/EcsAp0eEKDkgTN/hQB3c9+67VZZSwJ+UjI/Omi7kL7jEyp13FyM/SuDHj6JvvadIvOflnzj8xUq+PLUrhra7Qeiup/pQB6AkwKhhvDA87X/LtSLdqAPMbdxgFien1rz4+NdPMiyfZ7wyKCFYleAcZ/kPyp3/CdWeP9Ten2yuKAO+W9QoQFBYerc/yqP+0dxAaNWXGM7uc/SuEPjiwIINrdj6OtRf8ACX6c6gPHeqfZEP8AUUAd4NRliY+WZAO6qxUfoear3F9CbmB3iI8tt27kZxzXDv4n0x8Efa1PvEv/AMVSDxJp+MGW4IJ5BiBGPzoA+hNP+NF3p0YFlYQTsVCs9xI3H0ArjvGnxD1/xSzJqWoywWjZ/wBDtCY4h9cct+JNeYHxPpiAbWuT7LCOPzaq9z4vswP3FhJK/ZpHCc/QZ/nQB00eAdsQYuOcHNYOteJobNmjtAtxcDgnJ2If6/hxXM6pr9/qIZJZfLhP/LKL5V/HufxrJoAsXt5cX05mu5nlkPGWPQeg9BVeiigAooooAKKKKACinxlA4MqsydwrYP54NFADKKKKACiiigAooooAKKKKAFBxS55ptFAD9w7iglTTKKAH4B70oTPcUyigCTym7AGkKMp5GKYCR0JpQ7f3jQBftdW1O1wLa+u4gP4VlYD8s1eHirXsDGpXPAx1H+FYfmP604MT3oA3/wDhMfEQ5/tK4PflVP8ASg+NfEWAP7VnGPQKP6Vg72Hc05JHOcsTQBqz+LNfm+/rF8P9yYr/ACxWZd311eEG8uZ7gjoZZC38zU0TEjk55qRvTjH0oAzc0E1oliCBxj6U0yEAYC/98igDPoq/LK4BIOD9KgeaTj5jzQBWpacZHPVj19abQAlFLSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFADkRnYKilmPQAZNFNooA/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan showing a loculated parapneumonic effusion (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charlie Strange, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_41_33439=[""].join("\n");
var outline_f32_41_33439=null;
